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ABSTRACT
The aim of this investigation was to characterize those 5-HT receptors 
present in three different tissues of the common garden snail. Helix aspersa, 
into one or more of the categories already described for vertebrate 5-HT 
receptors. Specific 5-HT receptor agonists and antagonists which had been 
developed and used to help characterize, and subsequently classify, the various 
types of 5-HT receptor in vertebrates, were utilized in this study. The three 
preparations from H elix  included: i) identified neurones in the visceral 
ganglion ii) the heart and iii) the pharyngeal retractor muscle (PRM).
The action of 5-HT on identified neurones in the visceral ganglion was 
studied using the electrophysiological techniques of both voltage- and current- 
dam p. Under voltage-dam p conditions the response of the identified  
neurones to iontophoretic application of 5-HT was seen to be an inward 
current of approximately 3-10 nA. Under current-damp conditions the 
response to 5-HT was an excitatory depolarization leading to the firing of 
action potentials of approximately 3-15 mV. Both responses showed rapid 
desensitization to repetitive applications of 5-HT and were blocked by 
tubocurarine. No specific 5-HT receptor antagonist to this 5-HT response in 
Helix neurones was found. The action of 5-HT was mimicked by 5-CT and a- 
Me-5-HT both of which showed similar-sized responses to 5-HT, whereas 
sumatriptan gave smaller responses than those of 5-HT.
5-HT had a positive inotropic effect on the heart. The excitatory action 
of 5-HT on the heart was studied using an organ bath methodology with 
application of the 5-HT receptor agonists and antagonists at suitable 
concentrations. N o specific 5-HT receptor antagonist was found for the 
cardioexcitatory effect of 5-HT. The full rank order of potency for the 5-HT 
receptor agonists tested was 5-HT > methylergometrine = ergotamine = 5-CT > 
a-Me-5-HT = sumatriptan > methysergide -  2-Me-5-HT = tryptamine > 8-OH- 
DPAT.
5-HT caused relaxation in the PRM and was found to inhibit, in a dose- 
dependent manner, acetylcholine (ACh)-induced contraction in the muscle. 
This inhibition of ACh-induced contraction by 5-HT in the PRM was studied 
using an organ bath methodology with application of 5-HT receptor agonists
and antagonists at suitable concentrations. N o specific 5-HT receptor 
antagonist for the inhibition of ACh-induced contraction was found. The 
rank order of 5-HT receptor agonist potency was 5-HT > 5-CT > sumatriptan = 
ergotamine = methysergide »  a-Me-5-HT = 2-Me-5-HT.
The effect of 5-HT on cyclic adenosine 3',5'-monophosphate (cAMP) 
levels within Helix heart and pharyngeal retractor muscle (PRM) tissue were 
monitored in this investigation. 5-HT caused a dose-dependent increase in 
cAMP both in Helix heart and PRM tissue.
The 5-HT receptors within Helix are not readily characterized into any 
of the categories of 5-HT receptor that have been already classified in 
vertebrates: Helix 5-HT receptors appear to be unique in the fact that they are 
unclassifiable in terms of the vertebrate 5-HT receptor classification. The 
evidence presented in this investigation is discussed in terms of the molecular 
biology of receptors: this includes the hypothesis that the 5-HT receptors 
particularly in Helix heart and PRM tissue could be related to a family of G- 
protein-coupled receptors whereas the neuronal 5-HT receptors in Helix are 
more likely to be integral to an ion channel.
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MOLECULAR STRUCTURES OF SOME OF THE RELEVANT 5-HT 
AGONISTS AND ANTAGONISTS
The following pages give the structures of the most frequently used 5-HT 
compounds in the present study. The structures were calculated with the 
CAChe molecular modelling system (Tektronix). The compounds include 
5-HT, 5-CT, tryptamine, a-M e-5-H T, 2-Me-5-HT, m ethysergide, LSD, 
ketanserin and ondansetron. The atoms in each of the structures are labelled: 
C for carbon, H for hydrogen, O for oxygen, N  for nitrogen, F for fluorine and S 
for sulphur. The small black dots, attached to some of the atoms, indicate lone 
pairs of electrons. My sincere thanks to Dr. Colin Thomson who kindly gave 
up his time to help me optimize the structures of these compounds with this 
molecular modelling programme.
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CHAPTER ONE 
GENERAL INTRODUCTION
Historical perspective
5-hydroxytryptamine (5-HT) or serotonin, as it is also known, is one of 
the biogenic amines. However, unlike dopamine and noradrenaline which 
are catecholamines, 5-HT is derived from an indole nucleus and is therefore 
classified as an indoleamine.
Physiologists of the 19th century were aware of a substance in the blood 
serum that caused constriction of blood vessels and increased vascular tone. 
In the late 1940s, investigators were successful in isolating this serum-born 
substance, and named it serotonin (Rapport et aL, 1948). They later deduced 
that the active com ponent of their crysta llin e  com plex was 
5-hydroxytryptamine (Rapport, 1949). About the same time, a group of Italian 
workers had been investigating a substance found in high concentrations in 
enterochromaffin cells of the intestinal mucosa in the gut which they had 
called enteramine (Erspamer, 1940). Enteramine also occurred in the skin and 
salivary glands of lower animals such as toads, salamanders and octopuses. 
Erspamer and Asero (1952) w ent on to identify enteramine as being 
5-hydroxytryptamine, identical to serotonin.
The distribution and possible roles of 5-HT
5-HT has a unusual distribution in nature and is not confined to 
vertebrates. Jacques and Schacter (1954) discovered 5-HT in the venom of the 
wasp, Vespa vulgaris, and it has been found in a number of fruits including 
bananas (Udenfriend et a l ,  1959) and in the stinging apparatus of the nettle 
Urtica dioica (Brittain and Collier, 1957). It was found in the enterochromaffin 
cells of the intestine in all classes of vertebrates and in blood platelets and mast 
cells in mammals. Extensive listings of such occurrences have been given by 
Erspamer (1954).
The presence of 5-HT in the vertebrate central nervous system (CNS) 
was demonstrated first by Twarog and Page (1953). At that time, interest in 
5-HT was also greatly increased by its discovery in the nervous system of the 
dog (Amin et a l ,  1954). In the early 1960s, a group of Swedish scientists made
an influential and important discovery in the history of 5-HT research. Using 
the Falck-Hillarp technique (Falck et a l ,  1962) to visualise 5-HT within cells, 
with formaldehyde-induced fluorescence, they found that virtually all the 
5-HT-containing neurones of the CNS of the rat were located in discrete 
clusters within the midbrain, pons and medulla (Dahlstrom and Fuxe, 1964). 
Over the years improvements in techniques have helped to define more 
clearly the locations of serotonergic cell bodies, fibres and terminals.
5-HT has been found to have multiple actions in the vertebrate nervous 
system. It affects sensory, motor, autonomic and enteric neuronal activity as 
well as influencing vascular and other smooth muscle responses. Within the 
CNS, 5-HT seemed to function in both an inhibitory and excitatory manner. 
In contrast, in the periphery, 5-HT has mainly excitatory postsynaptic actions 
on autonomic and enteric nervous system neurones, as well as producing 
contraction of the uterus, ileum  and vasculature smooth muscle (see 
Vandermaelen, 1985).
The first systematic survey of the occurrence of 5-HT in invertebrates 
was undertaken by Welsh and Moorhead (1960). Using the fluorescence 
method to estimate the 5-HT content of nervous and non-nervous tissue from 
a variety of invertebrates, large amounts of 5-HT were detected both in 
annelids and molluscs. Although Welsh and Moorhead (1960) showed that 
5-HT is w idely distributed in both nervous and non-nervous tissues, they 
were not able to locate it in specific cell types. With the introduction of the 
Falck-Hillarp fluorescence microscopy technique (Falck et ah, 1962) for 
visualizing indoleamines and catecholamines in single cells and nerve tracts, 
it was possible to identify specific amine-containing cells. A further 
refinement was the introduction of biochemical techniques whereby the 
amine content of single neurones could be established quantitatively. Since 
then there have been many studies of the localization and possible function of 
5-HT in a wide range of invertebrates, particularly in the molluscs.
5-HT has potent actions on many invertebrate tissues but it was the 
molluscan heart, particularly that of the quahog clam, Mercenaria mercenaria, 
which was the first tissue to be examined in detail with respect to the identity 
of the 5-HT receptor (Greenberg, 1960a). In most cases the major action of 
5-HT was one of excitation but there were clear examples where 5-HT was
Endogenous 5-HT was shown to be released from the cerebro-buccal 
ganglionic ring of Aplysia (Gerschenfeld et ah, 1978). They demonstrated that 
the rate of spontaneous release of 5-HT varied between 0.4 and 1.2 pmol/hour. 
Direct stimulation of the gaint 5-HT-containing cerebral neurones resulted in 
an 80-100% increase in the release of 5-HT but only in the presence of 
chlorimipramine, a 5-HT uptake blocker.
The best evidence for 5-HT as a central transmitter comes from work on 
gastropods such as Helix (Cottrell and Macon, 1974) and Aplysia (Gerschenfeld 
and Paupardin-Tritsch, 1944a,b). It is the giant 5-HT-containing cerebral 
neurones in these gastropods which have been the subjects of extensive
basically inhibitory, e.g. on the heart of Modiolus  (Wilkens and Greenberg,
1973). At molluscan peripheral sites, 5-HT was not always found to be 
excitatory. Twarog and Cole (1972) found that 5-HT acted as a relaxing agent at 
the anterior byssus retractor muscle (ABRM) of Myti lus  and was released at 
this site following nerve stimulation (Satchell and Twarog, 1978). 5-HT has 
also been shown to have a relaxing action of the penis retractor muscle 
(Wabnitz and von Watchendonk, 1976) and of the pharyngeal retractor muscle 
(PRM) (Lloyd, 1980a) of Helix.
Evidence for 5-HT as a transmitter in molluscan ganglia
The idea that 5-HT is a neurotransmitter in invertebrates had been 
proposed by Welsh (1954). His study with Moorhead (1960) had yielded  
important data on 5-HT levels in the nervous tissue of invertebrates with 
particularly high 5-HT levels in both annelids and molluscs. 5-HT has been 
demonstrated histochemically in the nervous systems of Helix,  Anodonta , jBu cc in ium  and Limax  (Dahl et ah, 1966, Sedden et ah, 1968, Osborne and 4 
Cottrell, 1971). The levels of 5-HT in identified neurones of Tritonia  and 
Aplysia  ganglia were found to be between 4 and 6 pm ol/ cell body (Weinreich 
et ah, 1973). The synthesis of 5-HT from its precursor tryptophan has been 
demonstrated using identified neurones in Aplysia (Eisenstadt et ah, 1973). In 
their study [^H] tryptophan was pressure-injected into nerve cell bodies. 5-HT 
synthesis was found to be specific for the 5-HT-containing neurones since the 
pressure-injection of labelled tryptophan into cholinergic neurones produced 
only a negligible amount of 5-HT.
studies. These cells were first noted in Helix pomatia by Kunze (1921) and 
were then characterized electrophysiologically and according to their input 
properties by Kandel and Tauc (1966a,b). More general interest in these 
neurones was developed by Cottrell and Osborne (1970) who demonstrated 
that, in both Helix and Limax,  these neurones contained significant amounts 
of 5-HT. Cottrell (1970) went on to show that these glo^nt 5-HT-containing 
neurones in Helix provided excitatory inputs to three identified neurones in 
the ipsilateral buccal ganglion, which were subsequently labelled anterior, 
middle and posterior. It was this pathway in Helix pomatia which was studied 
with electrophysiological methods by Cottrell and Macon (1974) to provide 
further evidence of a transmitter role for 5-HT. In their study, stimulation of 
the giant 5-HT-containing cerebral neurones evoked excitatory post synaptic 
potentials in the middle buccal cell. Repetitive stimulation of the cerebral 
neurones caused summation of these excitatory post synaptic potentials, 
giving rise to an action potential. Iontophoretic application of 5-HT onto the 
middle buccal neurone produced a depolarizing response which was shown to 
be sodium-dependent and could be antagonized by morphine. Reserpine 
which depletes 5-HT in the cerebral 5-HT-containing neurone, reduced but not 
completely abolished the efficacy of transmission between this neurone and 
the middle buccal neurone.
Evidence for 5-HT as a transmitter in molluscan hearts
Evidence for a role for 5-HT as the excitatory transmitter in molluscan 
hearts came from a study by Loveland (1963), on Mercenaria heart. 
Methysergide antagonized the response of the heart not only to applied 5-HT 
but also to stimulation of the accelerating nerve to the heart. Loveland also 
used the Falck and Hillarp fluorescence histochem ical technique for 
visualisation of m onoam ine-containing neurones. He made stretched 
preparations of the atria with attached portions of ventricle. After drying at 
room temperature, with subsequent exposure to formaldehyde vapour, 
microscopic observation with ultra-violet (UV) light revealed a yellow  
fluorescing cardiac nerve passing through each atrium and terminating in the 
adjacent lateral regions of the ventricle. This yellow fluorescence was thought 
to be due mainly to the presence of 5-HT although the presence of other 
amines, particularly the catecholamines which also gave off a yellow  
fluorescence, could not be eliminated.
That 5-HT served as a mediator for cardio-excitation in molluscs was 
probable. H ow ever confirmation of the release of 5-HT from the 
cardioregulatory nerves had to be achieved. A two Helix heart/L oew i-type  
experiment was set up by S-Rozsa and Perenyi (1966) in order that the release 
of 5-HT from the cardioregulatory nerves might be demonstrated. On 
stimulation of the nerve going to one heart, the perfusate from this first heart 
was found to contain material which activated the second heart. 5-HT was 
subsequently detected in the perfusate both by spectrophotometric and 
chromatographic techniques.
Evidence for 5-HT as a transmitter in molluscan visceral and smooth muscle.
The other molluscan tissues where the action of 5-HT has been well 
investigated are the somatic and visceral muscles. These have included 
ABRM of M yti lu s ,  the penis retractor muscle of Helix and Strophocheilos and 
the PRM of Helix. The visceral muscles which have been investigated include 
the rectum of Mercenaria and Tapes and the crop of Helix.
There is substantial evidence for 5-HT as a neurotransmitter mediating 
relaxation at the ABRM in Mytilus.  5-HT was found to mimic the effects of 
stimulating the relaxing nerves. When the muscle was exposed to 5-HT at 
concentrations >lnM , relaxation of catch contraction in the muscle was 
proportional to the log%g of 5-HT concentration (Twarog ,1954). Von 
Watchendonk and Kappler (1977), using liquid scintillation counting and 
microchromatography, found 5-HT levels up to 4.3|ig.g"^wet weight for the 
ABRM. 5-HT was also released from the ABRM during stimulation of the 
pedal ganglion (Satchell and Twarog, 1978). Relaxation from either ACh- or 
electrically-induced contraction was faster following prolonged stimulation of 
the muscle (York and Twarog ,1973); another indication of the release of 5-HT 
from the nerves supplying the muscle. The pharmacological evidence for 
5-HT as a transmitter in the ABRM was less extensive. LSD and ergometrine 
relaxed the ABRM while other ergot derivatives showed no relaxant action i 
(Twarog, 1959). Northrop (1964), reported that methysergide blocked neural 
relaxation in the ABRM, while 2-Bromo-LSD was also observed to delay 
neural relaxation in the ABRM presumably by acting as a competitive 
inhibitor of 5-HT (Bullard, 1967). The organic mercurial, mersalyl, effectively
blocked both the response to 5-HT in the ABRM and the relaxant effect |
induced by inhibiting nerve stimulation. The blocking action of mersalyl was j
thought to be attributable to its combination with a sulphydryl group at or j
near the receptor site to which the indole nitrogen of 5-HT attached (Twarog et j
a l ,  1977). j
Evidence was accumulating also for the involvem ent of 5-HT in j
neuromuscular transmission in the Helix penis retractor muscle. The j
presence of 5-HT was confirmed by von Watchendonk and Kappler (1977), 1
w ho found 5-HT levels of 3.2p,g.g"fwet weight. W abnitz and von j
1Watchendonk (1976) showed that 5-HT relaxed the muscle and reversed tonic |
contractions induced by ACh. In contrast, a study of the penis retractor of Ij
another snail, Strophocheilos oblongus, showed that the muscle was excited by |
5-HT. At lower concentrations 5-HT relaxed the muscle (Jaeger, 1963). LSD |!
activated the muscle while 2-Bromo-LSD caused relaxation and antagonised |
the action of 5-HT. The pharyngeal retractor muscle (PRM) of Helix was also |
sensitive to 5-HT. Kerkut and Leake (1966) found that 5-HT increased the rate |Iof relaxation of the muscle following electrical stimulation of the brain. In an i]■iearlier study, Kerkut and Cottrell (1962) had found that 5-HT increased the rate |'i|of relaxation following contractions with ACh, |
Studies on the actions of 5-HT have not been limited solely to the ‘
molluscan somatic muscles but have also focused on the molluscan visceral J
;jmuscles. Greenberg and Jegla (1963) investigated the actions of 5-HT on the |Irectum of Mercenaria. 5-HT excited the rectum, inducing rhythmical activity |
at lower concentrations, while at high concentrations 5-HT increased the tone i|Iof the rectum. !i:3
'IInactivation of 5-HT within molluscs
5-HT was known to be inactivated by the enzyme, monoamine oxidase 
(MAO) in tissues such as the mammalian CNS (see Werman, 1966). This 
inactivation mechanism might also extend to invertebrates because MAO has 
been shown in molluscan muscle (Blaschko and Hope, 1957). It was likely that 
also 5-HT was partly inactivated by presynaptic uptake because an imipramine- 
sensitive uptake mechanism was found to exist in an excitatory 5-HT- 
mediated synapse within Helix  ganglia (Cottrell, 1971). Further studies on
5-HT uptake were carried out on the Helix brain by Stahl et al. (1977). They 
found that 5-HT was taken up by an active transport process which required 
extracellular sodium and was inhibited by 1-1 OmM ouabain. These studies 
indicated that several different mechanisms existed within the molluscs for 
the inactivation of 5-HT, the particular pathway depending upon the tissue in 
which the inactivation of 5-HT was taking place.
Multiple 5-HT receptors
The concept of multiple receptors for 5-HT was advanced first by 
Gaddum and Picarelli (1957) for the guinea pig ileum. They classified the 
receptors for 5-HT as M and D, based upon pharmacological studies in isolated 
segments of ileum. The D receptor, sited in the smooth muscle, was blocked 
by dibenzyline whereas the M receptor found in neuronal tissue was blocked 
by morphine. The existence also of multiple 5-HT receptors in the vertebrate 
brain had been suggested by electrophysiological studies in cat cerebral cortex, 
where the m icroiontophoresis of 5-HT produced either excitation or 
inhibition in the population of neurones tested (Roberts and Straughan, 1967). 
In their study, methysergide, LSD and cianserin blocked the excitatory but not 
the inhibitory effects. On the basis of these data, Roberts and Straughan (1967) 
proposed that there may be both excitatory and inhibitory types of 5-HT 
receptor in the brain. A similar multiple excitatory and inhibitory receptors 
concept was proposed for the invertebrate nervous system based on the 
diverse electrophysiological actions of 5-HT at several synaptic junctions in 
Aplysia and Helix by Gerschenfeld and Paupardin-Tritsch (1974a).
Peroutka and Snyder (1979) presented evidence for two distinct 5-HT 
binding sites for which LSD had a high affinity. At one site, termed 5-HT%, 
5-HT had a high affinity while at the other, termed 5-HT2, spiperone had a 
high affinity. Subsequent investigations have, however, revealed a far greater 
complexity, with at least five subtypes of 5-HT% recognition sites (termed 
5-HT%^, 5-HT%g, 5-HT%(2, 5-HT|p> and 5-HT%p) being demonstrated to date 
(see Peroutka, 1988; Leonhardt et ah, 1989). Furthermore there was also a 
suggestion of possible heterogeneity, or multiple affinity states, within the 
5 -HT2 category (McKenna and Peroutka, 1989). In an attempt to reconcile 
these differing terminologies introduced by Gaddum and Picarelli (1957) and 
Peroutka and Snyder (1979), Bradley et al. (1986) proposed a new classification
and nomenclature for functional 5-HT receptors, based upon data obtained 
from isolated peripheral tissues. A comparison of the pharmacological 
profiles of the 5-HT2 recognition site and the D receptor led to the conclusion 
that the two were essentially identical. The so-called D receptor therefore 
became redundant in favour of the more prevalent term 5-HT2 . The category 
"5-HT%-like" was introduced to include those functional receptors which 
demonstrated pharmacological similarities to the heterogeneous 5-HT% 
binding sites described for the CNS, and the M receptor was incorporated into 
a newly defined 5-HT3 class. The central binding site equivalent of the 5-HTg 
receptor (Kilpatrick et a l ,  1987) emerged subsequent to the recommendations 
of Bradley et ah (1986), along with the discovery of further subtypes of 5-HT 
receptor such as 5-HT4 (Clarke et al., 1989). The scheme developed by Bradley 
et al. (1986) stressed the role of functional responses and the use of potent 
selective and competitively acting receptor antagonists, and, to a lesser extent, 
agonists in the classification of 5-HT receptors.
Specific agonists and antagonists for the different 5-HT receptor types
The 5-HT% like group of functional receptors is the least well-defined 
because there are, as yet, no selective antagonists available. Some 5-HT2 
receptor antagonists, such as methysergide and methiothepin, have been 
found to have appreciable affinity for the 5-HT% binding sites and were found |
not to discriminate between the various 5-HT% subtypes or 5-HT%-like 1
r ecep to r-m ed ia ted  resp o n ses  (P eroutka and S n yd er, 1979). j
5-carboxamidotryptamine (5-CT) was found to be a selective agonist and, at |
most 5-HT|-like receptors, 5-CT was either equipotent or more potent than j
5-HT (Bradley et ah, 1986). Selective agents have been defined for the four j
5-HT% subtypes; 8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) |
(5-HT%/^), propranolol (5-HT%g), cyanopinodolol (5-HT%/^ and 5-H T ig), j
m esulergine (5 -H T ic)/ metergoline (5-HT%(] and 5-HT%%)), rauwolscine ■
(5-HT|p)) and yohimbine (S-HT^a  and 5-HT|p)) (see Peroutka, 1988). Another 1
selective agonist at some 5-HT%-like receptors, particularly those in the J
vasculature, is sumatriptan (Humphrey et al., 1988). j
Functional 5-HT2 receptors were identified by the potent blocking action 
of ketanserin (Bradley et al., 1986). Humphrey and Feniuk (1987), have
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suggested that a-Methyl-5-HT was a useful selective agonist for identifying 
5-HT2 receptors.
Until seven years ago no satisfactory antagonist of the 5-HTg receptors 
was available. Early investigations demonstrated blockade of 5-HT3 receptor- 
mediated responses by metoclopramide, quipazine and cocaine. MDL 72222 
and ICS 205-930, the first potent and selective 5-HT3 receptor antagonists, were 
recognised in the mid-1980s (Fozard, 1984c; Richardson et al,, 1985). These 
were follow ed by other selective 5-HT3 antagonists, which included
ondansetron (Butler et a l ,  1988), and 2-Methyl-5-HT proved to be a selective
5-HT3 receptor agonist (Richardson et a l ,  1985).
5-HT actions at the molecular level in vertebrates
Recently three 5-HT receptor subtypes, 5-HT%Q 5-H T |a  aiid 5-HT2 have 
been cloned by three different laboratories. All three receptors are single 
subunit proteins and members of the G-protein receptor super family. This 
receptor family was characterized by the presence of seven transmembrane 
domains for each receptor and the ability to activate G-protein-dependent 
processes, including activation or inhibition of adenylate cyclase activity and 
activation of phosphoinositide turnover (Hartig, 1989). Activation of 5-HT2 
and 5-H T ic receptors increased the activity of phopholipase C in hydrolysing 
phosphatidylinositol. The resulting diacylglycerol and inositol triphosphate 
products caused subsequent cellular responses. Agonists at 5-HT%A receptors 
led to the activation of a different G-protein which inhibited adenylate cyclase 
activity (see Pierce and Peroutka, 1989). 5-HT%g and 5-HT%p) were proposed to 
be equivalent receptors in different species, with the 5-HT%Q receptor being 
possibly a recent evolutionary derivation of the 5-HT%g receptor (Hoyer and 
Middlemiss, 1989). Both these receptors have been shown to be linked to the 
inhibition of adenylate cyclase at the cellular level (see Pierce and Peroutka, 
1989). In contrast to the 5-HT% receptor subtypes, the novel 5-HT4 receptor has 
been shown to be positively linked to cyclic adenosine 3',5'-monophosphate 
(cAMP) production, not only in guinea pig hippocampus but also for human 
atrial tissue and mouse colliculus neurones (Clarke et a l ,  1989; Kaumann et 
a l ,  1989). It has also been shown recently that 5-HT3 receptors are ligand-gated 
cation channels. 5-HT caused the opening of discrete channels in outside-out
patches of membrane excised from guinea-pig submucous plexus neurones 
(Derkach et al., 1989; Lambert et ah, 1989).
5-HT actions at the molecular level in molluscs
The second m essenger concept of hormone or transmitter action, 
involving adenylate cyclase, which had been developed by Sutherland and 
Robison (1966), had been well established in the control of certain biochemical 
processes in vertebrates. Furthermore Mansour et al. (1960) had shown that 
adenylate cyclase of the liver fluke, Fasciola, could be activated by 5-HT. The 
existence of various transmitter-sensitive adenylate cyclases implied that 
transmitters might act through the alteration of cAMP, which was itself 
formed from adenosine triphosphate (ATP) by the membrane-bound  
adenylate cyclases. Cyclic AMP-dependent protein kinase activity had been 
shown in a wide range of invertebrates (Kuo and Greengard, 1969). The latter 
authors suggested that a variety of actions attributable to cAMP was mediated 
by the single reaction mechanism of phosphorylation of protein kinases, 
which itself increased their activity.
5-HT had been implicated in the activation of cyclic nucleotides in 
many invertebrate tissues: for example in neurones of Helix ,  5-HT could 
induce an inward current which was associated with a decrease in potassium  
conductance (Deterre et a l ,  1982). This response could also be induced by 
cAMP and dopamine. When the response to one compound was maximal, in 
terms of inward current, the response to the other two was blocked. This 
indicated that 5-HT and dopamine activated adenylate cyclase via two distinct 
receptors, although it was not possible to find specific antagonists for 5-HT and 
dopamine.
The distribution of receptors for 5-HT and dopamine in Aplysia and  
Helix tissues was studied using [^H]LSD binding and adenylate cyclase 
stimulation techniques (Drummond et al., 1980a,b). Using [^HJLSD they 
identified dopamine and serotonin receptors in a particulate fraction derived 
from Helix CNS. These authors concluded that, in gastropod tissues, 5-HT- 
sensitive pH]LSD binding was related to a 5-HT receptor coupled to adenylate 
cyclase. In a subsequent paper, Drummond et al. (1980b) found that there was 
a high level of specific [^HjLSD binding in all the examined ganglia and
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nerves. The ability of 5-HT and dopamine to inhibit [H^]LSD binding varied 
depending on the tissue; in muscle most of the binding was sensitive to 5-HT 
whereas in the nervous system the ganglia contained up to 50% dopamine 
sensitive binding. The IC50 values (concentration required to inhibit 50% of 
the binding) for A p ly s ia  CNS and gill muscle and Helix CNS have been 
compared with data from the rat CNS (Bennett and Snyder, 1976), and found 
to be remarkably similar.
Adenylate cyclase was found in Spisula solida heart and 5-HT 
stimulated this enzym e (Cottrell and Osborne, 1969). In heart muscle 
microsomes of a molluscan bivalve, Macrocallistra nimhosa, 5-HT and cAMP 
both stimulated phosphorylation of microsomal calcium uptake (Higgins and 
Greenberg, 1974). 5-HT and cAMP induced a similar increase directly. Higgins 
and Greenberg suggested that 5-HT increased intracellular cAMP and altered 
the amount of calcium available for contraction, whereas cAMP mediated the 
action of 5-HT, either by phosphorylation and subsequent activation of the 
protein kinase or by direct activation of calcium uptake.
cAMP was also implicated in having a second messenger function in 
molluscan smooth muscle. Cole and Twarog (1972) suggested that cAMP was 
involved  in the 5-HT-induced catch relaxation of the ABRM. An 
investigation by Achazi et a l  (1974), of the cAMP system in the molluscan 
ABRM, showed an increase of cAMP levels following application of 5-HT. 
The possible involvement of cAMP in the effect of 5-HT within the different 
molluscan tissues will be discussed at greater length in the relevant chapters.
Aims of the present study
From the evidence presented here, 5-HT has potent actions on 
molluscan tissues and it is within this phylum that a transmitter role for 5-HT 
has been established most clearly. Very few studies of the action of 5-HT on 
nervous and non-nervous tissue have focused on the nature of the receptor or 
receptors responsible for the 5-HT effect seen in these tissues. The molluscan
5-HT receptor(s) has not been well characterized in contrast to those of 
vertebrates. This lack of characterization of molluscan receptors can, in part, 
be attributed to the fact that the demands of modern medicine have led to the 
development of specific 5-HT agonists and antagonists in vertebrates, with a
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commercial view to drug development. As a consequence, investigations into 
the invertebrate, and in particular the m olluscan, 5-HT receptor 
characterization have been overlooked in favour of the more financially 
rewarding vertebrate 5-HT receptor studies. Invertebrate research by 
physiologists has, therefore, concentrated on the mechanism of action of 5-HT 
rather than the 5-HT receptor itself. In the present study an attempt was made 
to characterize the 5-HT receptor for three preparations from the common 
garden snail. Helix aspersa. This was achieved using previously developed 
specific 5-HT agonists and antagonists: these have helped, not only in the 
characterization of the different 5-HT receptors in vertebrates, but also in their 
classification. The three preparations that were utilised in this study were 
(i)identified cells in the visceral ganglion, which showed a fast depolarising 
response to 5-HT, (ii)the isolated heart, which showed a positive inotropic and 
chronotropic response to 5-HT and (iii)the isolated pharyngeal retractor 
muscle (PRM), which showed a relaxant response to 5-HT. The 5-HT receptor 
of Helix  heart was studied using a standard organ bath technique with the 
specific 5-HT agonists and antagonists being bath-applied at suitable 
concentrations. The same method was used to study the 5-HT receptor 
m ediating relaxation, or, in this case, inhibition of acetylcholine (ACh) 
induced contraction in Helix PRM. In the latter two cases the effect of 5-HT on 
levels of cAMP was also investigated in order to give a clearer insight into the 
mechanism of action of 5-HT at the receptor. The 5-HT receptor in identified 
cells of Helix  visceral ganglion was studied using the electrophysiological 
techniques of current- and voltage-clamp. Each preparation is described 
separately with each chapter including a separate introduction, methods and 
materials, results and discussion sections. The final chapter includes a general 
discussion in order to compare and contrast the conclusions drawn from each 
previous chapter.
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CHAPTER TWO 
THE 5-HT RECEPTOR IN IDENTIFIED HELIX NEURONES 
INTRODUCTION
The 5-HT receptor in molluscan ganglia
Electrophysiological evidence: The molluscs, and in particular gastropods 
such as Aplysia  and Helix, offer ideal preparations for neurobiological studies 
since they possess nervous systems with large neurones which can be easily 
identified from preparation to preparation. Many of these identified neurones 
have also been shown to contain 5-HT as discussed earlier. With the 
development of electrophysiological methods,, such as the single electrode 
circuit which allows for both current and voltage recording with a single 
electrode (Wilson and Goldner, 1975), 5-HT has been shown to have potent 
actions on many central gastropod neurones. Electrophysiological studies of 
neurones in the abdom ino-visceral ganglionic mass of a gastropod. 
Cryptophallus aspersa, showed that 5-HT depolarized the neurones through a 
selective increase of their membrane perm eability to sodium  ions 
(Gerschenfeld and Stefani, 1966, 1968). They postulated that the 5-HT receptors 
were located at or near the axon hillock. These 5-HT receptors could be 
blocked by LSD and its derivative Bromo-LSD, dibenamine, morphine and 
tryptamine. In a later study of the central ganglia of Helix  aspersa,  
Gerschenfeld (1971) distinguished 5-HT inhibition mediated via two different 
mechanisms. 5-HT B receptors inhibited neurones by causing a selective 
increase in potassium  permeability whereas 5-HT C receptors caused 
inhibition by selectively increasing the membrane permeability to chloride 
ions.
There is now evidence to suggest six different types of response, within 
molluscan neurones, to the iontophoretic application of 5-HT (Gerschenfeld 
and Paupardin-Tritsch, 1974a). These workers found that the iontophoretic 
application of 5-HT onto Helix  and Aplysia  neurones caused three different 
types of excitation. 5-HT could also evoke three kinds of inhibition. Table 2.1 
overpage, taken from their paper, summarizes these 5-HT responses.
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TABLE 2.1 Summary of different types of 5-HT response of ganglionic
Response Effect Reversal
Potential(mV)
Ionic mechanism
A Fast
depolarisation
O Increase in sodium  
conductance
A' Slow
depolarisation
O Increase in sodium  
conductance
B Slow hyper­
polarisation
-75 Increase in 
potassium  
conductance
C Fast hyper­
polarisation
-56 Increase in chloride 
conductance
a Depolarisation -75 Decrease in 
potassium  
conductance
P Hyper­
polarisation
-30 Decrease in sodium  
and potassium  
conductance
The reversal potential values for A and A' were estimated by extrapolation 
(Taken from Gerschenfeld and Paupardin-Tritsch, 1974a).
Four of the responses which they labelled A, A', B and C were 
consequent upon an increase in membrane conductance while the other two, 
labelled a  and P, were caused by a decrease in membrane conductance. Four 
distinct receptors involved in the 5-HT responses associated with conductance 
increases were characterized by the action of specific antagonists. These data 
are summarized in Table 2.2 overpage.
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TABLE 2.2 Pharmacological profile of four 5-HT responses of Helix  and
Antagonist A A' B C
Tubocurarine block none none block
LSD block none block block
Tryptamine block none block block
7-Methyl-
tryptamine
block none none none
Bufotenine block block block none
5-Methoxy-
gramine
none none block none
N eostigm ine none none none block
The block was obtained with lOjiM antagonist (Taken from Gerschenfeld and 
Paupardin-Tritsch, 1974a).
7-Methyltryptamine blocked only the A-receptors, 5-methoxygramine 
only the B-receptors and neostigmine only the C-receptors. Curare was found 
to block the A- and C-receptors while bufotenine the A-, A'- abd B-receptors. 
N o specific antagonists were found for the 5-HT responses caused by 
conductance decreases.
In a subsequent paper Gerschenfeld and Paupardin-Tritsch (1974b) 
studied the connexions made by a pair of gaint neurones, in Aplysia  cerebral 
ganglia, to neurones situated in the ipsilateral buccal ganglion in order to 
investigate the possible physiological roles for the 5-HT responses they had 
previously described in the preceding paper. They found that of the six 5-HT 
responses, at least four intervened in the generation of synaptic potentials i.e. 
5-HT released from a single neurone was then able to mediate opposite 
synaptic actions on different buccal cells : excitation associated with sodium  
conductance increases and inhibition resulting from an increase in potassium  
conductance.
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An alternative approach to attempt to analyze the gastropod central 
5-HT receptors in terms of the mammalian central classification into 5-HT% 
and 5-HT2 as proposed by Peroutka and Snyder (1979) was undertaken by 
Bokisch et a l  (1983). The 5-HT excitatory type A response was used as the 
standard 5-HT response. RU 24969, a potent 5-HT% receptor agonist was tested 
together with MK 212, a preferential 5-HT2 agonist. MK 212 had clear agonist 
activity but it was 60-70 times less potent than 5-HT. In contrast RU 24969 had 
no clear agonist action. In this study MK 212 was also observed to be a specific 
antagonist of 5-HT. RU 24969 was also found to possess 5-HT antagonist 
activity though it was much less potent than MK 212. These data implied that 
the Helix excitatory type A receptor appeared to be similar to the mammalian 
5-HT2 receptor.
The structural requirements for the molluscan 5-HT receptors has not 
been fully determined but there are indications that in binding the 5-HT 
molecule the 5-hydroxy group, the indole nucleus, the length of the side chain 
and its charged nitrogen group have vital importance (Walker and Woodruff, 
1972, Walker, 1985).
Electrophysiology of 5-HTg receptors in neuronal cell lines
Cells of the murine neuroblastoma cell line, NIE-115, responded to 
locally applied 5-HT with a rapid membrane depolarisation associated with a 
conductance increase to monovalent cations (Peters and Usher wood, 1983). 
Both the 5-HT-induced depolarisation and the transient inwar(i current which 
underlay it, seen under voltage-clamp conditions, were blocked by selective 
5-HT3 antagonists but were unaffected by antagonists acting at 5-HT%-like or 
5-HT2 receptors. The responses to iontophoretically applied 5-HT were rapidly 
desensitized (Nejit et ah, 1988). The reversal potential obtained from the 
current-voltage curve of the peak amplitude of response in the NIE-115 cell 
line was 20mV (Nejit et a l ,  1989), while the reversal potential of the 
neuroblastoma x Chinese hamster brain cell line, NCB-20, was -2mV (Lambert 
et ah, 1989). This rapid depolarizing response to 5-HT, which was due to a 
transient inward current in these neuronal cell lines, was mediated by 5-HT3 
receptors. However, the response to 5-HT observed in these cell lines was 
similar to the depolarizing response of 5-HT as noted, and labelled the A
16
response, by Gerschenfeld and Paupardin-Tritsch (1974a). The responses to 
5-HT in both the neuronal cell lines and Helix neurones show ed rapid 
desensitization. In the case of the A-depolarizing responses to 5-HT, which 
had previously been shown to be sensitive to changes in extracellular sodium  
concentration, voltage-clamp experiments have shown that they reverse near 
the zero level: this suggested that they involved an increase in both sodium  
and potassium conductances (Gerschenfeld et a l ,  1981). More recently Bokisch 
and Walker (1986) have investigated the ionic mechanisms associated with 
the actions of putative transmitters on identified neurones of the snail. Helix  
aspersa. The ionic mechanism associated with 5-HT excitation was examined 
using two identified cells (El and E2) in the visceral ganglion. Iontophoretic 
application of 5-HT induced an inward current which had an extrapolated 
reversal potential of -3mV. In sodium-free saline the 5-HT-induced inward 
current was reduced by 30-50% of the control value. When sodium- and 
calcium-free solution was used the 5-HT-induced current was totally 
abolished. Bokisch and Walker concluded that this 5-HT excitatory response 
involved an increase both in sodium and calcium conductance. This was 
similar to the conductance increases in monovalent cations induced by 5-HT 
seen in the NIE-115 cell line by Peters and Usher wood (1983). Could it be a 
5 -HT3 receptor which mediates the A-depolarizing response in molluscan 
neurones as described by Gerschenfeld and Paupardin-Tritsch (1974a)?
A im s
The aim of the present study was to investigate the 5-HT receptor 
present in Helix aspersa neurones, in order to attempt characterization of the 
5-HT receptor into one of the vertebrate 5-HT receptor subtypes. This was to be 
achieved using the electrophysiological techniques of voltage-clamp and 
current-damp. The neurones in the suboesophageal ganglia of Helix aspersa 
had been well mapped by Kerkut et al. (1975) who had also noted which cells 
were depolarized by the iontophoretic application of 5-HT onto the identified 
cell soma. A more detailed electrophysiological, pharmacological and 
fluorescent study on twelve neurones from the suboesophageal ganglia by 
Loker et al. (1975) identified five large 5-HT-containing neurones in the 
visceral ganglion. The six neurones under investigation in the visceral 
ganglion were El, E2, E3, E4, E5 and E6 . Five of these neurones contained 5- 
HT, were depolarized by 5-HT and ACh and were hyperpolarised by dopamine.
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In contrast, neurone E4 was found not to contain 5-HT and was 
hyperpolarized by both ACh and dopamine. It was five of these six large easily 
identifiable neurones that were utilised in this study. They were E l, E2, E3, E4 
and E5. Because of the similarity between the depolarizing response of 5-HT 
in Helix neurones to the 5-HT response observed in neuroblastoma cells 
which was mediated by a well-described 5-HTg receptor, 5-HTg receptor 
agonists and antagonists were tested first on the preparation. This was 
followed later by other specific 5-HT vertebrate receptor subtype agonists and 
antagonists.
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METHODS AND MATERIALS
Preparation of animals
Common garden snails. Helix aspersa, were collected locally and kept in 
a enclosed bucket at room temperature until they were required. Prior to 
dissection the snails were enticed out of their shells by being placed in warm 
water (20-3QOC). Once out of its shell, the head of the snail was rapidly cut off 
using a sharp pair of scissors and the detached head pinned through the 
mouth to a wax bottomed dissecting dish. The dorsal midline at the back of 
the head was cut from top to bottom and the skin pulled back exposing the 
buccal mass. The cerebral ganglia, which com prise part of the 
circumoesophageal ring, were visible as a collar over the oesophagus which is 
itself attached to the buccal mass. The oesophagus was pulled from beneath 
the cerebral ganglia and the buccal mass cut away. A pair of forceps was then 
placed underneath the cerebral ganglia and these lifted to expose the 
suboesophageal ganglia beneath. The nerve connections were cut away and 
the isolated circum oesophageal ring placed in a beaker containing 
physiological saline (80mM NaCl, 5mM KCl, 5mM MgCl2, 7mM CaCl2, 20mM 
Hepes pH 7.5) (Meech and Thomas, 1977). The ganglia were then transferred 
to the recording chamber for further dissection before the experiments were 
started. Once the suboesophageal ganglia had been pinned to a Sylgard base of 
the bath, the layers of connective tissue covering the ganglion cells could then 
be removed. The connective tissue had to be removed before the neurones 
could be impaled with microelectrodes. This careful microdissection was 
achieved with fine forceps and a pair of fine scissors. The outer connective 
sheath is spongy in texture and was relatively easy to remove. However, the 
inner sheath is thin and transparent, and had to be carefully torn to expose the 
cells without causing them further damage.
Experimental set up in the recording chamber
The recording chamber was made of a rectangular block of Perspex 
supported by four small Perspex legs. A 5mm identation in the perspex block 
formed the small bath. Sylgard was used to coat the bath and this made a 
suitable base into which dissecting pins could be inserted. The bath was 
illuminated by a conventional Watson light source. This was achieved by
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using an tapered glass rod, the thick end of which was inserted by means of a 
rubber bung into the light source, while the thin tapering end was positioned 
in the bath below the level of the liquid. Adequate illumination was provided 
by the tip of the glass rod when it was positioned close to the preparation. The 
bath was observed through a Nikon stereoscan microscope.
The perfusion system
The preparation could be exposed to various solutions by means of a 
multi-way tap to which a maximum of six reservoirs could be connected. A 
diagram of the tap system is shown in Fig. 2.1. Large 100ml syringes were used 
as reservoirs and these were attached to smaller 5ml syringes. The syringes 
were held in place on the side of the Faraday cage surrounding the 
experimental apparatus by means of adjustable clips. Thin plastic tubing 
attached to the small syringes formed the inflow into the six-way tap. The 
single outflow of the tap led directly into the bath. The reservoirs were 
positioned higher than the recording chamber, thus providing the small 
hydraulic head necessary to create a flow of solution. The different solutions 
from the different reservoirs could be used to perfuse the bath by turning the 
tap outflow to the selected reservoir inflow. A clamp on the tubing from the 
outflow of the tap to the bath made it possible to control the flow of solution. 
The rate of flow per minute could then be measured by monitoring the 
amount of solution passing from the large to the small syringe. The flow rate 
was an important experimental parameter so it was measured periodically by 
the addition of a small amount of dye to the bath. The dye gave an indication 
of the movement of solution in the bath. For example, if the flow was too fast 
the dye would be swept around, but not over, the preparation whereas, if the 
flow was too slow small pockets of dye would remain in the bath. The flow  
had to be adjusted carefully in order to allow any drugs in the perfusate to 
have an effect, but also to allow them to be washed out of the bath once the 
effect had been observed.
A suction system disposed of the waste perfusate from the bath. The 
suction tube was positioned carefully so that the flow of solution was constant 
and the liquid in the bath was maintained at the desired level. The vacuum 
was produced by connecting the suction tube to an aspirator via a conical flask 
into which the waste collected.
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FIGURE 2.1
Diagram to show a close up view  of the 6-way tap system used in the 
experiments. Only one inflow is shown in this figure. Under normal 
conditions all six inflow s w ould be in use, for example, with different 
concentrations of antagonist that required perfusion through the bath. The 
reservoir was at least 2 feet above the height of the tap. This drawing was 
taken from the collection of equipment drawings on the Macintosh which was 
the work of Grant Gourlay.
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Intracellular recording
Intracellular recordings were made using the Dagan 8100 single 
electrode clamp system. This single electrode circuit had been developed by 
Wilson and Goldner (1975) to provide a means of voltage clamping with a 
single microelectrode. This technique is described in further detail in a 
following section. The electrical recordings were monitored with a Gould 
20MHz oscilloscope, and permanent records were made on a Gould 200 brush 
chart recorder. Both current and voltage records were filtered before being 
displayed on the chart recorder, in order to eliminate high frequency 
oscillations and noise. This was accomplished by using a low  pass filter 
consisting of a resistor and capacitor in series. A 160kQ resistor was used with 
a 0.1 pF capacitor. This low pass filter effectively removed noise above 9-lOHz. 
The experimental responses to 5-HT were sufficently slow to not be distorted 
by this filter. The bath was grounded with an A g/A gC l wire connected to the 
virtual ground of the Dagan 8100 probe. The A g/A gC l wire was made by 
coating a piece of silver wire with molten AgCl. A Grass S44 stimulator was 
connected to the Dagan, via a Grass SIU5 stimulus isolation unit so that 
pulses could be given to impaled cells. The stimulation rate, the delay 
between stimuli and the duration of stimuli could all be modified with this 
system.
Intracellular electrodes
Microelectrodes were made using filamented glass capillary tubes 
(Clark Electromedical) of 1.5mm diameter. They were pulled on a Narishige 
PP83 electrode puller and kept on plasticine in petri dishes until required. 
Recording electrodes were filled with 200mM KCl solution using a syringe and 
fine needle. The solution was filtered with a Millipore Swinnex 25 filter unit 
containing 0.22pm filter paper before use. The microelectrodes had a 
resistance of between 1 and 5MQ .
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Voltage- and current-clamp techniques
The single electrode circuit in the Dagan 8100 requires that a single 
electrode both records potential and passes current. This is accomplished 
through a switching circuit that alternates between a current-injecting mode 
and a voltage recording mode. The percentage of time spent injecting current 
and recording voltage is called the duty cycle. Current is injected for 50% of 
the time while membrane potential is recorded only during intervals between 
applications of current. The rate at which the clamp alternates between the 
two modes is called the switching frequency. The clamp relies on the time 
constant of the cell (membrane resistance x membrane capacitance) to smooth 
out the injected square waves of current and to provide an essentially steady 
DC current across the cell membrane. It was therefore important that the 
switching frequency be less than the time constant so that the membrane 
potential did not have time to wane appreciably. In all experiments the 
switching frequency was set at 3Hz. The voltage-clamp system used a negative 
feedback circuit to compare the actual potential of the cell to a commanded 
holding potential. Current is injected to compensate for any offset, including 
spontaneous events, that would otherwise shift the membrane potential. The 
injected current, equal and opposite to that flowing across the cell membrane, 
is monitored. From the holding potential, voltage commands to other 
membrane potentials can be applied. The currents required to produce and 
sustain the voltage step are recorded; they reflect the various currents present 
in the cell.
The Dagan could also be used in switched current-clamp mode. So that 
a neurone could be voltage-clamped adequately the electrode had to be able to 
pass current reliably during the course of the experiment. Electrodes with a 
resistance of 1-5MQ were found to be reliable. Before impaling a neurone and 
with the electrode in solution, the resistance of the recording electrode was 
tested using a bridge current circuit with the z test facility of the Dagan. 
Electrodes with resistances higher than 5MQ were discarded. The recording 
electrode was held in a micromanipulator. The gain of the negative feedback 
amplifier was set close to the maximum value because the higher the gain of 
the clamp, the more accurately the membrane voltage will follow the voltage 
command. The negative capacity compensation was set to a minimum.
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Electrodes were then inserted into the soma of identified neurones once the 
fine microdissection had exposed the neurones.
Application of agonists by iontophoresis
Drugs such as 5-HT and the other 5-HT agonists were applied onto the 
soma of the impaled neurones by iontophoresis. Iontophoresis was 
performed using a m icroiontophoresis W Pl M odel 160 programmer. 
Iontophoretic electrodes were made from filamented glass capillary tubes 
(Clark Electromedical) of 1.5mm diameter, pulled on a Narishige PN3 8903 
electrode puller. They were kept in petri dishes, held in place with plasticine 
until required. They were filled with appropriate drug solutions which had 
been filtered using Costar centrifuge filter units with 0.22pm cellulose acetate 
filters. The drugs were made up in distilled water at a concentration of 40mM. 
A small retain current was applied to the iontophoretic electrode to prevent 
leakage of the drugs into the bath. The retain current of 20nA was used 
routinely. Ejection currents were in the range of 200nA with an ejection time 
of two seconds. This could all be set up by connecting the iontophoresis 
programmer to a custom -m ade small pu lse generator. With this
arrangement, the time between pulses could also be set to whatever was 
required. Blockage of electrodes could be detected easily by either a decrease in 
retain current or by the appearance of a large artefact during the eject current. 
Blocked electrodes were replaced immediately.
Before each experiment the eject current was increased to ensure 
selection of a submaximal ejection pulse. A sigmoid curve was obtained if 
eject current was plotted against the size of response. It was important that the 
eject current was on the rising phase and not on the plateau phase of the 
curve. The iontophoretic electrodes, once in the bath solution, were 
positioned with their tips close to the impaled neurones. However, care had 
to be taken not to place the tip too close because the eject current might cause 
the iontophoretic electrode to impale the cell. With continuous flow through 
the bath, if the iontophoretic electrode was too far away from the impaled 
neurone, the drug was automatically washed away without effect. The 
agonists applied in this way were 5-CT and sumatriptan (both 5-HT% receptor 
agonists), 2-Me-5-HT (a 5-HTg receptor agonist) and a-Me-5-HT (a 5-HT2 
receptor agonist). The full names of the drugs and from where they were
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obtained are as follows: 5-HT creatinine sulphate (Sigma), 5-CT maleate, a-Me- 
5-HT maleate, 2-Me-5-HT hydrochloride and sumatriptan (all synthesised by 
the Chemistry Research Department at Glaxo Group Research).
Antagonists by bath application
Application of antagonists required that they be perfused through the 
bath at the relevant concentrations. The antagonists were made up in 
physiological saline at appropriate concentrations with the exception of 
ketanserin and ondansetron which were dissolved in O.IM tartaric acid to give 
a ImM stock solution. The subsequent dilutions were then made in 
physiological saline. All antagonists were made up fresh on the day of use and 
kept in the fridge (4 ^ 0  until required. The antagonists tested were 
methiothepin (a 5-HT% receptor antagonist), ketanserin (a 5-HT2 receptor 
antagonist), ondansetron, MDL 72222 and ICS 205-930 (all 5-HTg receptor 
antagonists). Methysergide was tested as an antagonist. The full names of the 
drugs tested and from where they were obtained are listed: methiothepin 
maleate (Hoffman La Roche), ketanserin tartrate (Janssen), MDL 72222 (Merrel 
Dow), ICS 205-930 (Sandoz), ondansetron (Glaxo) and methysergide maleate 
(Sandoz).
Layout of equipment
The recording chamber, m icrom anipulators, ligh tin g  system , 
microscope and perfusion system were all placed on a steel baseplate which 
was supported by four specially reinforced legs. This reduced vibration and 
aided stable recordings. A diagram of the layout is shown in Fig. 2.2. The 
baseplate with all the equipment on it was enclosed in a Faraday cage which 
was connected to earth to reduce electrical interference. The microscope 
baseplate and micromanipulators were also earthed. All the electronic 
apparatus was stacked in a freely moveable rack to the left of the cage.
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FIG URE 2.2
Diagram to show the layout of the experimental apparatus within the 
Faraday cage. The light source, which is not visible, was placed behind the 
recording chamber along with the aspirator flask which was used to collect the 
waste perfusate from the bath. All the equipment was positioned on a 
baseplate in order to give good stability. This drawing was taken from the 
collection of equipment drawings on the Macintosh computer which was the 
work of Grant Gourlay.
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RESULTS
Position of identified neurones El, E2, E3, E4 and E5 in the visceral ganglion.
All the identified neurones (El, E2, E3, E4 and E5) in the visceral 
ganglion gave a depolarizing response to 5-HT. Their position within the 
visceral ganglion is shown in Fig. 2.3. The photograph (Fig. 2.4) gives a more 
detailed picture of the cells, although here they are still enclosed within the 
inner connective sheath. The dye used to stain the cells was methylene blue
El was about 80-100jim in diameter. E2 was slightly larger, 100-150pm 
in diameter, and found close to E4. E3 was approximately 80-100|im in 
diameter and found close to the intestinal nerve. E4 was the largest cell of this 
group, being 150-200|xm in diameter and found at the bottom right hand 
corner of the ganglion. E5 was positioned above E4 and was roughly 100pm in 
diameter. All of these cells, with the exception of E4 which was usually silent 
were spontaneously active when impaled. Their resting potentials varied 
between -50mV and -60mV.
5-HT response in identified neurones El, E2. E3. E4 and E5
When 5-HT was applied iontophoretically to an identified voltage- 
clamped neurone within the visceral ganglion a large inward current was seen 
(Fig. 2.5 A). The effect of 5-HT was rapid in onset and 3-1 On A in amplitude. 
The response to 5-HT seen under voltage-clamped conditions is a more 
realistic representation of the response because it indicates that an inward 
current is responsible for the excitatory response which is observed under 
current-clamp conditions. When 5-HT was applied iontophoretically to an 
identified neurone under current-clamp conditions, a depolarizing excitatory 
response, lasting 20-30 seconds, was observed leading to the firing of action 
potentials (Fig. 2.5B). The size of the response in current-clamped neurones 
was 3-15mV. Under current-clamp conditions the cells were usually  
hyperpolarised by 10-20mV in order to reduce any spontaneous activity that 
the cells had at their resting membrane potential which might have interfered 
with the observed 5-HT response.
The response to 5-HT of the identified cells within the visceral ganglion 
under both voltage- and current-clamp conditions was easily desensitized with
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FIGURE 2.3
Diagram to show the dorsal view  of the suboesophageal ganglia. The 
identified neurones in each ganglion are numbered. The ganglia are lettered: 
A, left cerebral; B, right cerebral; C, left pleural; D, left parietal; E, visceral; F, 
right parietal; G, right pleural; H, left pedal; I, right pedal. The nerves are 
numbered: 1, left palliai; 2, anal; 3, intestinal; 4, right palliai. This drawing is 
taken from Kerkut et a l  (1975).
FIGURE 2.4
Photograph of the identified ceils in the visceral ganglion (E1-E5) which 
were used in the experiments. The cells have been individually labelled but 
they have not been fully exposed, they are still covered by the transparent 
inner sheath. Methylene blue was used to dye the cells. The intestinal nerve 
is marked with an I, the anal nerve with an A and the right palliai with a RP. 
Note that the neurones in the adjacent right parietal ganglion have been fully 
exposed and have consequently taken up more of the dye. The scale bar 
indicates 100pm.

FIGURE 2.5
A. Response of an identified neurone, E3, in the visceral ganglion to 
5-HT under voltage-damp conditions. The cell was held at a holding potential 
of -70mV. The iontophoretic application (200nA for 2s) of 5-HT is indicated by 
the filled circle. The preparation was continuously perfused throughout the 
experiment.
B. Response of an identified neurone, E3, in the visceral ganglion to 
5-HT under current-clamp conditions. The cell was hyperpolarised by lOmV 
from its resting potential in order to reduce any spontaneous activity. The 
resting potential of the cell was approximately -60mV. The iontophoretic 
application (200nA for 2s) of 5-HT is indicated by the filled circle. The 
preparation was continuously perfused throughout the experiment.
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repetitive iontophoretic applications of 5-HT (Fig, 2.6A and B). For 
experimental purposes, to avoid desensitization, iontophoretic applications of 
5-HT were made once every 3-4 minutes with continuous perfusion of 
physiological saline for the entire experiment. The flow of saline was 0.8- 
1.0ml m in'l. With the volume of the bath being only 0.5ml this ensured that 
the bath volume was changed at least once every minute.
This response seen with iontophoretic application of 5-HT is sensitive 
to blockade with tubocurarine at a concentration of lOOfiM (Fig. 2.7A and B). 
When the identified visceral ganglion cells were stimulated using single 
repeating current pulses (0.4pulses.s"^) under current-clamp conditions, 
iontophoretic applications of 5-HT caused a reduction in the voltage 
deflections observed in the neurone (Fig 2.9). The reduction in the size of the 
voltage deflections during the 5-HT-evoked responses indicated a decrease in 
membrane .resistance with an apparent increase in membrane conductance; 
i.e. current is flowing into the cell.
A second, different, 5-HT response observed within identified neurones El 
and E2
A much slower depolarizing excitatory response to iontophoretic 
application of 5-HT was seen in neurones El and E2. This response appeared 
similar to the one under investigation, but its time course was much slower 
(Fig. 2.8A). It show ed no desensitization with repetitive iontophoretic 
applications (200nA for 2s) of 5-HT (Fig. 2.8B). No inhibition of this 5-HT 
response was seen when lOOpM tubocurarine was perfused through the bath 
for 20 minutes (Fig. 2.8C). The fact that this response showed no 
desensitization made it easily distinguishable from the 5-HT response under 
investigation; by repetitively iontophoresing 5-HT onto the impaled cell 
under either current- or voltage-clam p conditions at the start of the 
experiment it was possible to immediately discriminate the 5-HT response 
being observed. This was ascertained at the beginning of each experiment in 
order to avoid confusion between the two 5-HT responses seen in the 
identified neurones within the visceral ganglion.
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FIGURE 2.6
A. Responses of an identified neurone, E4, in the visceral ganglion to 
5-HT under voltage-clamp conditions which show desensitization of the 5-HT 
response. The cell was held at a holding potential of -70mV. The 
iontophoretic application (200nA for 2s) of 5-HT is indicated by filled circles. 
The preparation was continuously perfused throughout the experiment. The 
first response of the cell is a control response to 5-HT. The second response is 
a response to 5-HT imm ediately after the recovery from the preceding  
response (less than 1 minute) and the third response is the response seen after 
adequate recovery time from the preceding 5-HT response (approximately 3 
minutes).
B. Responses of an identified neurone, E3, in the visceral ganglion to 
5-HT under current-clamp conditions which show a desensitization of the 
5-HT response. The cell was hyperpolarised by lOmV from its resting 
potential. The resting potential of the cell was approximately -60mV. The 
iontophoretic application (200nA for 2s) of 5-HT is indicated by filled circles. 
The preparation was continuously perfused throughout the experiment. The 
first response of the cell to 5-HT is a control response to 5-HT. The second 
response is a response to 5-HT immediately after recovery from the preceding 
response (less than 1 minute) and the third response was after adequate 
recovery time from the preceding response to 5-HT (approximately 3 minutes).
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FIGURE 2.7
Responses of identified neurones, E4 in A and E5 in B, in the visceral 
ganglion to 5-HT illustrating an inhibition of the 5-HT response by lOOpM 
tubocurarine under A, voltage-clamp conditions and B, under current-clamp 
conditions. In A the holding potential of the cell was -70mV. In B the cell was 
hyperpolarised from its resting potential by lOmV. The resting potential of the 
cell was approximately -60mV. In both A and B the iontophoretic application 
(200nA for 2s) of 5-HT is indicated by filled circles. Three responses to 5-HT are 
shown in both A  and B. The first is under normal conditions, the second is 
with lOGp-M tubocurarine perfused through the bath while the last is after 
recovery and washing with fresh physiological saline for 10 minutes.
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FIG URE 2.8
Responses of identified neurones, El and E2, w ithin the visceral 
ganglion to 5-HT which show a different response to 5-HT. All responses to 
5-HT are shown under current-clamp conditions with the cells hyperpolarised, 
by 15-20mV from their resting potential. The resting potential of the cells was 
approximately -55mV. Iontophoretic application (200nA for 2s) of 5-HT is 
indicated by filled circles. Continuous perfusion is maintained throughout 
the experiments.
A. Response of neurone El to 5-HT showing the longer time course of 
the response.
B. Responses of neurone El to repetitive iontophoretic applications of 
5-HT showing lack of desensitization of the subsequent 5-HT response.
C. Responses of neurone E2 to 5-HT showing no inhibition with lOOpM 
tubocurarine.
The first response is the control response of the cell to 5-HT, the second 
response is the 5-HT response in the presence of lOOpM tubocurarine while 
the last is the response to 5-HT after a wash period.
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FIGURE 2.9
Two examples A and B, of the response to 5-HT in identified neurones 
in the visceral ganglion under current-clamp conditions while the cells are 
being stimulated with single repeating pulses from a stimulator. In both A 
and B the cells were hyperpolarised from their resting potential by 10mV. The 
resting potential of the cells was approximately -60mV. Iontophoretic 
application (200nA for 2s) of 5-HT is indicated by the filled circles. Continuous 
perfusion was maintained throughout the entire experiments. The stimulator 
provided a stimulus of 3-4 volts at a rate of 0.4 pulses.s"^ with a duration of 
400ms.
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The reversal potential of the excitatory type A 5-HT response in the identified 
neurones
As already observed the 5-HT response under voltage-clamp conditions 
is an inward current. At hyperpolarised holding potentials, the size of the 
current response within the cell to 5-HT was quite large but, at more 
depolarized potentials, the size of the current response to 5-HT was reduced 
(Fig. 2.10). Evidence for the involvement of certain ions in this inward 
current is shown in the plot of current response against holding potential (Fig.
2.11). From -80mV to -lOmV a straight line plot gave an estimated reversal 
potential of between -10—OmV by extrapolation. N o values were obtained 
above a holding potential of -lOmV because activation of other voltage- 
dependent currents at more depolarized potentials made difficult the 
measurement of 5-HT-induced currents, close to their reversal potential.
With increased current activity at these more depolarized potentials, the 
holding potential of the neurone became increasingly difficult to maintain at 
the given level. A reversal potential of -10—OmV indicates that sodium is 
involved. However, a response involving only sodium ions would result in a 
more positive value nearer the sodium equilibrium potential of +55mV. As 
the reversal potential value obtained in this study was nearer the zero level, it 
w ould suggest that the fast depolarizing response to 5-HT involved an 
increase both in sodium and potassium conductances.
Difference in the 5-HT response in identified neurones with changes in 
iontophoretic eject current i
The response to iontophoretic application of 5-HT increased in 
amplitude with increases in the size (nA) of the iontophoretic eject current 
(Fig. 2.12). At high values of eject current the response did not increase, 
indicating that the maximum response has been reached. When log eject 
current is plotted against percentage maximum response a typical sigmoid 
curve is obtained (Fig. 2.13). In order to ensure that supermaximal 
concentrations of 5-HT were not being used in these experiments, the eject 
current was set using values on the slope of the curve, usually about 200nA.
In this way any effects of 5-HT agonists and antagonists could not be masked by 
utilising 5-HT at too high a concentration.
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FIG URE 2.10
The responses of an identified neurone, E3, in the visceral ganglion to 
local application of 5-HT under voltage-clamp conditions. Responses were 
recorded at different membrane holding potentials. The holding potential of 
the cell is as stated. Iontophoretic application (200nA for 2s) of 5-HT is 
indicated by the filled circles. Continuous perfusion was maintained  
throughout the experiment.
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FIG URE 2.11
Relationship between current response to 5-HT and holding potential of 
E3 neurone. The x axis gives the holding potential of the cell in mV while the 
y axis gives the current response in nA.
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FIGURE 2.12
The responses of E4 neurone within the visceral ganglion under 
voltage-clamp conditions to iontophoretic application of 5-HT at different 
iontophoretic eject currents. The holding potential of the cell was -80mV. 
The iontophoretic application of 5-HT (2s) is indicated by filled circles with the 
stated eject current in nA. Continuous perfusion was maintained throughout 
the experiment.
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FIGURE 2.13
Plot to show the dependence of the response in E3 neurone in the 
visceral ganglion on the size of eject current in nA. The x axis gives log of the 
eject current while the y axis gives percentage maximum response.
The effects of 5-HT agonists
In looking at the effects of agonists on the identified cells within the 
visceral ganglion the 5-HT response was always used as a reference. Once a 
response to 5-HT had been obtained the iontophoretic electrode was removed 
and replaced with one similar but containing the 5-HT agonist under 
investigation. The iontophoretic electrode was placed in, as near as possible, 
the same position as the 5-HT iontophoretic electrode had been so that the 
iontophoresing of the agonist would be under similar conditions to that of 
5-HT.
5-CT, the specific 5-HT| receptor agonist, at the same concentration 
(40mM) within the iontophoretic electrode and under the same retain and 
eject conditions as 5-HT, excited a response very similar to 5-HT under both 
voltage and current-clamp conditions (Figs 2.14A and B). In every case the 
response was either equal to, or slightly smaller than that of 5-HT. This may 
be explained by 5-CT having less potent actions than 5-HT on the 5-HT 
receptor present in the cell membrane. However this was difficult to 
determine definitively because the process of iontophoresis is qualitative 
rather than quantitative.
a-Me-5-HT, the 5-HT2 receptor agonist, also mimicked the action of 
5-HT when iontophoresed onto the identified cells of the visceral ganglion. It 
elicited a depolarizing excitatory response similar to 5-HT (Figs. 2.15 A,B and 
C) under current-clamp conditions. The response to a-Me-5-HT was not 
attempted under voltage-clamp conditions. Once again the response to a-Me- 
5-HT was the same or slightly smaller than 5-HT indicating a similar potency 
of a-Me-5-HT at the 5-HT receptor on the cell membrane. However, because 
the response was qualitative only, the potency of a-Me-5-HT for the receptor 
under investigation could not be established definitively.
Sumatriptan, another 5-HT% receptor agonist, mimicked to a certain 
extent the action of 5-HT by eliciting a response similar to, but much smaller 
than, that elicited by 5-HT (Figs. 2.16A,B and C). The depolarizing excitatory 
responses elicited by sumatriptan were observed only under current-clamp 
conditions. In contrast, 2-Me-5-HT, a 5-HTg receptor agonist elicited no 
response from the identified  cells w hen the drug was applied
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iontophoretically (Figs. 2.17A and B). Once again, the conditions of retain and 
eject and the concentration of the agonist in the iontophoretic electrode were 
the same as that for 5-HT. It could then be suggested that, because 2-Me-5-HT 
failed to elicit any response, 2-Me-5-HT had no affinity for the 5-HT receptor 
present on the cell membrane. A summary of the results obtained with the 
agonists is given in Table 2.3 below.
TABLE 2.3 Summary of the 5-HT agonists tested on identified Helix neurones. 
The concentration given is the concentration within the iontophoretic 
electrode.
Agonist Concentration
(mM)
n Effect
5-HT 40 40 Inward current (3-1 On A) 
under v-clamp at potentials
of -7 0 -----80mV
Depolarization (3-15mV) 
under c-clamp at potentials 
of between -6 0 -----80 mV
5-CT 40 12 Mimicks effect of 5-HT in 
V -  and c-clamp. Responses 
same size as 5-HT or slightly 
smaller
a-Me-5-HT 40 10 Mimicks effect of 5-HT in 
c-clamp. Responses same 
size as 5-HT or slightly 
smaller
Sumatriptan 40 10 Mimicks effect of 5-HT in 
c-clamp. Responses much 
smaller than those of 5-HT
2-Me-5-HT 40 8 No effect seen with this 
agonist
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FIG URE 2.14
Responses of identified neurones, E5 and E3, within the visceral 
ganglion to 5-HT and 5-CT under A voltage-clamp conditions and B current- 
clamp conditions. In A the holding potential of the cell was -70mV. In B the 
cell was hyperpolarised from its resting potential by 15mV. The resting 
potential of the cell was approximately -55mV. Iontophoretic application 
(200nA for 2s) of 5-HT is indicated by filled circles and that of 5-CT is indicated 
by asterisks. In both A and B the first response is a control response to 5-HT 
followed by a response, in the same cell, to 5-CT. The third response is the 
response to 5-HT after that of 5-CT. Continuous perfusion was maintained 
throughout the experiments. The interval between responses is four minutes.
<c
LO c/)o
>Eo
(/)o
■1
y
*
< m
;
FIG URE 2.15
Responses of three identified neurones, E3, E4 and E2, (A, B and C) 
within the visceral ganglion to 5-HT and to a-M e-5-HT under current-clamp 
conditions. In A, B and C the cells were hyperpolarised by lOmV from their 
resting potentials. The resting potential of the cells was approximately -60mV. 
Iontophoretic application (200nA for 2s) of 5-HT is indicated by filled circles 
while that of a-Me-5-HT is indicated by asterisks. In A , B and C the first 
response is a control response to 5-HT. The second response, of the same cell, 
is to a-Me-5-HT. The third response is a response to 5-HT after that of a-M e- 
5-HT. The time interval between iontophoretic application was 4 minutes. 
Continuous perfusion was maintained throughout the experiments.
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FIGURE 2.16
Responses of three identified neurones, E3, E4 and E5 (A, B and C) 
within the visceral ganglion to 5-HT and to sumatriptan under current-clamp 
conditions. In A, B and C the cells were hyperpolarised by lOmV from their 
resting poentials. The resting potential of the cells was approximately -60mV. 
lontophoretic application (200nA for 2s) of 5-HT is indicated by filled circles 
while that of sumatriptan is indicated by asterisks. In A , B and C the first 
response is a control response to 5-HT followed by the second response, in the 
same cell, to sumatriptan. The third response is a response to 5-HT after that 
of sumatriptan. The time internal between iontophoretic applications was 4 
minutes. Continuous perfusion was maintained throughout the experiments.
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FIGURE 2.17
Responses of two identified neurones, El and E3 (A and B), within the 
visceral ganglion to 5-HT and to 2-Me-5-HT under current-clamp conditions. 
In A and B the cells were hyperpolarised by lOmV from their resting 
potentials. The resting potential of the cells was approximately -60mV. 
lontophoretic application (200nA for 2s) of 5-HT is indicated by filled circles 
while that of 2-Me-5-HT is indicated by asterisks. In A and B the first response 
is a control response to 5-HT followed by the second response, in the same cell, 
to 2-Me-5-HT. The third response is a response to 5-HT after that of 2-Me- 
5-HT. The time interval between iontophoretic applications was 4 minutes. 
Continuous perfusion was maintained throughout the experiments.
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Effects of 5-HT antagonists
These experiments showed much similarity of the excitatory response 
to 5-HT to that observed in neuroblastoma cell lines, in terms of a fast 
depolarizing response which showed desensitization and a similar value for 
the reversal potential. Accordingly, the 5-HTg receptor antagonists which 
blocked the 5-HT responses in these cell lines were tested first on the 5-HT 
response in the identified neurones. These antagonists were ondansetron, ICS 
205-930 and MDL 72222. Ondansetron was tested at concentrations ranging 
from O.lpM-lOjiM by being perfused through the bath over a time period of 40 
minutes. Even at a concentration of lOfxM ondansetron had no antagonistic 
effect on the response to 5-HT in the identified neurones under voltage-clamp 
conditions (Fig. 2.18C). At lower concentrations also ondansetron had no 
effect on the inward current elicited by 5-HT under voltage-clamp conditions 
(Figs. 2.18A and B). There was a lack of antagonist effect shown by ICS 205-930 
at a concentration of IpM both under voltage- and current-clamp conditions 
(Figs. 2.19A and B). The response to 5-HT remained unchanged for at least 30 
minutes despite the perfusion of antagonist, through the bath. The final 
5-HT3 antagonist applied, MDL 72222, also had no effect on the 5-HT response 
observed under both current- and voltage-clamp conditions (Figs. 2.20A and 
B). There was no change in the 5-HT response in the presence of IpM MDL 
72222 despite its continued perfusion over a 40 minute period.
The other specific antagonists tested were methiothepin, a 5-HT% 
receptor antagonist, and ketanserin, a 5-HT% receptor antagonist. In this case, 
methysergide, an LSD derivative, was also tested as an antagonist. No 
antagonistic effect was observed on the 5-HT response by methiothepin, 
ketanserin or methysergide, all at concentrations of IpM. The 5-HT response 
both under current and voltage-clamp conditions remained unchanged even 
though these antagonists were perfused through the bath for 40 minutes. 
Because the 5-HT response with the above three antagonists remained 
unchanged the results are not shown as figures. Table 2.4 overpage 
summarizes the antagonists tested, the concentration at which they were 
tested and the lack of an effect seen.
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TABLE 2.4 Summary of the 5-HT antagonists tested on Helix  identified 
neurones
Antagonist Concentration
(pM)
n Effect
Ondansetron 0.1 ,1  and 10 8 N o effect seen
ICS 205-930 1 8 No effect seen
MDL 72222 1 7 N o effect seen
M ethiothepin 1 8 No effect seen
Ketanserin 1 8 No effect seen
Methysergide 1 8 No effect seen
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FIGURE 2.18
Responses of identified neurones, E3 and E4, within the visceral 
ganglion to 5-HT in the absence and presence of increasing concentrations 
(A-C) of ondansetron under voltage-clamp conditions. In A , B and C the 
holding potential of the cells was -75mV. In A , B and C three responses to 
5-HT are shown. The first is a control response to 5-HT, the second a response 
to 5-HT in the presence of ondansetron and the third is a response to 5-HT 
after a wash period. In A the concentration of ondansetron was 0.1 pM, in B it 
was IpM and in C the ondansetron concentration was lOpM. lontophoretic 
application (200nA for 2s) of 5-HT is indicated by filled circles. Continuous 
perfusion was maintained throughout the experiments.
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FIGURE 2.19
Responses of identified neurones, E3 and E5, w ithin the visceral 
ganglion to 5-HT in the presence and absence of l^iM ICS 205-930 under A  
voltage-clamp conditions and B current-clamp conditions. In A the holding 
potential of the cell was -70mV. In B the cell was hyperpolarised by lOmV 
from its resting potential. The resting potential of the cell was approximately 
-60mV. The iontophoretic application (200nA for 2s) of 5-HT in indicated by 
filled circles. In A and B three responses to 5-HT are shown. The first is a 
control response of the cell to 5-HT, the second is a response, of the same cell, 
to 5-HT in the presence of lp.M ICS 205-930 while the last is the response to 
5-HT after a wash period. Continuous perfusion was maintained throughout 
the experiments.
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FIG URE 2.20
Responses of identified neurone, E4, within the visceral ganglion to 
5-HT in the presence and absence of IpM MDL 72222 under A voltage-clam p  
conditions and B current-clamp conditions. In A the holding potential of the 
cell was -75mV. In B the cell was hyperpolarised from its resting potential by 
15mV. The resting potential of the cell w as approxim ately -60mV. 
lontophoretic application (200nA for 2s) of 5-HT is indicated by filled circles. 
In A and B three responses to 5-HT are shown. The first is a control response 
of the cell to 5-HT, the second is a response, in the same cell, to 5-HT in the 
presence of IpM MDL 72222 while the last is the response to 5-HT after a wash 
period. Continuous perfusion was maintained throughout the experiments.
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DISCUSSION I
"I5-HT response for identified cells |
The response seen with iontophoretic application of 5-HT onto the five |
identified cells (E1-E5) in the visceral ganglion of Helix aspersa corresponded j
well to the A response described by Gerschenfeld and Paupardin-Tristsch j
(1974a). In their investigation, the A response was rapidly depolarizing, with -j
the potential returning to its initial level in about 20 seconds. The A response |
showed desensitization to successive iontophoretic applications of 5-HT and J
was blocked by tubocurarine. In the present study, iontophoretic application of |i|5-HT under voltage-clamp conditions gave an inward current which rapidly j
densensitized following repeated 5-HT applications: under current-clamp 1
conditions a depolarizing excitatory response was observed. The membrane 
resistance of neurones, E1-E5, was reduced, with iontophoretic application of 
5-HT, evoking an increase in membrane conductance. The observed reversal 
potential was similar to that found by Gerschenfeld et al. (1981) and provided 
further evidence that an increase of conductance to sodium  ions was 
mediating the response seen with 5-HT. Further experiments to determine 
the ionic dependence of the 5-HT response under both voltage- and current- 
clamp conditions were not undertaken.
Block of the 5-HT response in identified neurones by tubocurarine
Tubocurarine at a concentration of lOOpM reversibly antagonised the 
response to 5-HT in the identified cells of the visceral ganglion. Non-specific 
blocking actions have been shown for tubocurarine in a number of 
preparations. Stefani and Gerschenfeld (1969), for example, showed that D- 
tubocurarine reversibly blocked a fast depolarizing response of ACh and a fast 
depolarizing response of 5-HT, in central neurones of the snail 
Cryptomphallus aspersa. Gerschenfeld and Paupardin-Tritsch (1974a) further 
showed that D-tubocurarine blocked fast depolarizing and fast hyperpolarising 
responses of 5-HT both in Helix  and Aplysia  neurones. Yavari et a l  (1979) 
found that D-tubocurarine antagonized 5-HT, ACh, dopamine and glutamate 
fast depolarizing responses in a dose-related manner. These non-specific 
actions of D-tubocurarine which resulted from the interaction of this 
antagonist and ionic channels in nerve membranes for sodium and chloride
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ions was suggested by Carpenter et al. (1977). The interaction of drugs and 
ionophores has been demonstrated for a number of antagonists in nerve-cell 
membranes. Kehoe (1972a) showed that tetraethylammonium selectively 
blocked potassium  channels in Aplysia neurones thereby preventing  
cholinergically- or dopamine-induced inward or outward currents. It is 
possible, therefore, that tubocurarine, in this instance, is achieving its blockade 
of the 5-HT response by a non-specific interaction with the ionic channels 
which contribute to the inward current seen in response to iontophoretic 
application of 5-HT.
Second 5-HT response observed in El and E2 neurones
This slower 5-HT response which showed no desensitization and no 
block with tubocurarine was indicative of the A* response seen in H elix  
neurones by Gerschenfeld and Paupardin-Tritsch (1974a). Pellmar and Wilson 
(1977) analysed some Aplysia neurones showing both A and A' responses 
using the voltage-clamp technique. Their data showed an unconventional 
long excitatory response to 5-HT. The response at hyperpolarized potentials 
was simply an increase in sodium conductance, whereas at more depolarized 
potentials the current was enhanced and accompanied by an apparent decrease 
in membrane conductance. This unusual component has now been shown to 
be due to 5-HT activation of a voltage-sensitive calcium conductance (Pellmar 
and Carpenter, 1979, 1980). This finding would account for the fact that 
Bokisch and Walker (1986) found that in neurones El and E2^  the 5-HT 
excitatory response involved an increase both in sodium  and calcium  
conductance. It was only in these two identified neurones that the slower 
5-HT response was observed.
Characterization of 5-HT receptor on identified neurones
Since the description of six pharmacologically distinct 5-HT-induced 
responses in Helix  and Aplys ia  neurones by Gerschenfeld and Paupardin- 
Tritsch (1974a), there has been little further data on the characterization of the 
four distinct 5-HT receptors which were postulated to exist in these molluscan 
neurones by Gerschenfeld and Paupardin-Tritsch (1974a). This is not 
surprising because the pharmacological tools used in the study by 
Gerschenfeld and Paupardin-Tritsch (1974a) to define what they suggested as
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four distinct 5-HT receptors are crude by todays standards. The concentrations 
that were utilized in their study bear no resemblance to the concentrations of 
the high affinity 5-HT receptor antagonists that have been used recently to 
characterize the 5-HT receptor types in vertebrates. For example, there is 
evidence to suggest that tubocurarine has a non-specific effect by blocking ion 
channels rather than interacting with specific receptors (Yavari et a/., 1979) and 
neostigmine is widely used as an anti-cholinesterase. Rather than the four 
distinct 5-HT receptors that were suggested to exist on H elix  neurones 
(Gerschenfeld and Paupardin-Tritsch, 1974a), it seems more probable that the 
authors were describing various com ponents of a com plex phasic 
physiological response elicited by 5-HT in these molluscan neurones.
From work by Bokisch et al. (1983) on Helix neurones it was postulated 
that the 5-HT excitatory type A receptor was similar to the mammalian 5-HT2 
receptor. However the agonists, MK 212 and RU 24969, that Bokisch et al. 
(1983) used to characterize the Helix excitatory receptor have been shown not 
to be as specific as was originally thought. MK 212 has been proved to be 
unselective for 5-HT2 receptors and RU 24969 has equal selectivity for 5-HT% 
and 5-HT2 receptors. In the present study, IpM ketanserin lacked antagonistic 
activity towards the 5-HT excitatory response seen in the identified neurones 
in the visceral ganglion and higher concentrations of ketanserin were not 
tested. This lack of antagonism for the depolarizing 5-HT response by 
ketanserin would appear to indicate that the 5-HT receptor on Helix neurones 
does not fall into the vertebrate 5-HT2 receptor type. In contrast, looking at the 
actions of the specific 5-HT2 agonist, a-Me-5-HT, it would appear more likely 
than the 5-HT receptor on Helix neurones could be of the 5-HT2 type. 
However from the structure-activity study on the excitatory receptor for 5-HT 
in Helix  neurones performed by Woodruff and Walker (1972), a -m e th y l  
analogues of 5-HT were found to produce responses similar to 5-HT although 
the compounds were slightly less potent. This observation was in agreement 
with that found by Greenberg (1960) for Mercenaria heart, where the a-methyl 
analogue of 5-HT was very similar in action to 5-HT. This is also mirrored by 
the finding in this study that a-methyl-5-HT proved to be only 3 times less 
potent than 5-HT on the isolated Helix heart. Yet for the heart preparation, 
ketanserin also lacked antagonistic effect to 5-HT. It is therefore concluded 
that the lack of antagonist action by ketanserin indicates that a 5-HT2 receptor
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is not present on the neurones and that the agonist activity shown by a-Me-5- 
HT could be attributed to its affinity for Helix  5-HT receptor by virtue of a 
property, as yet unknown.
None the less the results seen with the 5-HT receptor agonists are 
confusing: both 5-CT and sumatriptan, which are 5-HTi receptor agonists, also 
elicited responses similar to, if not the same as, 5-HT. 5-CT certainly appeared 
to be more potent than sumatriptan whose responses from the same cell were 
always smaller than those of 5-HT.
Difficulties with iontophoretic application of agonists
The technique of iontophoresis is well established, but it necessitates a 
relating of the effects on neuronal activity to the current passed and to the 
time for which it is applied rather than to the quantity of the substance 
released from the electrode. Inevitably, therefore, the technique is more 
qualitative than quantitative. Bradley and Candy (1970) found that in the 
range normally used in the iontophoretic study of these compounds, the 
release of [^H]ACh and [^H]5-HT was directly proportional to the electrical 
charge passed. However, Kelly (1975), in his review of the principles of 
microiontophoretic application of drugs, concluded that the actual amount of 
material released by a particular current varied from microelectrode to 
microelectrode and from substance to substance in a quite unpredictable way. 
Although the effects of this variability could normally be overcome, it made 
the interpretation of apparently negative results extremely difficult. Nejit et 
aL (1988) suggested that in order to apply known concentrations of agonists, 
which was impossible with standard iontophoresis techniques, a superfusion 
system for whole cells be used. In their study they utilised a continuous flow  
system  which, for adjustable periods, could be switched to solutions 
containing agonists or antagonists by a servo-motor operated valve. This flow  
could then be applied to the cell in question from a capillary of 1mm diameter 
located at approximately 1mm from the cell. Such a system was not employed 
in the present study. Nevertheless despite the qualitative nature of the 
results, conventional iontophoresis proved adequate for investigating the 
5-HT receptor on identified Helix neurones.
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A possible 5-HTg receptor
Due to the above-noted similarities with the 5-HT responses in cultured 
neuroblastoma cell lines and in other tissues, it was deduced that the receptor 
on identified Helix neurones mediating the A response (as described by 
Gerschenfeld and Paupardin-Tritsch 1974a), might be of the 5-HTg type. Three 
specific 5-HT3 receptor antagonists, ondansetron (at 0.1, 1 and lOpM), MDL 
72222 (at IpM) and ICS 205-930 (at IpM) were all tested against the 5-HT 
response in the identified Helix neurones. None of these compounds, at these 
concentrations, displayed antagonistic action towards the 5-HT response. 
Hales et al. (1988) found that InM ondansetron reversibly reduced whole cell 
currents evoked by 5-HT NCB-20 neuroblastoma hybrid cells. In NIE-115 
neuroblastoma cells O.lnM ICS-205-930 reduced the maximum evoked  
response to 5-HT by about 50% (Nejit et a l ,  1988). Thus it appeared that the 5- 
HT3 receptors present in these neuroblastoma cell lines are sensitive to low  
concentrations of these specific antagonists which show high affinity for this 
receptor type. Even in neurones of guinea pig submucous plexus, where there 
is thought to be a 5-HT3 receptor, the effect of 5-HT was blocked by ICS 205-930 
(10-500nM) and ondansetron (lO-lOOOnM) (Derkach ef «/., 1989). This indicates 
a lower affinity of these antagonists at this 5-HT3 receptor, but a block was still 
observed by both compounds at IpM. Therefore a IpM concentration of the 
specific 5-HT3 antagonists was considered sufficient to cause a block of the 
5-HT response in identified Helix cells if a 5-HT3 receptor were present.
Richardson and Engel (1986) proposed the existence of three subtypes of 
5 -HT3 receptors termed 5 -HT3A, 5-HT3 g and 5-HT3C. Their evidence for this 
subclassification stemmed from substantial differences in the affinities of 
certain antagonists for the 5-HT3 receptors present on i)sympathetic ganglion 
cell somata and primary visceral afferents (3A subtype), ii)the terminals of 
postganglionic sympathetic neurones in the rabbit heart (3B subtype), and 
iii)enteric neurones of the guinea pig ileum (3C subtype). However, recent 
evidence suggested that species, rather than tissue, differences might at least in 
part have explained the reported heterogeneity of 5-HT3 receptors (Butler et 
a l ,  1990). Burridge et al. (1989) and Lattimer et al. (1989) have demonstrated 
that several 5-HT3 receptor antagonists display lower affinities in guinea pig 
vagus nerve compared to rat vagus nerve. Furthermore, antagonist affinities
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in guinea pig vagus agreed well with those that have been determined in the 
ileum from the same species; this suggested a common receptor type in the 
two tissues.
Despite the evidence from vertebrates that there could be a species 
difference in the 5-HT3 receptor, it is unlikely that in Helix a 5-HT3 receptor 
exists because of the inability of the specific 5-HT3 receptor antagonists to 
inhibit the depolarizing response to 5-HT. This hypothesis, however, cannot 
be totally discounted: it could be postulated that the Helix  neuronal 5-HT 
receptor might be a ligand-gated ion channel as the 5-HT3 receptor has been 
found to be in vertebrates (Derkach et al., 1989), but that it does not show the 
same recognition sites as the vertebrate 5-HT3 receptor. In this way the 
response to 5-HT in Helix neurones could show many similarities, as indeed it 
does, with the 5-HT response mediated by 5-HT3 receptors without being 
susceptible to inhibition from the specific 5-HT3 receptor agonists and 
antagonists. This hypothesis would assist also in interpreting the blockade of 
the 5-HT depolarizing response by tubocurarine. It has been argued by Yavari 
et al. (1979) that tubocurarine exerts its blocking effect by non-specific 
interaction with ion channels not receptors. This is the most probable action 
of tubocurarine in Helix neurones; it exerts its blockade of the 5-HT response 
by blocking the ion channel, which is gated by 5-HT. This gating of the ion 
channel by 5-HT can be achieved in one of two ways — either the receptor is 
directly linked to an ion channel, like that of 5-HT3 receptors (Derkach et a l ,  
1989) or the receptor is indirectly linked to the channel via cAMP which itself 
causes opening of the channel. The latter hypothesis is the more probable of 
the two as there is a difference in the timing of the 5-HT response — the 5-HT 
response in Helix  neurones is much slower, being in the region of 20-30 
seconds, whereas the 5-HT response mediated by the 5-HT3 receptor-channel 
complex is considerably faster, being in the millisecond range.
A possible 5-HT-j receptor
Bokisch et a l  (1983) concluded that the excitatory type A 5-HT receptor 
on Helix  neurones was similar to the mammalian 5-HT% receptor, with 
respect to the agonists but not the antagonistic properties of the compounds 
tested. RU24969, which at the time was thought to be a potent 5-HT% receptor 
agonist, was tested and had no clear agonist action although it did antagonize
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the excitatory effects of 5-HT. In the present investigation other specific 5-HT% 
receptor agonists and antagonists were tested. Methiothepin, a 5-HT% receptor 
antagonist, failed to block any 5-HT response at a concentration of IjiM. Both 
5-HT% receptor agonists (5-CT and sumatriptan) proved to be potent agonists, 
although from the electrophysiological results presented here a comparison of 
potency values is difficult. 5-CT elicited responses similar in time course and 
size to 5-HT whereas the responses to sumatriptan were of similar time course 
but smaller than those of 5-HT. It appeared, from this evidence, that 5-CT and 
sumatriptan were acting at the same receptor site as 5-HT.
Effect of methysergide
The LSD derivative, methysergide, at a concentration of IpM, had no 
effect on the response elicited by 5-HT in identified Helix neurones. Having 
been found to be an agonist on the 5-HT receptor in the Helix heart and PRM 
m ethysergide was predicted to have a similar effect on the neurones. 
However in the present study, the action of the ergot and LSD derivatives on 
Helix heart failed to provide conclusive evidence that these compounds were 
exerting their effects through the 5-HT receptor. The high degree of agonism  
shown by these compounds on Helix  heart and PRM tissue suggests the 
possibility of a separate "ergot" receptor which when activated shows similar 
effects to 5-HT. The lack of response of methysergide on the identified visceral 
ganglion neurones indicates a possible difference in the affinity of the 
neuronal membrane of Helix to the LSD and ergot derivatives.
Conclusion
In the present study, no specific 5-HT receptor antagonist was found to 
block the excitatory 5-HT response, thought to be the A response described by 
Gerschenfeld and Paupardin-Tritsch (1974a). This lack of action for any of the 
tested 5-HT receptor antagonists made characterization difficult. If the 
excitatory 5-HT receptor on Helix neurones was of the 5-HT2 type as suggested 
by Bokisch et al. (1983), it w ould  more than likely be linked to 
phosphatidlyinositol turnover as is the case for vertebrate 5-HT2 receptors. 
This intracellular mechanism has yet to be linked to 5-HT receptors in 
molluscan ganglia. It is cyclic nucleotides, such as cAMP, that have been 
implicated in the mechanism of action of 5-HT at many sites in invertebrates.
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The binding studies by Drummond et al. (1980a,b) provided evidence that the 
5-HT receptors in Aplysia  and Helix nervous tissue were linked to adenylate 
cyclase. Cyclic AMP appeared to mimic the action of 5-HT in identified 
neurones in Aplysia (Pellmar, 1981). In a number of Helix  neurones, 5-HT 
induced an inward current which was associated with a decrease in potassium 
conductance (Deterre et a l ,  1982), This response could also be induced by 
cAMP.
Also confusing the characterization of the neuronal 5-HT receptor in 
Helix  are the results with the different specific 5-HT agonists. 5-CT and 
sumatriptan, both 5-HT% receptor agonists, elicited responses similar to 5-HT 
in the identified neurones. Thus in terms of agonist pharmacology, the 5-HT 
receptor would appear to have characteristics of both 5-HT% and 5-HT% 
receptors whereas for antagonist pharmacology no characterization can be 
made. Despite the lack of antagonism by the 5-HTg receptor antagonists, it is 
interesting to speculate that neuronal 5-HT receptors in Helix  could be ion 
channels as has been show n for 5-HTg receptors in vertebrates. The 
similarities between the Helix  neuronal 5-HT depolarizing response, under 
investigation, and the 5-HT response m ediated by 5-HTg receptors in 
vertebrates are extensive and would appear to indicate that the ionic channels 
mediated by 5-HT, in each case, are the same. However the recognition sites of 
H el ix  neuronal receptors and vertebrate 5 -HT3 receptors must differ in 
structure because of the difference in affinity of the two receptors to the specific 
5-HT receptor agonists and antagonists.
The present data thus imply that the 5-HT receptor on the identified 
Helix neurones is unique in that it cannot be either characterized or classified 
into any of the presently acknowledged vertebrate 5-HT receptor categories. In 
order to evaluate this hypothesis, further investigation is necessary.
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CHAPTER THREE 
THE 5-HT RECEPTOR ON HELIX HEART
INTRODUCTION
Primary studies of the action of 5-HT on molluscan hearts
The stimulatory action of 5-HT on molluscan hearts was first described 
by Erspamer and Ghiretti (1951). They demonstrated that enteramine, so 
called because of its derivation from enterochromaffin cells of the 
gastrointestinal mucosa (and later identified as 5-HT (Erspamer and Asero, 
1952)), provoked a marked increase in the amplitude and frequency of systolic 
contractions of both Octopus and Helix hearts, whether isolated or in situ. The 
tonus of the hearts also rose conspicuously and with larger doses of 5-HT a 
persistent systolic arrest could be seen. The stimulant action extended also 
over the pulsatile arteries such those of the kidney and gills, with  
reinforcement of their contractions or renewal of their rhythmic activity if this 
had disappeared. The hearts of Murex trunculus, Murex hrandaris, Dolium 
galea and Aplysia limacina were, however, found to be less sensitive than 
either Helix or Octopus hearts
At about the same time Welsh (1953) found that the heart of Mercenaria 
mercenaria was stimulated by low  concentrations of 5-HT. The Mercenaria 
heart was believed to be singly innervated by inhibitory neurones which were 
thought to release acetylcholine (ACh), the most likely candidate for such an 
inhibitory transmitter. Antagonists of ACh, such as mytolon, were applied to 
the clam heart. These antagonists inhibited the ACh receptors and on 
stimulation of the visceral ganglion the frequency and amplitude of heart beat 
was increased markedly. This was strong evidence for double neuronal 
innervation of the clam heart. When adrenaline and noradrenaline were 
applied to the clam heart they were found to excite the organ, but only in high 
concentrations: both substances caused an increase in the rate of the heart 
(Welsh, 1953). Other excitatory drugs tested on the heart included certain ergot 
alkaloids, which were found to act at lower concentrations. The excitation 
produced by 5-HT mimicked closely the excitatory effects induced by indirect 
stimulation of the ganglion controlling the clam heart which had previously 
been treated with ACh inhibitors. Further studies by Welsh (1954) included
40
the use of several agents, such as LSD and the ergot alkaloids, that inhibited 
5-HT; when these were applied to the heart the excitatory function of the 
nerves Innervating the heart was abolished. Welsh considered this strong 
circumstantial evidence that a neurotransmitter substance was produced to 
excite the clam heart and that this substance was 5-HT.
An extensive study was carried out by Greenberg (1960 a,b) on 
Mercenaria heart. Hearts exposed to high concentrations of 5-HT or other 
tryptamine analogues for long periods became tachyphylactic to low doses of 
these substances. However high doses of 5-HT (> 20pM) still excited the 
tachyphylactic heart but the response was like that of the catecholamines.
Greenberg (1960b) and Bertaccini and Zamboni (1961) tested a number of 
tryptamine analogues on the isolated hearts of M e r c e n a r ia  and H e l i x  
respectively. Of interest in Greenberg's study was the potency of LSD which 
was found to have an exceedingly low  threshold concentration on the 
Mercenaria  heart. Greenberg suggested that the LSD molecule must bind 
tightly to the 5-HT receptor to account for this high potency and that this gave 
an indication of the most likely conformation of 5-HT for maximum activity. 
It was an interesting observation that LSD was so potent on molluscan heart 
tissue. The interaction between LSD and 5-HT had previously been shown on 
the rat uterus where it was in fact an antagonist, giving a pA2 valus of 8.7 
(Gaddum, 1953).
Development of molluscan hearts as bioassays
Since the studies of Welsh (1953, 1954), the heart of M e r c e n a r i a  
mercenaria has been considered one of the most suitable preparations for the 
bioassay of 5-HT. The response of this heart showed, like that of Helix and  
Octopus,  three components: an increase in amplitude and frequency of heart 
rate and an increase in the resting tone of the muscle. The relative 
importance of these components varied with the 5-HT concentrations. At low  
to moderate concentrations (InM -lpM ), a positive inotropic effect was 
dominant whereas at high concentrations (>10|iM) a large increase in muscle 
tone was seen. Because of its sensitivity to low concentrations of 5-HT it was 
the Mercenaria  heart that was first used as a bioassay to demonstrate the 
presence of 5-HT in mammalian urine and tissues (Twarog and Page, 1953).
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Gaddum and Paasonen (1955) investigated the action of 5-HT on a range 
of molluscan hearts in an attempt to establish a convenient bioassay for 5-HT 
which involved molluscs living either in Britain or in its coastal waters. This 
had the advantage for workers in Britain in being more easily available than 
Mercenaria mercenaria,  whose native habitat is the coastline of the U.S.A. 
The heart of Solen siliqua was stimulated by Ipg.l"^ 5-HT, and also by LSD and 
ergometrine. 5-HT (Ipg.L^) also excited the hearts of Cyprina islandica, Mya  
arenaria. Helix aspersa. Helix pomatia and Spisula solida (Gaddum  and 
Paasonen, 1955). LSD, ergometrine, dihydroergotamine and hydergine all 
increased the amplitude of the Helix aspersa heart beat, but could not be 
shown to block 5-HT. LSD and 6-methygramine failed to block the action of 
5-HT on the heart of Helix pomatia.
Innervation of molluscan hearts
Most molluscan hearts were thought to receive both inhibitory and 
excitatory innervation, usually via the visceral ganglion and nerve. The 
extrinsic nerve supply of Helix pomatia was described by Ripplinger (1957). It 
was shown to consist of two branches which originated in the visceral nerve. 
One branch entered the heart at the pulmonary vein-atrium junction and the 
second joined at the ventricle-aorta junction. Later Ripplinger and Ripplinger 
(1975) showed that the inhibitory innervation in Helix  terminated in the AV 
region. Cottrell and Osborne (1969) described a dense network of nerve fibres 
in the AV junction of the heart of Helix pomatia.  Their results, both with 
light and electron microscopy, suggested that this system had a neurosecretory 
function. By means of a fluorescent histochem ical technique they 
demonstrated the presence of 5-HT and/or one of the primary catecholamines 
within the nerve fibres of the Helix pomatia heart.
Attempt to characterize the 5-HT receptor present on the Helix heart
Evidence from extensive studies on vertebrate central 5-HT receptors 
suggested that there was more than one type of 5-HT receptor as discussed 
previously. As 5-HT had such potent actions on molluscan hearts which 
indicated the presence of a specific 5-HT receptor, an attempt to classify this 
receptor in terms of 5-HT% or 5-HT2 was made by Boyd et al. (1985). The 
actions of a number of agonists and antagonists were studied on the 5-HT
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receptor present within the heart muscle cells of Helix  aspersa.  They 
concluded from the agonist studies that the 5-HT receptor was possibly of the 
5-HT%-like type as RU24969 had appeared to be more 5-HT%-like than MK212. 
This was supported by the finding that ketanserin, a potent 5 -HT2 receptor 
antagonist, was only a weak antagonist of this 5-HT receptor. However, they 
were unable to clearly separate the Helix heart excitatory 5-HT response into 
either the 5-HT%-like or 5-HT2 type of receptor.
Involvement of cAMF in the action of 5-HT on molluscan hearts
Additional evidence that implicated cAMP as an intracellular mediator 
of 5-HT-induced excitation was presented by Higgins (1974). 5-HT (IpM) 
increased adenylate cyclase activity and intracellular cAMP levels in the 
ventricular muscles of the bivalves Mercenaria mercenaria and Macrocall is ta  
nimhosa,  but had no effect on cGMP. A positive correlation between the 
excitatory action of 5-HT and the simultaneous increase in intracellular cAMP, 
suggested that this nucleotide mediated the excitatory action of 5-HT. Cyclic 
AMP, dibutyryl cAMP and phosphodiesterase inhibitors had no effect on the 
mechanical activity of isolated bivalve hearts but m ethysergide (IpM) 
antagonised the action of 5-HT on the Mercenaria heart.
Higgins and Greenberg (1974) investigated the effects of cAMP, cAMP- 
induced phosphorylation and 5-HT on calcium uptake by bivalve heart 
microsomes. They found that the cAMP-mediated phosphorylation of 
microsomal protein augmented calcium uptake, but 5-HT and cAMP also 
directly induced a similar increase. Their study suggested that cAMP could 
mediate 5-HT action by either the activation of a cAMP-dependent protein 
kinase or by direct modification of the amount of membrane-associated 
calcium. Wolleman and S-Rozsa (1975), showed that 5-HT (IpM) stimulated 
the activity of adenylate cyclase prepared from heart tissue of Anodonta  and 
Helix.  Higgins (1977) found that a high concentration of 5-HT specifically 
desensitized the isolated ventricle of Mercenaria and that this 5-HT-induced 
tachyphylaxis was paralleled by a 5-HT-specific desensitization of the 
myocardial adenylate cyclases and a decrease in cAMP.
Hess et al. (1981) studied the effects of theophylline and IBMX on the 
contractility, cAMP content and phosphodiesterase activity of M. mercenaria
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ventricle. They found that both IBMX and theophylline were relatively poor 
inhibitors of Mercenaria myocardial cAM P-dependent phosphodiesterase 
activity, and that this accounted for the inability of these agents to increase 
either myocardial intracellular cAMP levels or contractility. Later Drummond 
et ah (1985) reported the stimulation of adenylate cyclase in the heart of 
Aplysia californica by 5-HT and forskolin, a plant diterpene which had been 
found to have a stimulating action on membrane-bound adenylate cyclase in a 
variety of mammalian tissues. From their experiments it was clear that 5-HT 
stimulated enzyme activity in the Aplysia heart by a receptor-mediated process 
which was antagonised by 5-HT receptor blockers. 5-HT-stimulated enzyme 
activity was also antagonised by low  calcium ion concentration and they 
suggested that this divalent cation exerted regulatory properties on the 
enzyme. Adenylate cyclase activity was augmented by forskolin. At the same 
time Paciotti and Higgins (1985) were studying the potentiation of the 5-HT- 
induced increases in myocardial contractility in Mercenaria ventricle by 
forskolin. They found that forskolin (lOjiM) increased the myocardial 
mechanical response and intracellular cAMP at all doses of 5-HT. However, 
forskolin alone significantly elevated cAMP levels but did not affect 
contractility.
Cardioactivity not associated with 5-HT in molluscan hearts
Throughout the 1960s, cardioactivity not associated w ith the 
neurotransmitters 5-HT, ACh and the catecholamines was detected in extracts 
of molluscan ganglia (Greenberg et ah, 1973). Frontali et ah (1967) had 
previously used gel filtration to resolve this activity into five cardioexcitatory 
peaks. The number of peaks varied with the species and three of the peaks, 
designated A, B and C, from the ganglia of Mercenaria were shown to be 
peptides.
By 1980 only peak C from the pooled ganglia of the sunray clam, 
Macrocallistra nimhosa, had been fully purified, identified and synthesized. It 
proved to be a tetrapeptide with a blocked carboxyl terminal, Phe-Met-Arg- 
Phe-N H 2, which subsequently became known as FMRFamide (Price and 
Greenberg, 1977). Higgins et ah (1978) tested both FMRFamide and 5-HT on 
the ventricle of the bivalve Mercenaria mercenaria: both agents increased 
myocardial contractility, intracellular cAMP concentration of intact hearts and
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adenylate cyclase of a myocardial membrane fraction. In the bivalve, they 
found FMRFamide was 5-10 times more potent than 5-HT. All the effects of 
5-HT, but none of those of FMRFamide, were blocked by methysergide. This 
effect of methysergide proved that FMRFamide and 5-HT activated separate 
receptors, but that they shared the same common intracellular mechanism  
involving adenylate cyclase and cAMP. Moreover, Higgins (1977) had shown 
that Mercenaria hearts made tachyphylactic to 5-HT could yet respond to 
FMRFamide, showing increased contractile force, raised levels of cAMP and 
increased adenylate activity. In Helix  heart, FMRFamide was found to 
increase the myocardial contractility, although it proved to be only a weak 
agonist compared to 5-HT (Greenberg and Price, 1980).
FMRFamide itself appears now to be ubiquitious among molluscs. In 
some gastropods, however, related peptides also are known. In particular, 
pulm onate ganglia were found to have activity not attributable to 
FMRFamide. In Helix aspersa, the ganglia contained not only FMRFamide but 
also related peptides distinguishable by their chromatographic behaviour and 
biological activity (Cottrell et a l ,  1981). Price et al. (1985) identified a novel 
FMRFamide-like peptide in Helix ganglia, pQDPFLRFamide, which was found 
to be 100 times more potent than FMRFamide on the isolated Helix heart: this 
suggested it acts as a cardioregulatory hormone.
Evidence for other transmitter action in molluscan hearts
From evidence in vertebrates, ACh acting on nicotinic receptors on the 
cardiac sympathetic nerves in the isolated rabbit heart was shown to be 
excitatory causing an increase both in atrial and ventricular tension. It was 
with this preparation that some 5-HT-like agonists were observed to have a 
dual mechanism of stimulant action which involved not only receptors 
sensitive to 5-HT but also nicotinic receptors (Fozard and Mobarok Ali, 1978). 
The action of ACh on the cardiac nerves in vertebrates was in contrast to its 
action on invertebrate hearts, particularly molluscan hearts. ACh had been 
found to be the most potent compound for inhibition of the heart in molluscs 
(Prosser, 1940). Welsh (1943) had used the heart of Mercenaria as a bioassay for 
the quantitative estimation of ACh in tissue extracts.
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It had been suggested also that catecholam ines m ight act as 
neurotransmitters in molluscs. Catecholamines were certainly found to be 
present in the nervous system of some molluscs (Osborne and Cottrell, 1970), 
and were usually excitatory on hearts, causing increases both in amplitude and 
rate of beat. Noradrenaline was generally much less active than dopamine on 
the hearts, with adrenaline being virtually inactive. Thus, receptors for the 
catecholamines are clearly present on molluscan hearts but whether they fall 
into the same categories as those described for vertebrates remains to be seen. 
Evidence for a possible interaction between 5-HT and noradrenaline on 
isolated vertebrate hearts emanated from a study on the isolated rabbit heart, 
in which 5-HT caused noradrenaline release from noradrenergic nerve 
terminals by a receptor mechanism (Fozard and Mwaluko, 1976).
The final compound thought to have possible action on the Helix heart 
is histamine. By far the most convincing evidence for a transmitter role for 
histamine in invertebrates was in the gastropod CNS. Histamine had a 
powerful action on Helix neurones and this action was antagonised by the H% 
antagonist mepyramine (Kerkut et a l ,  1968): histamine excited some cells 
while inhibiting others. Studies attempting to classify the histamine receptors 
into H% and H2 on Helix aspersa neurones have been undertaken (Caine, 
1978). The data showed that there were differences between the histamine 
receptors of different neurones and so there was difficulty in classifying them 
in terms of H% and H2 . Evidence for histamine receptors on the Helix heart is 
decidedly lacking but their presence in the heart and the cardiovascular system 
in vertebrates suggested the possibility of their presence on invertebrate hearts.
Dependence of molluscan heart on calcium ions
It has long been known that the isolated superfused ventricle of Helix  
aspersa is dependent on external calcium for force generation in isometric 
contractions induced by AC stim ulation (Burton and Mackay, 1970). 
Intracellularly recorded action potentials from molluscan hearts have a typical 
cardiac form, in that a slowly rising prepotential appears to trigger a spike 
which gives way to a prolonged plateau during repolarisation (Irisawa et a l ,  
1967; Kiss and S-Rozsa, 1973). The resting potential in Helix pomatia  
ventricular muscle cells was dependent mainly upon external potassium, but
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was diminished by the sodium diffusion potential, as shown by a 20% 
hyperpolarisation in the absence of external sodium. The action potentials of 
the ventricular cells were abolished in zero external sodium  or in zero 
external calcium substitutions being made by Tris and sucrose respectively. 
Thus both sodium and calcium participated in the generation of the Helix  
action potential. A relationship between plateau duration and force of 
contraction was found to be evident in molluscs which showed this type of 
cardiac action potential. The higher the plateau, the larger the force of 
contraction. 5-HT was found to increase the plateau height (Hill, 1974a; Hill 
and Yantorno, 1979). Thus it w ould appear that calcium was intimately 
involved in the generation of the cardiac action potential and could 
contribute to the excitatory effect seen with 5-HT in molluscan hearts.
A im s
From the wealth of evidence presented here, it is apparent that 5-HT 
has a potent cardioactive effect on molluscan hearts. From this evidence, 
5-HT is presumed to be the excitatory transmitter, particularly on Mercenaria 
and Helix  hearts. The aim of this study was to attempt to characterize the 
excitatory 5-HT receptor, present on the heart of Helix aspersa, into one of the 
existing 5-HT receptor types already identified in vertebrates. This has been 
achieved by using a standard organ bath techniqué and isolated Helix hearts. 
The method involved monitoring the positive inotropic effect of bath-applied 
5-HT. In this way the effects of the specific 5-HT agonists and antagonists 
could also be clearly monitored.
From evidence already given, it would appear that cAMP was involved 
in the effect of 5-HT in molluscan hearts. It was therefore decided to test this 
hypothesis by measuring the effect of 5-HT on cAMP levels in Helix  heart 
tissue. In order to establish that 5-HT was not causing the release of other 
supposed transmitters by stimulation of receptors other than those of 5-HT, a 
series of suitable antagonists were tested against the action of 5-HT in the Helix 
heart. The action of the novel molluscan cardioactive peptides was observed 
so that a comparison could be made not only of the utility of the Helix heart as 
a preparation but also of the methods here employed as opposed to those 
employed in other studies. Though the main aim of this study was to 
characterise the 5-HT receptor mediating the inotropic effect of 5-HT on the
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isolated Helix  heart, other factors were taken into consideration. These 
included looking at the method of inactivation of 5-HT in the isolated heart 
and looking at the possible role played by calcium in the inotropic effect of 
5-HT in the preparation.
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METHODS AND MATERIALS
Anim als
Helix aspersa were purchased from Blades Biological. They were kept in 
a humid environment at room temperature in tanks enclosed with mesh wire 
and fed with lettuce at regular intervals. All snails used in this study were 
kept in the active state for at least one week before use.
Dissection
With the aid of sharp scissors, the snail's shell was totally removed by 
cutting round the spiral of the shell. The whole snail was then pinned by the 
head and mantle in a wax-bottomed dissecting dish with the head facing 
forwards. The heart is located in one of the grooves of the spiral and could 
easily be identified from (i) the darker colouration which delineated the heart 
area and (ii) the vessels leading to and from the heart, which like the heart 
itself, were outlined by darker colouration. Fig. 3.1 shows the position of the 
heart in Helix.  The pericardium was carefully cut open to avoid damage 
either to the heart or to the nephridium, which lies to the left hand side. Both 
perfused and non-perfused heart methods were assessed before a decision was 
made as to which one was to be used for the experiments. These two methods 
will be described separately below.
Perfused heart method
In this method, once the heart had been exposed, a small hole was cut 
in the atrium and a fine glass cannula inserted into the atrium and through to 
the ventricle. Using thread, the cannula was tied off as near to the AV 
junction as possible. The cannula was then lifted out of the animal and the 
rest of the atrium cut away so as to free the atrium end of the heart. A small 
wire hook was then attached to the aorta and the aorta cut distal to the 
insertion of the hook, thus freeing the whole ventricle. The ventricle was 
then mounted via the cannula onto a closed loop system originally devised by 
Payza (1987), but modified by Lesser (1990). The experimental apparatus is 
shown in Fig. 3.2. The hook in the aorta was threaded to a force transducer 
(L.V.D.T. type SMI Sangano transducer) which acted via a transducer 
amplifier onto a JJ two channel CR452 type pen recorder. The heart was
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perfused with physiological saline (80mM NaCl, 5mM KCl, 7mM CaCl2, 5mM 
M gC l2 , 20mM Hepes; pH 7.5) which flowed out of the aorta to bathe the 
external surface of the heart. This waste was collected in a beaker beneath the 
cannulated heart. The flow rate of saline was adjusted by two clips to provide 
a rate of 1-2 ml per minute: this varied from animal to animal, dependent on 
the intrinsic heart beat of each animal. In this way the heart preparations were 
spontaneously active and could remain beating for several hours. After 
setting up the heart, it was perfused for 30 minutes, to allow it to equilibrate 
and to wash away any free proteins or enzymes. Aliquots of 5-HT solutions of 
known concentration, made up in physiological saline, were applied with a 
needle and syringe, via an injection cap. The response to a single dose of 5-HT 
was measured as the percentage increase in myocardial contractile force above 
the control amplitude. 5-HT was the only drug to be tested in this method 
over the range InM-lOOpM. This method was not used for the other 
experiments, the reasons for which are discussed later
Non-perfused heart method
Once the heart had been exposed, a piece of thread was placed 
underneath the AV node and the junction tied off, leaving a small thread 
loop. The atrium was then cut away. A small wire hook was placed in the 
area where the aorta joins the ventricle and while the ventricle was still 
attached to the animal. Once the hook was firmly in place the aorta was cut 
distal to the hook's point of insertion. The isolated ventricle was then 
mounted in a 10ml organ bath suspended between an L-shaped stainless steel 
wire support and the small wire hook, which was attached to a Dynamometer 
(UFl) isometric transducer. This transducer was in turn connected to a 
Lectromed 8-channel pen recorder. The experimental apparatus is shown in 
Fig. 3.3. As with the perfused hearts, the response to 5-HT was measured by 
the increase in myocardial contractile force above the control amplitude and 
expressed as a percentage relative to the maximum response achieved with 
5-HT in that preparation. The preparations were maintained at room 
temperature (18-20^C) in a gassed (95% O2 5% C02 ) physiological saline (80mM 
NaCl, 5mM KCl, 5mM MgCl2, 7mM CaCl2/ 20mM Hepes; pH 7.5). Once again, 
when set up, the hearts were spontaneously active and remained beating for 
several hours. Initially, a series of force-tension curves were devised for the 
hearts in order to indicate the optimum resting tension of the isolated hearts.
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FIGURE 3.2
Diagram of the experimental apparatus used in the perfused heart 
method. The physiological saline reservoir was kept above the height of the 
heart with the level of saline constantly monitored in an attempt to keep the 
pressure constant. The silicon tubing was clamped at various points to control 
the flow of saline to the perfused snail heart. The saline overflowed at the tip 
of the ventricle to bathe the outside of the heart. The cannula, inserted into 
the ventricle of the snail heart was attached to a small Y- shaped tube which 
was joined in turn to the silicon tubing. A small injection cap on the Y- 
shaped tube allowed for the injection of known quantities of drugs. The heart 
was kept in place and its movement monitored by a small wire hook 
positioned in the ventricle-aorta region. This in turn was connected to a 
transducer via a thread loop. Any movement monitored by the transducer 
was amplified and recorded on a pen recorder.
FIGURE 3.3
Diagram of the experimental apparatus used in the non-perfused heart 
method. The isolated ventricle (A) was mounted in a 10ml jacketed organ 
bath (B) in physiological saline at room temperature aerated by a 95% O2, 5% 
CO2 mixture (C). The heart was fixed between an L-shaped stainless steel wire 
support (D) which was kept rigid in a clamp present above the bath. A wire 
hook (E) was attached to a transducer (F). The transducer in turn, was 
connected to an 8-channel pen recorder.
This was achieved by increasing the tension on the heart by stepwise increase 
of the amount of stretch on the heart. This value could be read off the chart 
recorder which was fully calibrated daily. With each increase in tension a 
submaximal concentration of 5-HT (IpM) was added to the bath. The response 
to 5-HT was seen as an increase in heart beat amplitude giving a value for 
force involved in the response. Between each 5-HT application, the 
preparation was washed to remove any residual 5-HT before the next increase 
in tension. The curves varied from heart to heart but a range of optimum  
resting tensions was obtained and used in the subsequent experiments.
After an initial 30 m inute equilibration period, a cum ulative 
concentration-effect curve to 5-HT was established. Successive concentrations 
from lOnM-lOOpM were applied to the heart. The response of the heart to 
increasing concentrations of 5-HT was seen as increases in heart beat 
amplitude. Once the response, in amplitude, to the previous concentration 
had reached a plateau, the subsequent concentration of 5-HT was added 
without washing. When two consecutive concentrations of 5-HT produced no 
further am plitude in heart beat, the tissues were washed with fresh 
physiological saline to remove the 5-HT. This cumulative concentration- 
effect curve to 5-HT was established in all preparations; first, to test the 
viability of the ventricle and its sensitivity to 5-HT and, second, to provide a 
control curve before the application of test agonists, antagonists and other 
drugs under investigation.
Determination of agonist potency
The effect of agonists on the myocardial contractile force was tested by 
constructing a cumulative concentation-effect curve to. the agonist up to a 
maximum concentration of lOOpM This was done once the amplitude of the 
heart had returned to normal after the washing period which followed the 
initial cumulative concentration-effect curve to 5-HT. In control preparation, 
the cumulative concentration-effect curve to 5-HT was repeated to assess 
changes in sensitivity of the tissue to 5-HT. Agonist responses were measured 
as the increase in myocardial contractile force above the control amplitude. 
Each response was expressed as a percentage of the maximal effect. From log 
concentration-effect curves, the concentration producing half-maximal effect 
(EC50 ) was obtained. The equipotent concentration ratio (ECr) for the test
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compound relative to 5-HT (5-HT = 1) was calculated by dividing the EC50  
value for the test compounds by the EC50 value for 5-HT. Where quoted the 
pECgo value was the negative logarithm%o of the EC50  value. Arithmetic 
mean EC50  values for each agonist were calculated from each individual 
curve. The 5-HT receptor agonists tested on the isolated heart were 5-CT, 
sumatriptan and 8 -OH-DPAT (all 5-HT% receptor agonists), a-Me-5-HT (a 
5-HT2 receptor agonist), 2-Me-5-HT (a 5-HT3 receptor agonist) and tryptamine.
Determination of antagonist potency
Likely antagonists of this myocardial contractile response were tested by 
examining their ability to antagonise the increase in amplitude produced by 
5-HT. In all preparations, cumulative concentration-effect curves to 5-HT 
were obtained. After washing, all but one of the preparations (which served as 
a control and thus remained untreated) were exposed to a known 
concentration of vehicle or antagonist. After 30 minutes a cumulative 
concentration-effect curve to 5-HT was repeated in all preparations. If 
antagonistic action was established and after washing, the preparations were 
then exposed to increasing concentrations of the antagonists before another 
concentration-effect curve to 5-HT was generated. In this way, the agonist 
concentration-ratio could be calculated for each antagonist concentration 
(Apperley et ah, 1976). This was achieved by dividing the concentration of 
5-HT required to produce a response at that point in the presence of 
antagonist, by that required for 5-HT in the absence of antagonist. These 
estimates could then be used to calculate pA2 and slope values by linear 
regression analyses of Schild plots (Arunlakshana and Schild, 1959). The 5-HT 
receptor antagonists tested on H elix  heart were methiothepin (a 5-HT% 
receptor antagonist), ketanserin and ritanserin (both 5-HT2 receptor 
antagonists), cocaine, ondansetron and ICS 205-930 (all 5-HTg receptor 
antagonists) and finally metoclopramide (an M receptor antagonist).
Statistics
Values were expressed as the arithmetic mean ± s.e. mean of n, n being 
the number of experiments
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Effects of Other Drugs
Other compounds which did not fall into the categories of either 5-HT 
agonists or antagonists were treated in the same way as the 5-HT receptor 
antagonists, being allowed to equilibrate in the bath for 30 minutes before the 
5-HT cumulative concentration effect curve was repeated. There were three 
exceptions which were treated as agonists, the ergot derivatives, the molluscan 
cardioactive peptides and isoprenaline. A low calcium saline was also tested 
on the isolated heart preparation. The calcium concentration in the 
physiological saline was reduced from 7mM to 3mM with substitition by 
sucrose to maintain isotonicity. The 4mM calcium was replaced by 12mM 
sucrose in order to replace each of the three ions into which CaCl2 dissociates 
in solution. These other drugs included a muscarinic blocker (atropine), a 
nicotinic blocker (hexaméthonium), an adrenergic p blocker (propranolol), an 
adrenergic a  blocker (phentolamine), a histamine (H%) blocker (mepyramine), 
a histamine (H2) blocker (ranitidine), the cardioactive peptides (FMRFamide 
and pQDPFLRFamide), a MAO inhibitor (pargyline), two 5-HT uptake 
inhibitors (fluvoxamine and zim elidine), a phosphodiesterase inhibitor 
(IBMX), a cAMP activator (forskolin), an adrenergic p agonist (isoprenaline) 
and finally the ergot derivatives (ergotamine, methylergometrine, LSD and 
methysergide). All the drugs tested and their full names and sources are listed 
below.
Drugs used
5-HT creatinine sulphate (Sigma), methiothepin maleate (Hoffman La 
Roche), phentolam ine m esylate (Ciba), atropine sulphate (Sigma), 
mepyramine maleate (May and Baker), methysergide hydrogen maleate 
(Sandox), metoclopramide monohydrochloride (Sigma), ketanserin tartrate 
(Janssen), IBMX (Sigma), isoproterenol (isoprenaline) bitartrate (Sigma), 
forskolin (Calbiochem), FMRFamide and pQDPFLRFamide (Peninsula 
Laboratories), ergotamine tartrate (Sigma), methylergometrine hydrogen 
maleate (Sandoz), pargyline hydrochloride (Sigma), fluvoxamine maleate 
(Duphar), zimelidine hydrochloride (Astra), verapamil hydrochloride (Sigma), 
ritanserin tartrate (Janssen), tryptamine hydrochloride (Sigma), ICS 205-930 
(Sandox), hexaméthonium bromide (Koch Light Laboratories), propanolol
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mhydrochloride (Sigma) and D-lysergic acid diethyl amine tartrate (Sandoz). 
Ranitidine hydrochloride, ondansetron, sumatriptan, a-Me-5-HT, 2-Me-5-HT 
and 8-OH-DPAT were all synthesised by the Chemistry Research Department 
at Glaxo Group Research.
All drugs were dissolved in physiological saline with the exception of 
ketanserin, ondansetron and ritanserin which were dissolved in O.IM tartaric 
acid and forskolin which was dissolved in DMSO with subsequent serial 
dilutions, in both cases, in physiological saline. Isoprenaline was always made 
up with lOOpM ascorbic acid to retain its stability. All drug concentrations 
quoted are final bath concentrations.
Measurement of cAMP formation
Hearts were dissected from the snails as previously described with as 
much of the atrium removed as possible, leaving only the AV node attached 
to the ventricle. Also at the ventricular end as much of the aorta was 
removed as possible. These were then incubated in gassed (95% O2 5% CO2) 
physiological saline (80mM NaCl, 5mM KCl, 7mM CaCl2  ^5mM Mg CI2, 20mM 
Hepes, pH 7.5) at room temperature for two hours. This depleted any 
endogenous 5-HT (Wolleman and S-Rozsa, 1975) and allowed adequate 
recovery time from the traumatisation of surgery. Following incubation the 
hearts were transferred to fresh physiological saline and incubated for a 
further 30 minutes in normal physiological saline or physiological saline 
containing the cAMP phosphodiesterase inhibitor IBMX (IGOpM) and test 
antagonists, where appropriate at appropriate concentrations. The hearts were 
then exposed to vehicle control or 5-HT for a further two minutes, after which 
they were rapidly frozen in liquid nitrogen to terminate cAMP formation.
The cAMP was extracted by homogenisation of the hearts in absolute 
ethanol using a glass-glass tissue grinder (Jencons Scientific). The extracts 
were then centrifuged at 15,000g for two minutes and the supernatants 
contained in the ethanol removed and dried under a gentle stream of nitrogen 
gas. When dry, the ethanol extracts were redissolved in a buffer (pH 7.5) 
comprising Tris-HCl (50mM) and EDTA (4mM). These samples were then 
assayed for cAMP content using a commercially available competitive 
binding-assay kit (Amersham International pic). The assay kit combined the
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high specificity and affinity for cAMP of a highly purified and stabilised 
binding protein with a charcoal separation step. The assay was based on the 
competition between unlabelled cAMP and a fixed quantity of the tritium 
labelled compound for binding to a protein which has a high specificity and 
affinity for cAMP. The amount of labelled protein cAMP complex that had 
formed related inversely to the amount of unlabelled cAMP present in the 
assay sample. Measurement of the protein-bound radioactivity enabled the 
amount of unlabelled cAMP in the sample to be counted. Separation of the 
protein bound cAMP from the unbound nucleotide was achieved by 
absorption of the free nucleotide onto coated charcoal follow ed by 
centrifugation. An aliquot of the supernatant was then removed for liquid 
scintillation counting. The concentration of unlabelled cAMP in the sample 
was then determined from the linear standard curve.
The remaining extracted pellets, after centrifugation, were dissolved in 
sodium hydroxide (IM) for the subsequent determination of protein contents 
by the method of Lowry et ah (1951). The procedure was based on the 
measurement of proteins with Folin-Ciocalteu phenol reagent after alkaline 
copper treatment which led to the development of a colour change whose 
optical density could then be determined. Standard solutions of BSA ranging 
from 25-100|j.g,ml"^ in O.IM sodium hydroxide, unknown samples diluted 1:10 
with distilled water to give samples in O.IM sodium hydroxide and blanks 
were added to appropriately labelled tubes. 2.5ml of alkaline copper tartrate 
was then added to each tube, mixed and left to stand at room temperature for 
10 minutes. 250jil of diluted (1:1 with distilled water) Folins reagent was 
added to each tube, mixed and left to stand for 30 minutes at room  
temperature. The optical density of each sample was then determined at 
750nm on a Pye Unicam SP-6-500 UV spectrophotometer. Using a plot of 
protein concentration (BSA standards) versus absorbance at 750nm, a standard 
curve could be generated. By the use of linear regression analysis, the 
unknown protein concentrations could then be determined from their 
absorbance values. Results were expressed as pmol cAMP formed.mg"^ tissue 
protein. These values were the arithmetic mean ± s.e. mean of n, n being the 
number of experiments.
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Histology
Several hearts were dissected out and placed in 10% buffered formalin. 
The slides were then prepared by the Histology Department, Glaxo Group 
Research. The hearts were embedded in wax before cutting longitudinal and 
transverse sections. A dye, Erlich's haematoxylin, was used to stain the cells. 
The slides were then view ed under an optical microscope with attached 
camera to produce photographic slides which were then developed by the 
photographic department at St. Andrews University.
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RESULTS
Structure of the Hel ix  heart
The Helix  heart is composed of a muscular ventricle attached to a 
smaller, less muscular atrium (Fig. 3.4). In Helix there is a pair of valves 
between the atrium and the ventricle which are shown and clearly marked 
with an arrow in Fig. 3.4. However the valve situated in the aorta is not 
visible in this section. An asterisk marks the place where this valve should be 
present (Fig. 3.4). The myocardial fibres in the Helix heart are arranged in a 
complex network of branching and anastomosing trabeculae (Fig. 3.5). The 
muscle bundles are arranged with the loose, large trabeculae towards the 
lumen of the ventricle and the smaller, more closely knit trabeculae towards 
the exterior. This is shown in Fig. 3,5. The Helix heart was capable of beating 
spontaneously and rhythmically in isolation. Cardiac action potentials could 
be spontaneously initiated within the more or less unmodified myocardial 
cells which made up the trabeculae. In this way the Helix heart was said to be 
myogenic (see Jones, 1983). An indication of the size of the isolated heart is 
given by the scale bars shown on the relevant sections.
Differences observed between the two previously described methods
Two different methods have been described previously for measuring 
the isolated heart's response to 5-HT. The experimental apparatus for the two 
methods was given in Figs. 3.2 and 3.3. Several sets of results were obtained 
with each method before a decision was made as to which method would be 
more suitable. These results are demonstrated in Figs. 3.6 and 3.7 and show  
the traces obtained from each method. Analysis of these traces led to the log 
concentration-effect curves shown in Figs. 3.8 and 3.9, The method finally 
chosen was the non-perfused heart method due to various underlying 
problems with the perfused heart method.
The system used in the perfused heart method is closed (see Fig. 3.2): 
any change in the liquid level in the reservoir therefore changed the pressure 
which in turn had an effect on the rate of beating of the perfused heart. 
Another persistent problem was that of dead space within the tubing. It was 
not possible with this method to tell i) how much of the injected bolus of 5-HT
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FIGURE 3.4
Photograph of a histological longitudinal section of the Helix  heart. 
Note the larger, more muscular ventricle, attached to the much smaller, less 
muscular atrium. An arrow indicates the presence of a pair of valves between 
the atrium and the ventricle. The valve situated in the aorta is not so clearly 
delineated.in this section. An asterisk marks the area in which the valve is 
usually located in the w hole animal. The small black dots indicate the 
position of the nuclei within the myocardial cells of the Helix heart. The scale 
is equivalent to 1mm.

FIG URE 3.5
Photograph of a histological transverse section of Helix  ventricle. This 
section clearly demonstrates the complex network of beam-like projections 
into which the myocardial fibres are arranged within the ventricle. The small 
black dots indicate the position of the nuclei in the myocardial cells of the 
ventricle. The scale is equivalent to 0.5mm.
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reached the heart and ii) at what concentration the 5-HT reached the heart. 
There was also the problem concerning tachyphylaxis in the perfused heart 
method. This method was more sensitive to the high concentrations of 5-HT 
and the heart became tachyphylactic to 5-HT concentrations above lOpM; this 
can be seen in Figs. 3.6 and 3.9 as a lowering of the inotropic response to 5-HT 
within the heart. Consequently, the maximum inotropic response to 5-HT 
seen in this method was difficult to measure accurately and the response (Fig. 
3.6) could be quantified only as a percentage increase in response above the 
control value (Fig. 3.9) Because the response of each heart to 5-HT varied 
markedly with this method, standardization of the data was impossible, 
leading to four different sets of results rather than just one set showing the 
arithmetic mean ± s.e. mean of n=4. Despite the fact that the perfused heart 
method showed greater sensitivity to 5-HT, with a threshold of approximately 
InM (Fig. 3.9) in contrast to a threshold of 10-30nM (Fig. 3.8) with the non- 
perfused method, it was the latter method that was chosen for the remainder 
of the experiments. The significance of this difference in sensitivity between 
the two methods will be discussed in detail later.
Response of Helix heart to 5-HT
From the recording traces in Figs. 3.6 and 3.7 it can be seen that 5-HT has 
potent positive inotropic effects. Positive chronotropic effects on Helix heart 
were observed only with the non-perfused heart method (Fig. 3.7). However, 
for experimental purposes only the inotropic effect of 5-HT was monitored 
because the chronotropic effects were variable and only occurred at high 
concentrations of 5-HT. In the non-perfused heart, 5-HT had a threshold 
value of between 10-30nM, reaching a maximum inotropic response at a 
concentration of 30|iM. From Fig. 3.8 it can be seen that the 5-HT inotropic 
response on the isolated Helix  heart was reproducible as indicated by the 
extent of overlap of the two 5-HT curves obtained consecutively with the same 
preparation. Even if a third 5-HT concentration-effect curve was performed on 
the same preparation, the curve was identical to those already obtained from 
that heart (result not show n here). This demonstrated not only good  
reproducibility of the 5-HT response on the same preparation but also 
indicated a lack of decrease in sensitivity of the heart tissue to 5-HT during the 
time course of the experiments. A control curve to 5-HT similar to that seen 
in Fig 3.8 was obtained for every experiment although the control 5-HT curve
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FIG URE 3.6
The response of the perfused Helix  heart to increasing concentrations of 
5-HT is shown in this figure which is a trace recording obtained from one 
preparation. The black arrows represent the administration of 0.1ml of 
increasing 5-HT concentration which are as stated. The response of the 
perfused heart to 5-HT was not measured cumulatively and each successive 
concentration of 5-HT was allowed to wash out before the next concentration 
was administered. Note that the perfused heart exhibited tachyphylaxis at a 
5-HT concentration above lOpM.
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FIG URE 3.7
The response of non-perfused Helix  heart to increasing concentrations 
of 5-HT. The trace recording obtained from one preparation is shown. The 
black arrows indicate the addition of 5-HT to the bath. The stated 5-HT 
concentration being the final bath concentration to which the Helix heart was 
exposed. In this method the concentration-effect of 5-HT on the isolated snail 
heart was cumulative as can be seen from the trace. The scale is as shown. In 
this method even at a 5-HT concentration of 30|iM, the Helix  heart failed to 
exhibit tachyphylaxis.
O)
CM
c
E
CM
CO
&
3L
CO
CO
Q>I
IIi
-O100 1
80-
60-
40 -
2 0 -
48 6 5•7
log 5-HT concentration (M)
FIGURE 3.8
The concentration-effect curve for 5-HT on the isolated Helix  heart 
using the non-perfused heart method is shown in this figure by closed circles. 
The X axis represents log of the 5-HT concentration while the y axis represents 
the percentage maximum inotropic response. A control concentration-effect 
curve for 5-HT on the same preparation, is also shown in the figure with open 
circles. Vertical bars represent the arithmetic means ± s.e. mean of n=22 .
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FIGURE 3.9
log 5-HT concentration (M)
The concentratlon-effects of 5-HT on the isolated Helix heart using the 
perfused heart method are shown in this figure. The different symbols 
represent values obtained from n=4 experiments. The y  axis gives the 
percentage increase in response above the control value while the x axis gives 
log of the 5-HT concentration. Note that at 5-HT concentrations >10pM the 
perfused heart exhibited tachyphylaxis.
is not shown on all the figures in order to be able to see the effect of the other 
drugs more clearly.
Force-tension relationship in the isolated heart
After a decision was made as to which method was to be used in 
investigating the 5-HT receptor present in the Helix heart, the force-tension 
relationship in the heart was investigated. Force-tension curves were 
obtained from four separate preparations (Fig. 3.10). A value for the optimum  
resting tension of Helix heart could then be ascertained from these curves at a 
point where the greatest rate of rise of force is seen for a small increase in 
tension. The value was found to be in the range 0.5-1 g depending on the 
individual heart.
Effect of other transmitter antagonists on the inotropic response to 5-HT in the 
heart
Figure 3.11 relates to a series of experiments performed on the isolated 
H e l i x  heart using antagonists other than those which were known to 
specifically block the different 5-HT receptor types. The cholinergic antagonist 
atropine, which blocks muscarinic receptors, at a concentration of IpM, had no 
effect on the inotropic response to 5-HT in the isolated Helix  heart. This is 
indicated by the extent of overlap of the two 5-HT curves, one in the absence 
and the other in the presence of atropine, which is shown in Fig. 3.11. The 
extent of overlap of the 5-HT concentration-effect curves was measured, in 
every case, by the dose-ratio value. Likewise these results, or lack thereof, 
were mimicked by the nicotinic antagonist, hexam éthonium  and the 
adrenergic antagonists propranolol and phentolam ine. N either  
hexaméthonium, propranolol or phentolamine, at a concentration of IjiM, 
had any effect on the 5-HT inotropic response in Helix  heart. Because the 
figures all proved to be similar to Fig. 3.11 it was decided to use Fig. 3.11 as the 
example and consequently none of the others are shown. Finally, the 
histaminergic antagonists, mepyramine and ranitidine, at a concentration of 
IpM, also showed no effect on the 5-HT inotropic response in Helix heart. 
These results are summarized in Table 3.1 overpage.
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FIGURE 3.10
Tension (g)
The relationship between the force generated by the isolated Helix heart 
in response to 5-HT and the tension applied to the heart is demonstrated in 
this figure which shows the results from four preparations. The tension 
applied to the heart is given by the x axis, while the y axis gives the force 
generated by the heart in response to a submaximal concentration of 5-HT. 
The concentration of 5-HT used was IpM. The force-tension curves obtained 
from the four isolated hearts varied from animal to animal as can be seen 
from this figure.
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FIGURE 3.11
The concentration-effect curves for 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence (open circles) of atropine at a 
concentration of IpM are shown in this figure. The x axis gives log of the 
5-HT concentration while the y axis gives the percentage maximum inotropic 
response. Vertical bars represent the arithmetic mean ± s.e. mean of n=6 .
TABLE 3.1 Summary of the other antagonists tested on Helix  heart.
Antagonist Concentration 
tested (pM)
n Effect
Atropine 1 6 dose-ratio = 1.0
H exam éthonium 1 6 dose-ratio = 1.0
Propranolol 1 6 dose-ratio = 1.0
Phentolamine 1 6 dose-ratio = 1.0
Mepyramine 1 6 dose-ratio = 1.0
Ranitidine 1 6 dose-ratio = 1.0
Effect of 5-HT agonists on the inotropic response of the heart
The specific 5-HT receptor agonists tested on the isolated Helix heart 
were 5-CT, sumatriptan, 8-OH-DPAT, a-Me-5-HT, 2-Me-5-HT and tryptamine. 
5-HT was the most potent agonist on Helix  heart (pECgQ value of 5.7). 5-CT 
and a-Me-5-HT both mimicked the effects of 5-HT (Fig. 3.12), but were less 
potent (pECgo values of 4.9 and 4.7 respectively). Sumatriptan, 2-Me-5-HT, 
tryptamine and 8-OH-DPAT behaved like partial agonists by eliciting a 
maximum inotropic response, of only 66% in the case of sumatriptan (Fig.
3.13), of only 56% in the case of 2-Me-5-HT (Fig. 3.13), 54% in the case of 
tryptamine (Fig. 3.14) and finally of only 47% in the case of 8-OH-DPAT (Fig.
3.14). 5-CT was 6 times less potent than 5-HT on Helix heart. a-Me-5-HT and 
sumatriptan showed a potency value of approximately 9 times less potent than 
5-HT. 2-Me-5-HT was 29 times less potent than 5-HT, tryptamine was 32 times 
less potent than 5-HT and 8-OH-DPAT being 43 times less potent than 5-HT on 
the isolated Helix heart. The above results are summarised in Table 3.2 
overpage. The rank order of potency for the specific 5-HT receptor agonists 
was found to be 5-HT > 5-CT > a-Me-5-HT = sumatriptan > 2-Me-5-HT = 
tryptamine > 8-OH-DPAT.
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FIGURE 3.12
log 5-HT concentration (M)
The concentration-effect curves for 5-HT (closed circles), 5-CT (open 
circles) and a-Me-5-HT (triangles) on the isolated Helix heart are shown in this 
figure. The x axis gives log of the 5-HT concentration while the y axis gives 
the percentage maximum inotropic response. Vertical bars represent the 
arithmetic mean ± s.e. mean of n=8 .
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FIGURE 3,13
log 5-HT concentration (M)
The concentration-effect curves for 5-HT (closed circles), 2-Me-5-HT 
(open circles) and sumatriptan (triangles) on the isolated Helix  heart are 
shown in this figure. The x axis gives log of the 5-HT concentration while the 
y axis gives the percentage maximum inotropic response. Vertical bars 
represent the arithmetic mean ± s.e. mean of n=8 .
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FIGURE 3.14
log 5-HT concentration (M)
The concentration-effect curves for 5-HT (closed circles), tryptamine 
(open circles) and 8-OH-DPAT (triangles) on the isolated Helix  heart are 
shown in this figure. The x axis gives log of the 5-HT concentration while the 
y axis gives the percentage maximum inotropic response. Vertical bars 
represent the arithmetic mean ± s.e. mean of n=8 .
TABLE 3.2 Summary of the 5-HT agonists tested on the Helix heart. The EC50 
and ECr values are molar values.
Agonist n EC50 ECr % maximum  
response
5-HT 22 5.7 ±0.1 1 100
5-CT 8 4.9 ± 0.8 6.0 ± 0.8 9 3 ± 3
(X-jMe-5“HT 8 4.7 ±0.1 9.2 ± 2.0 88 ± 2
Sumatriptan 8 4.7 ±0.1 9.5 ±1.0 66 ± 3
2-Me-5-HT 8 4.2 ±0.3 29.0 ± 3.0 56 ± 5
Tryptamine 8 4.2 ±0.3 32.0 ± 5.0 5 4 ± 8
8-OH-DPAT 8 4.0 ± 0.1 43.0 ± 6.0 4 7 ± 4
Effects of the ergot derivatives on the inotropic response in the heart
The ergot derivatives ergotamine and methylergometrine and the 
lysergic acid derivatives methysergide and LSD all had an agonist action on 
the inotropic response in the isolated H e l ix  heart. Fig. 3.15 shows the 
co n cen tra tion -effect curves for m eth y serg id e , ergotam in e and  
methylergometrine. From this figure it would appear that methysergide, 
ergotamine and methylergometrine behaved like partial agonists because they 
elicited a maximum response of 58% for methysergide, of 70% for ergotamine 
and 73% for methylergometrine. When a 5-HT concentration-effect curve was 
obtained in the presence of lOOpM methysergide (Fig. 3.16), there was only a 
modest reduction in the inotropic response to 5-HT in the isolated Helix heart. 
Only a very modest reduction was seen in the 5-HT concentration-effect curve 
after exposure to lOOpM ergotam ine (Fig. 3.17) and to lOOjJiM 
methylergometrine (Fig 3.18). The effect of LSD on the isolated Helix heart is 
shown in Fig. 3.19. It is interesting to note that even at a maximum  
concentration of l|iM , LSD would appear to be as potent if not more so than 
5-HT on the isolated Helix  heart; LSD did show, nonetheless, a much slower
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FIGURE 3.15
log 5-HT concentration (M)
The concentration-effect curves for 5-HT (closed circles), methysergide 
(open circles), ergotamine (triangles) and methylergometrine (squares) on the 
isolated Helix heart are shown in this figure. The x axis gives log of the 5-HT 
concentration w hile the y axis gives the percentage maximum inotropic 
response. Vertical bars represent the arithmetic mean ± s.e. mean of n=9.
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FIGURE 3.16
log 5-HT concentration (M)
The concentration-effect curves for 5-HT on the isolated Helix heart in 
the absence (closed circles) and in the presence (open circles) of methysergide 
at a concentration of lOOjiM are shown in this figure. The x axis gives log of 
the 5-HT concentration while the y axis gives the percentage maximum  
inotropic response. The 5-HT curve obtained in the presence of methysergide 
takes into account the agonist inotropic effect of lOOpM methysergide and 
hence the inotropic response to 5-HT is measured on top of that already 
observed with methysergide. Vertical bars represent the arithmetic mean ± 
s.e. mean of n=9.
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FIGURE 3.17
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix heart in 
the absence (closed circles) and the presence (open circles) of ergotamine at a 
concentration of lOOpM are shown in this figure. The x axis gives log of the 
5-HT concentration while the y axis gives the percentage maximum inotropic 
response. The 5-HT curve obtained in the presence of ergotamine takes into 
account the agonist inotropic response of lOOjiM ergotamine and hence the 
inotropic response to 5-HT is measured on top of that already observed with 
ergotamine. Vertical bars represent the arithmetic mean ± s.e. mean of n=9.
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FIGURE 3,18
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence (open circles) of 
methylergometrine at a concentration of lOOpM are shown in this figure. The 
X axis gives log of the 5-HT concentration while the y axis gives the percentage 
maximum inotropic response. The 5-HT curve obtained in the presence of 
methylergometrine takes into account the agonist inotropic response of 
lOOfiM methylergometrine and hence the inotropic response to 5-HT is 
measured on top of that already observed with methylergometrine. Vertical 
bars represent the arithmetic mean ± s.e. mean of n=9 .
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FIGURE 3.19
log 5-HT concentration (M)
The concentration-effect curves to 5-HT (closed circles) and to LSD 
(open circles) on the isolated Helix heart are shown in this figure. The x axis 
gives log of the 5-HT concentration while the y axis gives the percentage 
maximum inotropic response. The full range of concentration for LSD was 
limited by the molarity of the initial stock solution which only allowed a final 
bath concentration of IpM. At a concentration of IpM LSD is seen to have 
two values of maximum response. The difference in these two values is 
temporal. The lower value, at an inotropic response of 14%, was obtained 
after 3 minutes whereas the higher value, at 42% maximum inotropic 
response, was obtained after 30 minutes. Vertical bars represent the arithmetic 
mean ± s.e. mean of n=6 .
reaction time, taking at least 30 minutes to exert a maximum response. 
M ethylergometrine and ergotamine were approximately equipotent as 
agonists, being 3.5 times less potent than 5-HT: methysergide was less potent 
still, being 28 times less potent than 5-HT. The results are summarised in 
Table 3.3 below.
TABLE 3.3 Summary of the ergot derivatives tested on the Helix heart. The 
EC5Q and ECr values are molar values.
Ergot
derivative
n EC50 ECr % maximum  
response
Methyl­
ergometrine
9 5.2 ± 0.2 3.3 ± 0.7 73 ± 8
Ergotamine 9 5.0 ± 0.3 5.0 ± 0.8 70 + 6
Methysergide 9 4.2 ± 0.2 28.0 ±3.0 58 + 4
Effects of the 5-HT receptor antagonists on the inotropic response to 5-HT in 
the heart
The specific 5-HT receptor antagonists tested were methiothepin, 
ketanserin, ritanserin, ondansetron, ICS 205-930, metroclopramide and 
cocaine. ICS 205-930 at concentrations higher than lOpM is also thought to be 
a novel 5-HT4 receptor antagonist; hence in this study it was tested up to a 
concentration of lOOpM.
The extent of overlap of the two 5-HT concentration-effect curves seen 
in the presence and absence of l|iM  methiothepin (Fig. 3.20) indicate a 
complete lack of antagonism by this drug to the 5-HT inotropic response in 
Helix  heart. Ketanserin, even at a concentration of lOpM only, exhibited a 
small shift of the 5-HT concentration-effect curve to the right giving a mean 
dose ratio of 1.4 (Fig.3.21). This again indicates that ketanserin has no 
antagonist action on the inotropic response seen with 5-HT on the isolated 
Helix heart. Ritanserin, on the other hand, caused a dose-dependent lowering 
of the maximum inotropic response elicited by 5-HT (Fig. 3.22). The effect of 
ondansetron is shown in Fig. 3.23. No antagonistic action was observed; in
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FIGURE 3.20
log 5-HT concentration (M)
The concentration-effect curves for 5-HT on the isolated Helix heart, in 
the absence (closed circles) and in the presence (open circles) of IjiM  
methiothepin are shown in this figure. The x axis gives log of the 5-HT 
concentration w hile the y axis gives the percentage maximum inotropic 
response. Vertical bars represent the arithmetic mean ± s.e. mean of n=8 .
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FIGURE 3.21
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence of IpM ketanserin (open 
circles) and lOjiM ketanserin (triangles) are shown in this figure. The x axis 
gives log of the 5-HT concentration while the y axis gives the percentage 
maximum inotropic response. Verticals bars represent the arithmetic mean ± 
s.e. mean of n -8 .
O)
s0r
'K
s
1  I
a
100 n
80-
6 0 “
40 "
2 0 -
1T T
-7 -6 -4
FIGURE 3.22
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix heart in 
the absence (closed circles) and in the presence of IpM ritanserin (open circles) 
and lOpM ritanserin (triangles) are shown in this figure. The x axis gives log  
of the 5-HT concentration while the y axis gives the percentage maximum  
inotropic response. Vertical bars represent the arithmetic mean ± s.e. mean of 
n=8 .
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FIGURE 3,23
log 5-HT concentration (M)
The concentration-effect curves for 5-HT on the isolated Helix heart in 
the absence (closed circles) and in the presence (open circles) of IpM  
ondansetron are shown in this figure. The x axis gives log of the 5-HT 
concentration while the y axis gives the percentage maximum inotropic 
response. Vertical bars represent the arithmetic mean ± s.e. mean of n=8 .
120
100 -
80-
60-
40 -
2 0 -
8 6■7 5 •4
FIGURE 3.24
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence of IpM ICS 205-930 (open 
circles), lOjiM ICS 205-930 (triangles) and lOOjiM ICS 205-930 (squares) are 
shown in this figure. The x axis gives log of the 5-HT concentration while the 
y axis gives percentage maximum inotropic response. Vertical bars represent 
the arithmetic mean ± s.e. mean of n=8 .
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FIGURE 3.25
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence of IpM metoclopramide (open 
circles) and lOpM metoclopramide (triangles) are shown in this figure. The x 
axis gives log of the 5-HT concentration while the y axis gives percentage 
maximum inotropic response. Vertical bars represent the arithmetic mean ± 
s.e. mean of n=8 .
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FIGURE 3.26
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence (open circles) of IjxM cocaine 
are shown in this figure. The x axis gives log of the 5-HT concentration while 
the y axis gives percentage maximum inotropic response. Vertical bars 
represent the arithmetic mean ± s.e. mean of n=8 .
fact quite the opposite effect was apparent at 5-HT concentrations >10pM, 
because ondansetron caused a small potentiation of the 5-HT maximum  
inotropic response. This result was repeated with ICS 205-930 (Fig. 3.24). In 
the presence of lOOpM ICS 205-930, and at 5-HT concentrations above lOjiM, a 
small potentiation of the 5-HT maximum inotropic response was seen. At 
concentrations of IpM and lOpM, ICS 205-930 has no antagonist action on the 
5-HT inotropic response in Helix heart. Metoclopramide at concentrations of 
IpM and lOpM would appear also to have no antagonistic action. In the 
presence of IpM the 5-HT curves were superimposed, whereas in the presence 
of lOjxM metoclopramide there was a small shift to the right, with a mean 
dose-ratio of 1.1 (Fig. 3.25). For IjiM cocaine (Fig. 3.26), once again, the two 
5-HT curves were superimposed, indicating a lack of antagonist action on the 
5-HT inotropic response in Helix heart These results are summarised in Table 
3.4 below.
TABLE 3.4 Summary of the 5-HT receptor antagonists tested on Helix heart.
Antagonist Concentration 
tested (|iM)
n Effect
M ethiothepin 1 8 dose-ratio = 1.0
Ketanserin 1 and 10 8 dose-ratios of 0.8 ± 0.1 
and 1.4 ± 0.4
Ritanserin 1 and 10 8 dose-dependent 
lowering of maximum  
response
Ondansetron 1 8 dose-ratio = 1.0
ICS 205-930 1 ,10  and 100 8 dose-ratios = 1.0
Metoclopramide 1 and 10 8 dose-ratios of 1.0 and 
1.1 ±0.4
Cocaine 1 8 dose-ratio = 1.0
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Effect of a MAO inhibitor on the inotropic response to 5-HT in the heart
Pargyline, a specific monoamine oxidase inhibitor, at a concentration of 
lOjxM was seen to have little effect on the 5-HT inotropic response in Helix  
heart (Fig. 3.27). The 5-HT curves were superim posed except at high 
concentrations of 5-HT (>10pM) where a small potentiation was observed. 
The effect of 10|iM pargyline was tested also on a tryptamine concentration- 
effect curve (Fig. 3.28). Pargyline showed no potentiation of the inotropic 
response to tryptamine in Helix heart.
Effects of two 5-HT uptake inhibitors on the 5-HT inotrop ic response in the 
heart
Two specific 5-HT uptake inhibitors were also tested also on the 5-HT 
response in Helix heart. They were fluvoxamine and zimelidine, both tested 
at a concentration of lOpM. Fluvoxamine (Fig. 3.29) and zimelidine (Fig. 3.30) 
both would appear to have very poor inhibitory action against the 5-HT 
uptake system within Helix  heart tissue. This is indicated by the extent of 
overlap of the two 5-HT concentration-effect curves in each case.
Involvement of calcium in the 5-HT inotropic response in the heart
Verapamil, a calcium channel blocker, at a concentration of l|iM  
lowered the maximum inotropic response to 5-HT in Helix heart (Fig. 3.31). 
The fact that calcium ions contribute to the 5-HT inotropic response in Helix  
heart was demonstrated also by lowering the calcium concentration of the 
physiological saline (Fig. 3.32) When the calcium concentration was reduced 
from 7mM to 3mM, an increase in the sensitivity of Helix heart tissue to 5-HT 
was observed; this was noted as a shift of the 5-HT concentration-effect curve 
to the left. A potentiation of the 5-HT maximum inotropic response was 
observed also under these conditions.
Effects of the molluscan cardioactive peptides on the isolated heart
In Helix heart the cardioactive neuropeptide FMRMamide had no effect 
on the heart-beat amplitude or the heart rate when added to the bath as an 
agonist over the concentration range lOnM-lOOpM. The 5-HT concentration- 
effect curve obtained in the presence of lOOpM FMRMamide (Fig.3.33) was
64
120*1
100 -
</)
80-
60-
40-
2 0 -
8 ■5 •46■7
FIGURE 3.27
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and the presence (open circles) of lOpM pargyline 
are shown in this figure. The x axis gives log of the 5-HT concentration while 
the y axis gives percentage maximum inotropic response. Vertical bars 
represent the arithmetic mean ± s.e. mean of n=8 .
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FIGURE 3.28
The concentration-effect curves to tryptamine on the isolated H elix  
heart in the absence (closed circles) and in the presence (open circles) of lOfxM 
pargyline are show n in this figure. The x axis gives log tryptamine 
concentration while the y axis gives percentage maximum inotropic response. 
In this case the response obtained with lOOpM tryptamine was taken as being 
100% maximum response i.e. tryptamine was assumed to be a full agonist. 
Vertical bars represent the arithmetic mean ± s.e. mean of n=8 .
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FIGURE 3.29
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence (open circles) of 10|iM 
fluvoxamine are shown in this figure. The x axis gives log of the 5-HT 
concentration w hile the y axis show s percentage maximum inotropic 
response. Vertical bars represent the arithmetic mean ± s.e. mean of n=9.
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FIGURE 3.30
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated snail heart, in 
the absence (closed circles) and in the presence (open circles) of lOjxM 
zim elidine are shown in this figure. The x axis gives log of the 5-HT 
concentration while the y axis gives percentage maximum inotropic response. 
Vertical bars represent the arithmetic mean ± s.e. mean of n=9.
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FIGURE 3.31
log 5-HT concentration (M)
The concentration-effect curves for 5-HT on the isolated Helix heart in 
the absence (closed circles) and in the presence (open circles) of IpM verapamil 
are shown in this figure. The x axis gives log of the 5-HT concentration while 
the y axis gives percentage maximum inotropic response. Vertical bars 
represent the arithmetic mean ± s.e. mean of n=9 .
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FIGURE 3.32
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The concentration-effect curves to 5-HT on the isolated Helix  heart in 
normal physiological saline (closed circles) and in physiological saline with a 
low  calcium concentration (open circles) are shown in this figure. The x axis 
gives log of the 5-HT concentration while the y axis gives percentage 
maximum inotropic response. Normal physiological saline contains 7mM 
calcium whereas in the low  calcium saline the calcium concentration was 
3mM. The isotonicity of this saline was maintained by the addition of sucrose. 
Vertical bars represent the arithmetic mean ± s.e. mean of n=10.
superimposed upon the control curve, indicating that FMRMamide acted 
neither as agonist nor antagonist to the 5-HT inotropic response in Helix  
heart. H ow ever, the related extended FM RM amide-like peptide  
pQPFLRFamide was found, like 5-HT, to have a positive inotropic effect. The 
concentration-effect curve of the extended peptide was found to be to the left 
of the 5-HT control curve (Fig. 3.34). This indicates the greater potency of the 
extended peptide, which has a mean EC50 value of 6.7 compared to that of 
5-HT which has a mean value of 5.7, a 10-fold difference. The threshold value 
for the extended peptide on Helix heart was approximately 5-lOnM.
Effect of isoprenaline on the isolated heart
The potent p receptor agonist, isoprenaline, was tested also on Helix  
heart. It had no effect as an agonist on heart-beat amplitude when tested over 
the concentration range lOnM-lOOpM. The 5-HT concentration-effect curve 
obtained in the presence of lOOjiM isoprenaline was superimposed on the 
control curve (Fig. 3.35).
Effects of IBMX and forskolin on the 5-HT inotropic response in the heart
The phosphodiesterase inhibitor, IBMX tested at a concentration of 
lOjiM, had no effect on the contractile response elicited by 5-HT in Helix heart. 
In the presence of IBMX (lOpM) the 5-HT concentration-effect curve was 
unaffected, being superimposed on that of the control (Fig. 3.36).
Forskolin, a plant diterpene which is a strong activator of cAMP, had no 
effect on the 5-HT excitatory response in Helix heart. In the presence of lOjiM 
forskolin, the 5-HT curve overlapped with that of the control (Fig. 3.37), 
indicating a complete lack of effect by forskolin on the 5-HT inotropic response 
seen in Helix heart.
Effect of 5-HT on cAMP levels in Helix heart tissue
5-HT caused a dose-dependent increase in cAMP levels within Helix  
heart (Fig. 3.38). From the results, the threshold 5-HT concentration for the 
stimulation of cAMP was between 50 and lOOnM. Also indicated is the lack of 
effect of lOO^M IBMX on the stimulation of cAMP levels in Helix heart tissue. 
Forskolin (lOpM), in the absence of 5-HT, increased cAMP levels to 5 times 
greater than the control level (Table 3.5). Methysergide caused a small dose-
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FIGURE 3.33
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix  heart 
before (closed circles) and after (open circles) FMRFamide over a concentration 
range of lOnM-lOOpM had been added to the bath, are shown in this figure. 
The X axis gives log of the 5-HT concentration while the y  axis gives percentage 
maximum response. Vertical bars represent the arithmetic mean ± s.e. mean 
of n=9.
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FIGURE 3.34
log 5-HT concentration (M)
The concentration-effect curves for 5-HT (closed circles) and 
pQDPFLRFamide (open circles) on the isolated Helix heart are shown in this 
figure. The x axis gives log of the 5-HT concentration while the y axis gives 
percentage maximum inotropic response. Vertical bars represent the 
arithmetic mean ± s.e. mean of n=9.
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FIGURE 3.35
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix heart in 
the absence (closed circles) and the presence (open circles) of lOOp-M 
isoprenaline are shown in this figure. The x axis gives log of the 5-HT 
concentration while the y axis gives percentage maximum inotropic response. 
Isoprenaline itself over a concentration range of lOnM-lOOjiiM had no effect on 
heart beat amplitude when added to the bath as an agonist. Verticals bars 
represent the arithmetic mean ± s.e. mean of n=9 .
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FIGURE 3,36
log 5-HT concentration (M)
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence (open circles) of lOpM IBMX 
are shown in this figure. The x axis gives log of the 5-HT concentration while 
the y axis gives percentage maximum inotropic response. Vertical bars 
represent the arithmetic mean ± s.e, mean of n=9 .
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FIGURE 3.37
The concentration-effect curves to 5-HT on the isolated Helix  heart in 
the absence (closed circles) and in the presence (open circles) of lOpM forskolin 
are shown in the figure. The x axis gives log of the 5-HT concentration while 
the y axis gives percentage maximum inotropic response. Vertical bars 
represent the arithmetic mean ± s.e. mean of n=9 .
dependent increase in cAMP levels when pre-incubated with the hearts for 30 
minutes in the absence of 5-HT (Table 3.5). This increase was only a fraction of 
that seen with 5-HT. When methysergide was pre-incubated with the hearts 
in the presence of 5-HT (lOpM) the effect on cAMP levels was cumulative and 
the increase in cAMP levels then seen was larger than that seen for lOpM 
5-HT in the absence of methysergide.
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FIGURE 3.38
The increase seen in cAMP levels in Helix  heart tissue with increasing 
concentrations of 5-HT are shown in this figure. The bar chart shows two sets 
of results. The first set of results (solid columns) were obtained under normal 
conditions and functioned as controls while the second set (dashed columns) 
were obtained in the presence of lOOpM IBMX. The x axis gives log of the 
5-HT concentration and shows a control value, marked by the letter C, 
obtained in the absence of 5-HT and the y axis gives increase in cAMP in 
pmoles.mg-1 protein. Vertical bars represent the arithmetic mean ± s.e. mean 
of n=5.
TABLE 3.5 Summary of the effects of 5-HT, forskolin, methysergide.
Treatment n pmoles cAMF.mg“l  
protein 
normal
pmoles cAMP.mg-1 
protein 
IBMX (lOOpM))
Control 5 2 8 ± 6 31 ± 6
5-HT 5 5 6 ± 8 48 ± 9
(lOnM)
5-HT 5 77±12 81 ± 9
(lOOnM)
5-HT 5 688 ±90 611 ± 106
(Ip-M)
5-HT 5 1158 ±110 955.± 106
(10|lM)
Forskolin 5 139 ± 11 132 ± 9
(lOjiM)
Methysergide 3 99 ± 8
(lOOnM)
Methysergide 3 139 ± 8
(IpM)
Methysergide 3 153 ± 12
(lOiiM)
Methysergide(lOOnM) 3 1249 ± 137
+ 5-HT (lOpM)
Methysergide (IpM) 3 1329 ±137
+ 5-HT (lOfiM)
Methysergide (lOjiM) 3 1417 ± 120
+ 5-HT (10|iM)
Isoprenaline 3 29 ± 5
(lOpM)
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DISCUSSION
The difference in sensitivity of the Helix heart to 5-HT observed for the two 
m ethods
As the preceding results have shown, 5-HT has a marked inotropic and 
chronotropic effect on the isolated Helix heart. For experimental purposes the 
inotropic effect only of 5-HT was monitored because the chronotropic effect 
was found to be variable and occurred only at high concentrations of 5-HT. 
The two methods for monitoring the inotropic effect of 5-HT on the isolated 
heart differed only in threshold concentration for 5-HT. For the perfused 
heart method, the threshold concentration was between 1 and lOnM whereas 
for the non-perfused heart method the threshold concentration was 10-30nM, 
a 10-fold difference in sensitivity to 5-HT. One possible reason for the 
difference in sensitivity of the Helix heart to 5-HT could be the actual method 
employed. In the perfused heart method the heart was internally perfused 
exposing the interior of the heart to the stated concentration of 5-HT. By 
contrast, in the non-perfused heart method the ventricle was tied off and 
thereby closed to the surrounding medium. The means of entry of external 
medium, containing the experimental drugs, were limited in this method; 
through the small piece of aorta which was open to the external environment 
or by diffusion. How much of the medium penetrated inside of the heart was 
unknown, but was presumably dependent on the amplitude of heart beat of 
each individual preparation.
Ripplinger (1957) had shown that one branch of the extrinsic nerve 
supply to the Helix heart terminated in the AV junction. Later Cottrell and 
Osborne (1969) described a dense network of nerve fibres in the AV junction of 
Helix. They suggested that this network could have a neurosecretory function. 
Could it be possible that the majority of the 5-HT receptors in the Helix heart 
are located at or near the nerve terminals in the AV junction, with a greater 
distribution on the internal surface of the heart in comparison to the external 
surface of the heart ? Such a distribution of 5-HT receptors could then explain 
the greater sensitivity of the heart to 5-HT in the perfused method because this 
method inflicted the lesser damage of the two on the AV junction. The 
perfused heart method results in the internal surface of the heart being in
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direct contact with the drug-containing medium; the non-perfused does not. 
However a combination of other events, such as sites of loss, presence of 
deactivating enzymes and uptake sites for 5-HT can not be overlooked when 
discussing the difference in sensitivity to 5-HT between the two methods.
Despite the between-method difference in sensitivity of Helix heart to 
5-HT, the non-perfused heart method was still preferred over the perfused 
heart method. The endogenous molluscan cardioactive neuropeptides, 
FMRFamide and pQDPFLRFamide, were tested on the isolated Helix heart as a 
reference point to ascertain the reliability of the method used. In most studies 
with Helix hearts (e.g. Kerkut and Cottrell, 1963; Boyd et ah, 1985; Payza, 1987) 
the perfused heart method had been preferred. FMRFamide was found to be a 
weak agonist on the Helix heart by Greenberg and Price (1980), but in the 
present study it had no effect on the isolated heart. In contrast, 
pQDPFLRFamide was found to be more potent than 5-HT. This supports the 
finding by Price et ah (1985), who found that pQDPFLRFamide was about 100 
times more potent than FMRFamide on this preparation. They suggested that 
an increased resistance to proteolytic degradation might explain, at least in 
part, the relatively high potency of pQDPFLRFamide compared to FMRFamide 
on the heart of Helix.  This potent action of pQDPFLRFamide in stimulating 
the Helix heart served to demonstrate the fact that there was little difference 
between the perfused and non-perfused heart methods.
Another possible reason for the difference in sensitivity to 5-HT could 
be related to the state of the activity of the snails. Such changes in sensitivity 
to 5-HT in Helix aspersa heart were noted first by Kerkut and Laverack (1960). 
They observed that the heart of the winter-hibernating or aestivating snail had 
a threshold response to a 5-HT dilution of 10“^ 2g p i compared to the heart of a 
non-hibernating or active snail which had a threshold response of lO'^g.L^ 
5-HT. In Helix aspersa 5-HT levels appeared to show seasonal variation both 
in heart and nervous tissue (Cardot, 1971). Snails kept in dry conditions fell 
into an aestivating state and showed a rise in the 5-HT levels both in the brain 
and heart. When aroused from hibernation, the 5-HT level fell both in the 
heart and ganglia (Hiripi and Salanki, 1973). The snails used in the present 
perfused heart experiments had all been in a state of aestivation as a result of 
being kept in a dry environment for anything up to two months before use. 
However, all the animals used in the non-perfused heart method were in the
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active state, having been kept in a humid environm ent at constant 
temperature and with regular feeding. Seasonal changes in the 5-HT level 
within the Helix hearts could therefore be attributable, at least in part, for the 
differences in sensitivity of Helix heart to 5-HT observed in the experiments.
5-HT as sole mediator for the observed inotropic effect on the isolated heart
That the inotropic effect observed with 5-HT on the isolated Helix heart 
was solely attributable to 5-HT has been investigated in this study. None of 
the different antagonists, at a concentration of IjxM, had any effect on the 5-TIT 
concentration-effect curve or on the mechanical activity of the heart when 
they were added to the organ bath.
Certainly ACh played no role in the inotropic effect seen with 5-HT in 
Helix  heart. This was hardly surprising because ACh has been shown to 
mimic the actions of endogenously released cardioinhibitory transmitter, with 
which it is considered identical (Prosser, 1940). The cardioactive effects seen by 
5-HT-like agonists acting, not only on tryptamine receptors, but also on 
nicotinic receptors in the sympathetic cardiac nerves in the isolated rabbit 
heart (Fozard and Mobarok Ali, 1978) relates to a system probably confined to 
the vertebrates.
Neither of the catecholamine blocking compounds tested on the 
isolated heart had any effect. It was therefore assumed that catecholamines 
played no part in the excitatory action of 5-HT on Helix heart. 5-HT did not 
seem to be causing the release of noradrenaline from the isolated Helix heart, 
as has been shown in the isolated rabbit heart (Fozard and Mwaluko, 1976). 
With respect to 5-HT being an excitatory transmitter in the molluscan heart, it 
would appear that in this phylum 5-HT plays a role equivalent to that of the 
catecholamines, adrenaline and noradrenaline, in vertebrates. Despite the 
evidence for catecholamine excitation of the Helix pomatia heart (Osborne and 
Cottrell, 1970), from these results it was assumed that if these compounds 
acted at all they had only a very low potency compared to 5-HT. Clearly there 
were no and p2 adrenoreceptors on Helix heart because isoprenaline had no 
effect on the heart beat amplitude or heart rate. Isoprenaline also had no effect 
on the level of cAMP in Helix heart cells. It is in the vertebrate heart that the 
P receptor is found and where it is responsible for the positive inotropic and
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chronotrophic effects of catecholamines. The P receptor mediates these effects 
through adenylate cyclase and stimulation of cAMP levels.
5-HT agonist potency
Of all the specific 5-HT receptor agonists tested on Helix  heart, none 
proved to be as potent as 5-HT itself. The full rank order of potency of the 
agonists, including the ergot derivatives because they had been observed to 
have agonist actions on the isolated heart, was 5-HT > methylergometrine = 
ergotamine ~ 5-CT > a-Me-5-HT = sumatriptan > methysergide = 2-Me-5-HT = 
tryptamine > 8-OH-DPAT. This rank order of potency is not comparable to 
others which have been elucidated for the different 5-HT receptor types in the 
vertebrates.
5-HT receptor antagonist potency
The inotropic effect of 5-HT was found to be resistant to antagonism by 
the 5-HT% receptor antagonist methiothepin, by the 5-HT2 receptor antagonist 
ketanserin, by the 5-HTg receptor antagonists cocaine, ondansetron and ICS 
205-930 and by the M receptor antagonist metoclopramide. Ritanserin showed 
dose-dependent lowering of the maximum inotropic response observed with 
5-HT. Ritanserin has been shown in most vascular and tracheal preparations 
to act as an unsurmountable, apparently non-competitive, 5-HT2 receptor 
antagonist. An exception is the rabbit femoral artery where the antagonism 
was competitive (Van Neuten et ah, 1986). This non-competitive action of 
ritanserin w ould therefore explain the dose-dependent lowering of the 
inotropic response to 5-HT seen in this study. The small potentiations seen 
with high concentrations of ICS 205-930 (>10pM) plus >10jiM 5-HT and 
ondansetron (IjiM) plus >10pM 5-HT cannot be explained in terms of a 
particular 5-HT receptor subtype or by the action of these drugs.
Some of the findings in this study paralleled those of Boyd et a l  (1985). 
5-HT produced excitation at concentrations >1-1 OnM and involved an increase 
in contraction size and amplitude of the heart beat. 8-OH-DPAT had direct 
excitatory action but it differed temporally from that produced by 5-HT. The 
5 -H T 3 receptor antagonist MDL 72222 produced excitation at high 
concentrations similar to that seen with ondansetron and ICS 205-930 in this 
study. Ketanserin was a weak antagonist only against 5-HT excitation of Helix
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heart. The 5-HT receptor mediating cardioexcitation in the Helix heart could 
not be separated clearly into either 5-HT% or 5-HT2  types of receptor by Boyd et 
ah (1985). From the present study the 5-HT receptor is clearly not either 5-HT% 
or 5 -HT2 , due to the complete lack of antagonism either by methiothepin and 
ketanserin. Neither w ould the 5-HT receptor appear to be of the 5-HTg 
subtype, owing to the lack of effect of cocaine, ondansetron and ICS 205-930.
The novel 5-HT4  receptor, and its possible involvement in molluscan 
hearts, was implicated by Kaumann et a l  (1989). The 5-HT receptors of the 
human atrium were found to resemble the cerebral 5-HT receptors, designated 
5 -HT4  by Dumuis et a l  (1988). The 5-HT4 receptor was found to be positively 
linked to cAMP and it was this increase in cAMP, as noted by Sawada et ah 
(1984) in molluscan hearts, which led Kaumann et a l  (1989) to suggest that the 
5-HT receptor on molluscan hearts might be of the 5 -HT4  subtype. Both 
Kaumann et a l  (1989) and Dumuis et a l  (1988) found that ICS 205-930 was a 
fully competitive antagonist at this receptor although at a much lower 
blocking potency than would be expected from its affinity with 5-HTg receptors 
(Bradley et al ,  1986). The possibility of the presence of a 5 -HT4  receptor on the 
isolated Helix heart could not be demonstrated by the results in this study. ICS 
205-930, even at lOOpM, had no antagonist effect on the 5-HT inotropic 
response within Helix heart. The lack of effect of metoclopramide provided 
evidence that the Helix heart 5-HT receptor was not of the M receptor type.
Recent experimental evidence indicates that central 5 -HT4  receptors 
which are positively coupled to adenylate cyclase, are stimulated by a family of 
2-methoxy-4-amino-5-chloro substituted benzamide derivatives (Dumuis et 
a l ,  1991). In their study the ability of three azabicycloalkyl benzimidazolone 
derivatives, BIMU 1, BIMU 8 and DAU 6215, to stimulate cAMP formation in 
colliculi neurones in primary culture was tested. Two of the compounds, 
BIMU 1 and BIMU 8 , were found to be good agonists at the 5-HT4 receptors 
which are present on these neurones. Unfortunately this information was not 
available at the time of this investigation and consequently these novel 5-HT4  
agonists were not tested on this isolated heart preparation.
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Mediation by cAMP of the 5-HT inotropic response in the isolated heart
The evidence emerging from this investigation that the inotropic effect 
of 5-HT was mediated by cAMP was also significant. The cAMP results are in 
agreement with those obtained in earlier studies (Higgins and Greenberg, 1974; 
Higgins, 1977). 5-HT caused a dose-dependent increase in intracellular cAMP 
concentration which was not antagonized by methysergide. It is extremely 
unlikely that the 5-HT receptor is either 5-HT%A/ 5-HT%g or 5-HT%[) because 
each of these has been shown to be negatively linked to adenylate cyclase, 
resulting in decreases in cAMP, not the inverse as observed with 5-HT in 
Helix  heart. In vertebrates, the 5-HTg receptor was found to be coupled 
directly to a receptor-ion complex (see Bobker and Williams, 1990). This 
precludes the presence of a 5-HTg receptor in the isolated Helix  heart. From 
the 5-HT2 receptor antagonist potencies observed on Helix  heart, the 5-HT 
receptor under investigation is unlikely to be a 5-HT2 receptor; the 5-HT2 
receptor (along with the 5-HT%(] receptor) has been linked to phosphatidyl 
inositol turnover. Importantly Deaton and Gray (1990) have shown that 
phorbol esters increase both the beat frequency and amplitude of isolated 
hAercenaria ventricles. Phorbol esters have been demonstrated to directly 
stimulate protein kinase C, which is a crucial link in signal transduction for a 
variety of biologically active substances (Nishizuka, 1984). There is also 
increasing evidence of 5-HT receptors which are positively linked to cAMP 
and which do not appear to correspond to any of the other known subtypes. 
This situation is the case for NCB-20 cells (Cossery et al., 1990) and for porcine 
vena cava (Trevethick et a l ,  1986).
Corroborative pharmacological evidence for the hypothesis that cAMP 
is acting as the intracellular mediator for neurotransmitter-stimulated changes 
in molluscan heart contractility is lacking. Neither exogenous cAMP, nor its 
more lipid-soluble derivatives, had any effect on the contractility of the 
iso la ted  m olluscan  ventricle. Sim ilarly, the cyclic  nu cleotid e  
phosphodiesterase inhibitor, theophylline, did not alter the rate or strength of 
contraction (Higgins, 1974). The results of the present study with the 
phosphodiesterase inhibitor, IBMX, supported the finding of Hess et al. (1981) 
that IBMX was a poor inhibitor of hAercenaria mercenaria phosphodiesterase 
enzyme. IBMX at a concentration of lOOpM did not alter significantly the
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strength or rate of contraction of the isolated Helix  heart, nor did it have an 
appreciable effect on myocardial intracellular cAMP concentrations in the 
absence of 5-HT. Thus it could be seen that IBMX was a relatively poor 
inhibitor of Helix aspersa phosphodiesterase activity.
Although increasing the intracellular cAMP concentration may mediate 
some of the inotropic actions of 5-HT on Helix heart, other unknown  
mechanisms must be involved. Forskolin (lOpM) in the absence of 5-HT 
increased the intracellular cAMP concentration w ithout affecting the 
myocardial contractility. Forskolin had no effect on the inotropic or 
chronotropic effect of 5-HT when added directly to the bath. The increase in 
cAMP levels seen with forskolin were expected because forskolin was known 
to directly potentiate adenylate cyclase without neurotransmitter receptor 
activation (Seamon and Daly, 1982). 5-HT could conceivably have induced the 
membrane ionic events necessary to generate the myocardial response while 
cAMP could have mediated the other cellular events necessary to increase the 
magnitude of this response. It is unlikely that forskolin directly altered other 
intracellular enzym e activities (Seamon and Daly, 1982). Higgins and 
Greenberg (1974) demonstrated that cAMP stimulated phosphorylation and 
increased net calcium uptake by a microsomal fraction of M e r c e n a r ia  
ventricles. They proposed that cAMP stimulated the phosphorylation of 
proteins of the sarcoplasmic reticulum by a cAMP-dependent protein kinase. 
This is turn augmented the calcium sequestration by the sarcoplasmic 
reticulum and other intracellular calcium-sequestering membrane systems. 
Similarly, adrenergic agonists also increased mammalian ventricular cAMP 
levels, sarcoplasm ic reticulum  protein phosphorylation and calcium  
sequestration by isolated sarcoplasmic reticulum (Tada and Kirchberger, 1975). 
Such a mechanism could explain the positive inotropic response of the 
molluscan myocardium to 5-HT in that more calcium would be released per 
beat. This would increase actin-myosin cross-bridging and subsequently 
generate greater myocardial tension.
In the isolated Helix heart 5-HT caused inotropic and chronotropic 
effects with a threshold between 1 and lOnM. However, increases in cAMP 
were detectable only at 5-HT concentrations above lOOnM. A similar 
discrepancy between thresholds for 5-HT-induced mechanical events and 
elevation of cAMP levels has been reported in bivalve catch muscle (Kohler
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and Lindl, 1980) and in Aplys ia  heart (Mandelbaum et a l ,  1979). The very 
large changes in cAMP levels induced by 5-HT suggest that there may be an 
hierarchy of cAMP-mediated processes in the muscles studied, different 
processes being initiated by different levels of cAMP. These observations 
suggest that changes in cytoplasmic levels of cAMP cannot fully explain the 
cardioactive effects of 5-HT in H e l ix  heart, and there is, therefore, the 
possibility of the involvement of other intracellular second messengers.
The LSD derivatives and their effect on the isolated heart
The LSD derivatives have been demonstrated to have potent actions on 
molluscan hearts. Methysergide has been shown to antagonise the actions of 
5-HT on Mercenaria heart (Welsh, 1954; Greenberg, 1960; Loveland, 1963) and 
Pate l la  heart (Leake et al., 1971) whereas LSD, along with other ergot 
compounds, has been shown to stimulate Mercenaria (Greenberg, 1960) and 
Helix heart (Gaddum and Paasonen, 1955). In Aplysia heart LSD, Bromo-LSD 
and methysergide all had direct effects on the heart, which made their degree 
of block on the 5-HT response variable (Liebeswar et a l ,  1975).
Methysergide probably was the first specific antagonist of the contractile 
effects of 5-HT in a variety of smooth muscle preparations. However the 
nature of the interaction of methysergide with 5-HT differed between smooth 
muscle preparations. In some methysergide acted as a competitive antagonist, 
in others as a partial agonist and in yet others as an insurmountable 
antagonist (see Feniuk, 1984). Thus for both vertebrate and invertebrate 
tissues the actions of methysergide and other ergot derivatives are diverse and 
could be seen to range from agonist and antagonist.
In the present study all of m ethysergide, m ethylergom etrine, 
ergotamine and LSD were shown to have potent agonist actions on the 
isolated Helix  heart. The block of the 5-HT inotropic response, shown by 
methysergide, ergotamine and methylergometrine, at a concentration of 
lOOpM, was only a very modest one. This was in contrast to Boyd et al. (1985) 
w ho found that m ethysergide not only strongly antagonised the 5-HT 
response in Helix heart but in itself produced weak excitation of the heart. 
With the antagonism of the 5-HT response in the Helix heart by methysergide, 
methylergometrine and ergotamine being only minimal, the data was difficult
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to interpret. The high degree of agonism shown by the above three 
compounds made difficult the determination of their affinity for the 5-HT 
receptor in Helix heart.
The lack of high affinity shown by methysergide unfortunately fails to 
prove that the drug is acting through the same receptor as 5-HT. It may well 
be that all these agonist effects of 5-HT and methysergide are mediated 
through a common receptor, a possibility which remains unclear from the 
data presented here. A specific receptor-blocking drug, which failed to be 
forthcoming in this investigation, will be necessary in order to substantiate the 
hypothesis. Alternatively, the data with the ergot derivatives, in particular 
the potency of LSD as an agonist and the temporal difference exhibited by LSD, 
and to a lesser extent, methysergide, in eliciting a similar response to 5-HT in 
Helix  heart, suggests the possibility of the presence of a separate receptor 
which, has a high affinity for the ergot compounds on Helix  heart tissue. It 
could be speculated that this suggested separate receptor could be a peptide 
receptor.
The small dose-dependent increases in cAMP levels in Helix heart cells 
seen with methysergide did not provide any definitive evidence as to whether 
or not methysergide and 5-HT were acting at the same receptor. It served to 
prove that methysergide lacked antagonistic action towards the inotropic 
effects of 5-HT in Helix heart.
Inactivation of 5-HT in the isolated heart
For vertebrate brain tissue it is well known that the enzyme MAO is 
involved in the degradation of biogenic amines (Werman, 1966). Although 
small amounts of MAO have been shown to exist in Helix  brain (Guthrie et  
al., 1975), no investigations have been made into the presence of this enzyme 
within Helix  heart. From the lack of effect of pargyline, a specific MAO 
inhibitor, it would appear that Helix  heart either lacked this enzyme or that 
the enzyme itself was not sensitive to the inhibitors that were tested in the 
present study. This lack of effect of pargyline assisted in accounting for the low  
potency of tryptamine. It was thought that the low potency exhibited by 
tryptamine on the isolated Helix  heart could be due to its accessibility to 
enzymatic breakdown by MAO within the heart. This has been observed in
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other systems, such as the rat fundic strip, where it occurs because the cell 
membrane acts as a selective diffusion barrier excluding 5-HT but allowing the 
less polar tryptamine molecules to gain access to intracellular MAO enzymes 
with subsequent breakdown (Vane, 1959).
In the rat caudal artery preparation, both 5-HT and tryptamine had 
contractile actions although tryptamine was much less potent than 5-HT 
(Bradley et aL, 1985). This suggested that tryptamine was stimulating receptors 
distinct from those of 5-HT. However, in the presence of pargyline, the 5-HT 
antagonists were more potent against tryptamine, such that the pA% values 
were not significantly different from those against 5-HT. This indicated that 
tryptamine was indeed acting at the same receptor as 5-HT and that the 
differential inactivation of tryptamine by MAO largely accounted for the 
different susceptibilities of 5-HT and tryptamine to the antagonists examined. 
Pargyline also had no effect on the inotropic response to tryptamine in the 
isolated Helix heart. This indicated that tryptamine was only a weak agonist at 
the 5-HT receptor in Helix heart and its low potency could not be accounted for 
by its differential inactivation by MAO.
There have been few specific studies on the characteristics of the 5-HT 
uptake mechanism for invertebrates and those that have been undertaken are 
confined to the 5-HT uptake into neurones. It is known that Helix  central 
ganglia have specific high affinity mechanisms for the uptake of 5-HT, which 
were dependent on temperature and sodium ions (Osborne et aL, 1975). These 
specific uptake mechanisms were imipramine-sensitive (Cottrell, 1971). The 
lack of action of the 5-HT uptake blockers fluvoxamine and zimelidine on the 
5-HT response in Helix heart provided evidence that either 5-HT within Helix 
heart is deactivated by a novel method, which is highly unlikely or that the 
5-HT uptake system present in the heart tissue was unsusceptible to blockade 
by the specific drugs used. From the above evidence this latter hypothesis 
would seem the more feasible. There could perhaps be some difference in 
structure of the 5-HT uptake mechanism in the heart of the molluscs, 
compared to that of the vertebrates, which would account for the possible 
difference in susceptibility to the specific uptake inhibitors that were used.
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Involvement of calcium in the inotrop ic resp onse to 5-HT in the isolated
heart
The action of verapamil on the excitatory 5-HT response in the isolated 
Helix heart indicated a possible involvem ent of calcium channels with 
associated movement of calcium ions in the inotropic response to 5-HT in the 
isolated heart. Verapamil, a slow  calcium channel blocker, more properly 
described as a calcium entry blocker (Sperelakis, 1984), not only decreased the 
maximum inotropic response to 5-HT in the isolated heart but also caused a 
small decrease in sensitivity to 5-HT in the heart cells.
Molluscan cardiac m uscle cells possess an elaborate sarcoplasmic 
reticulum which could act as a site for intracellular calcium storage and 
release, although this molluscan cardiac muscle lacks a typical T-system  
(Sanger, 1979). Extracellular calcium influx, as well as release of calcium from 
extracellular stores, could both have a role in contraction of Helix heart. The 
influx of calcium through a calcium channel whose activity is regulated by 
5-HT may be necessary to mediate the excitation-contraction coupling within 
Helix heart muscle cells. 5-HT, by increasing not only the plateau height of the 
cardiac action potential, but also prolonging its plateau phase (Hill, 1974), 
serves to increase the time available for calcium entry into myocardial cells. 
This in turn would allow for increased force of contraction as observed with 
5-HT. Filippov et al. (1985) suggested that a slow calcium channel (but not a 
fast sodium channel) was responsible for the generation of action potentials in 
the heart of Spisula sachalinensis .  Their experim ents w ith  5-HT 
demonstrated that the regulation of molluscan heart tension by 5-HT was not 
related to the membrane potential-dependent ionic channels; rather the effect 
of 5-HT was mediated through chemosensitive calcium channels.
Of interest is the study by Huddart (1986) on the influence of, amongst 
other compounds, 5-HT on calcium efflux from locust foregut muscle. 5-HT 
stimulated calcium entry to the fibres, which was monitored as the subsequent 
calcium efflux in the experiments. This calcium entry was abolished in 
calcium-free media. Verapamil was also shown to block field stimulation- 
induced responses of the foregut. Huddart concluded that the effects of 5-HT 
on the contractile activity of the foregut muscle resulted from a rise in cellular
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free calcium. The mechanism for elevating this free cellular, or activator, 
calcium appeared to be an agonist-induced influx of calcium from the external 
medium via voltage-dependent slow calcium channels. This inward calcium 
signal was secondarily amplified by the triggering of a calcium response from 
cellular storage sites. It is possible, from the evidence discussed here, that this 
pathway might be common in invertebrates and an important agonist- 
induced mechanism to increase intracellular calcium; possibly via cAMP, by 
opening voltage-dependent slow calcium channels.
There is a significant modulatory effect exerted by divalent cations such 
as calcium upon the excitatory effect of 5-HT on the isolated heart. By 
lowering the external calcium concentration, the response of the isolated heart 
to 5-HT was potentiated. This was consistent across several cell types and 
tissues. Early intracellular recordings from NlE-115 cells demonstrated that 
depolarising responses to 5-HT were augmented by the omission of calcium 
from the recording solution (Peters and Usher wood, 1983), More recent patch- 
clamp studies on NlE-115 cells have shown that calcium, magnesium and 
other divalent cations modulate the amplitude and duration of the 5-HT- 
induced currents: the effect occurred in the absence of any change in the 
reversal potential of 5-HT and showed no obvious voltage dependency (Peters 
et a l ,  1988).
Precisely how a reduction in extracellular calcium facilitates the 
response to 5-HT in Helix heart remains unclear. In the Helix  heart, the influx 
of extracellular calcium, as well as release of calcium from intracellular stores, 
could both play a role in contraction of the heart. The results with verapamil 
support this hypothesis because verapamil failed to completely block the 
inotropic 5-HT response in the isolated heart. This appears to indicate that the 
release of calcium from intracellular stores is significant in the inotropic 
response to 5-HT in the isolated heart. Peters et al. (1988) suggested that 
calcium could affect the affinity of the 5-HT receptor by modulation of 
receptor-ion channel or receptor-enzyme coupling via changes in surface 
potential. This hypothesis remains to be verified.
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The possibility of the presence of more than one 5-HT receptor
Investigations of recent years have proved that 5-HT possessed both 
depolarizing (excitatory) and hyperpolarizing (inhibitory) effects on molluscan 
heart muscle cell membranes (Hill, 1974). It was suggested by Kiss and S-R6zsa 
(1978) that the different 5-HT responses of Helix heart muscle cells involved 
different specific 5-HT receptors, similar to the m olluscan neurones 
(Gerschenfeld and Paupardin-Tritsch, 1974). Kiss and S-R6zsa (1978) measured 
the effects of 5-HT on the membrane potential of Helix pomatia heart which 
had been pretreated with a wide range of drugs. Two types of 5-HT receptor 
were distinguished, one causing depolarization the other hyperpolarization. 
Concentrations of between 10“^  to 10"  ^ excited while 10“^  to lO"'^  inhibited. 
However no specific antagonist was found for either of the suggested 5-HT 
receptors.
Further evidence of the presence of more than one 5-HT receptor in 
molluscan hearts was put forward by Akagawa et a l  (1988). They found that 
5-HT had dual effects on the isolated ventricle of Achatina fulica. 5-HT at 
concentrations above InM enhanced frequency and amplitude of heart beat 
while at high concentrations ~ lOjiM 5-HT produced a periodic arrest of 
beating after potentiation. Methysergide inhibited the potentiation of heart 
beat and cinanserin strongly antagonized the periodic arrest of beating which 
suggested that the dual effect of 5-HT was mediated through separate receptors. 
In the present study 5-HT was observed both to have a positive inotropic and 
chronotropic effect. However only the inotropic effect was monitored in these 
experiments as the chronotropic effect was variable and only noted at high 
5-HT concentrations. Unlike that seen in Achatina heart no periodic arrest of 
beating was observed at 5-HT concentrations over lOpM in Helix  heart. 
Evidence from this investigation therefore, gives no indication of the presence 
of more than one 5-HT receptor on the heart muscle cells of Helix aspersa.
Conclusion
From the evidence presented it would appear that the 5-HT receptor 
which mediates the inotropic response of 5-HT on Helix  heart is unique and 
does not fall into any of the 5-HT receptor types which have been described in 
vertebrate tissues. This is supported by the results that 5-HT was mediating its
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inotropic action by activation of cAMP levels. Very few, the 5-HT4 and 5-HT%- 
like receptor, of the fully characterized and classified types has been positively 
linked to cAMF. The presence of a 5-HT4  receptor has been discounted, due to 
the failure of ICS 205-930 at high concentrations to antagonise the 5-HT 
inotropic response of Helix heart. The presence of a 5-HT%-like receptor has 
been discounted also because of the lack of effect of methiothepin. However it 
has become apparent in this investigation that the inotropic effect of 5-HT on 
the isolated heart could not be attributed entirely to cAMP activation. Paciotti 
and Higgins (1985) argued that if cAMP was the sole mediator of the effect of 
5-HT on molluscan hearts, 5-HT would theoretically be unable to elicit a 
response if the 5-HT receptor and associated adenylate cyclase were uncoupled: 
an interesting concept and one still to be evaluated.
The activation of Mercenaria heart by phorbol esters, reported by Deaton 
and Gray (1990), suggested the involvement of protein kinase C and associated 
inositol phospholipids. Is the action of 5-HT on molluscan hearts similar to 
that in the salivary gland of the blowfly, Calliphora erythrocephalal  There, 
5-HT increased the rate of secretion and both calcium and cAMP were second 
messangers for 5-HT. The first indication of a link between calcium  
mobilization and phosphatidylinositol breakdown in blowfly salivary glands 
was the demonstration that 5-HT increased phosphatidylinositol breakdown 
through a mechanism that was not secondary to elevated cAMP levels (Fain 
and Berridge, 1979). Since that time it has been demonstrated that separate 
5-HT receptors are involved  in activation of adenylate cyclase and 
phosphatidylinositol breakdown. Could it be that there is more than one 5-HT 
receptor present in Helix heart? This possibility requires further investigation 
because none of the data presented in this study gives any indication of the 
presence of more than one 5-HT receptor.
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CHAPTER FOUR 
THE 5-HT RECEPTOR ON HELIX PRM
INTRODUCTION
In addition to the potent actions of 5-HT on molluscan neurones and 
cardiac muscle, as described in the preceding chapters, 5-HT has been shown to 
have an effect on other molluscan tissues. Since the 1950s there has been an 
accumulation of evidence suggesting a transmitter role for 5-HT in molluscan 
somatic and visceral muscles. Most of the investigations on the action of 5-HT 
have been undertaken on the anterior byssus retractor muscle (ABRM) of 
M yti lu s .  In contrast, there have been few studies on the action of 5-HT on 
molluscan visceral muscle.
Action of 5-HT on molluscan muscle
The ABRM of Mytilus  edulis is a non-striated paramyosin-containing 
catch muscle which maintains the shell of these lamellibranchs closed for long 
periods. This muscle was found to be capable of two types of contraction; a 
brief contraction which persists only during stimulation and a prolonged 
contraction which continues long after stimulation has ceased. This sustained 
contraction was called catch. In this catch state there was an absence of 
electrical potentials and membrane depolarization (Twarog, 1960a). In the 
absence of the catch state in Mytilus nerve-musde preparation, 5-HT had no 
effect on resting membrane potential, junction potentials, spikes or 
contraction (Hikada et ah, 1967). 5-HT had been found to cause relaxation of 
catch contraction in the ABRM. The evidence for a transmitter role for 5-HT 
in the muscle has already been discussed.
The PRM of Helix is another molluscan somatic muscle found to be 
sensitive to 5-HT. It is a large discrete muscle which runs from the columellar 
region of the shell to the buccal mass. Each half of the muscle is innervated by 
a short nerve running from the suboesophageal ganglia. The PRM is 
innervated diffusely and there is no evidence for the presence of neuronal cell 
bodies in the muscle itself (Ramsay, 1940). The PRM was used first by Bozler 
(1930), who investigated heat production of smooth muscle. The mechanical 
properties both of resting and active PRM have been described (Abbott and 
Lowy, 1958a,b). Two of the major findings of these studies were that: i) the
82
PRM exerted no significant rest tension until it had been stretched past the 
largest length that it reached in the animal, and ii) that the contraction of the 
PRM far outlasted the active state in the muscle. The relationship between the 
mechanical and electrical properties of the PRM were studied by Sato et al. 
(1960). They recorded both neuromuscular junction potentials and muscle 
action potentials.
In addition the PRM has been shown to be sensitive to 5-HT. Lloyd 
(1978) found that the PRM contained large quantities of 5-HT. Application to 
the m uscle of fractions obtained by gel filtration of a PRM extract 
demonstrated that 5-HT was the only relaxing factor present in the muscle. 
Lloyd (1980) subsequently provided further evidence for the mediation of 
5-HT in the post-tetanic increase in relaxation rate by showing the effect of 
reserpine on the PRM. Reserpine markedly reduced the 5-HT content of the 
PRM. Furthermore, the PRM of reserpine-treated animals show ed no 
significant post tetanic increase in relaxation rate. He observed also that, on 
the PRM, the commonly used 5-HT antagonist methysergide was unsuccesful 
in blocking the action of 5-HT. It proved to be an effective agonist but an 
ineffective antagonist for the increase in relaxation rate in the PRM. The 
actions of 5-HT on the PRM were similar to its effect on the ABRM of Mytilus.  
When stimulated to contract in certain ways, the ABRM entered catch, a 
prolonged contraction (Twarog, 1954). Exogenous 5-HT caused a relaxation of 
this catch contraction. Lehman and Greenberg (1987), while investigating the 
effects of not only molluscan peptides, but also 5-HT and ACh, on visceral and 
somatic muscles of Helix aspersa, noted that the relaxing effect of 5-HT on the 
PRM was best observed after the muscle had been contracted with ACh.
Mediation of the effect of 5-HT by cAMP in molluscan muscle
There has been considerable interest in cAMP and the action of 5-HT in 
molluscs. Higgins (1974), Higgins and Greenberg (1974) and Achazi at al. (1974) 
have provided evidence that there is a correlation between 5-HT action and 
cAMP levels within molluscan tissues. In the ABRM, cAMP had been 
implicated as the second messenger in the relaxant action of 5-HT. Interest in 
this hypothesis led Cole and Twarog (1972) to survey the pharmacology of 
cAMP, dibutyryl cAMP and certain compounds said to act on adenylate cyclase. 
Although application of cAMP had no effect, dibutyryl cAMP produced 
relaxation similar to that evoked by 5-HT, but only at 5^C and not in all
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preparations. Theophylline, a phosphodiesterase inhibitor, potentiated the 
relaxation in the ABRM. Achazi et al. (1974) confirmed some of the above 
pharmacological results and extended the study. Marchand-Dumont and 
Baguet (1975) reported that cAMP induced relaxation in chemically treated, 
permeable muscle fibre bundles in Mytilus.  They proposed that the relaxing 
effect of 5-HT was due to an increase in the rate of calcium release from the 
contractile proteins and that this was mediated through cAMP.
In addition 45(2^2+ flux studies on the whole muscle (Bloomquist and 
Curtis, 1972, 1975a), and measurements of net Ca^+ flux with an extracellularly 
placed calcium electrode (Bloomquist and Curtis, 1975b), have shown that 
5-HT caused a transient increase in Ca^+ efflux. This suggested that changes in 
calcium concentration or calcium perm eability of the m uscle surface 
membrane were involved also in the relaxation of catch contraction. Ishii et 
al. (1989) investigated the effects of 5-HT and forskolin on intracellular free 
calcium in isolated and Fura-2 loaded smooth muscle cells from the ABRM of 
Myti lus.  Their results suggested that 5-HT had multiple effects on the 
intracellular free calcium concentration in the ABRM and that cAMP was 
implicated in this effect. One of the mechanisms which underlay these 
responses was the inhibition of an agonist-induced release of stored calcium. 
From these results it appeared that the relaxant effect of 5-HT on the M yti lus  
muscle was linked intimately both with cAMP levels and intracellular free 
calcium concentration though it still remained for the entire mechanism of 
catch to be elucidated.
Action of 5-HT on molluscan visceral muscles
Studies of the action of 5-HT have not been limited solely to the somatic 
muscles but have also focused on the molluscan visceral muscles. Greenberg 
and Jegla (1963) investigated the actions of 5-HT on the rectum of Mercenaria.  
5-HT excited the rectum, inducing rhythmical activity at lower concentrations, 
and at high concentrations 5-HT increased the tone. The actions of 5-HT were 
mimicked by tryptamine and LSD and antagonised by methysergide. 
Benzoquinonium, tubocurarine and morphine antagonised the tone increase 
while augmenting the beat induced by 5-HT. From their study they suggested 
two sites of action for 5-HT on the rectum: one which could be antagonised by 
methysergide, directly on the muscle and one presynaptically onto cholinergic 
nerve terminals which could be modified by ACh antagonists. They implied
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that the situation was somewhat similar to the hypothesis that had been 
proposed by Gaddum and Picarelli (1957) to explain the actions of 5-HT on the 
guinea pig ileum.
Lehman and Greenberg (1987) investigated the actions not only of 
FMRFamide peptides, but also of ACh and 5-HT, on several visceral and 
somatic muscles in Helix aspersa. Their muscle preparations included the 
ventricle, epiphallus, crop, tentacle retractor muscle and PRM. 5-HT induced 
phasic contractions of the epiphallus which were not reduced by methysergide 
or 2-bromo-LSD. The latter two drugs acted as weak agonists. On the crop, 
5-HT reduced the tone w hile increasing the frequency of spontaneous 
contractions. The action of 5-HT was not blocked by methysergide or 2-bromo- 
LSD. Both on the tentacle retractor muscle and PRM 5-HT had a relaxant effect 
which could not be distinguished by 5-HT antagonists.
An attempt to define the properties of the 5-HT receptor in the ABRM 
led to a structure-activity study by Twarog and Cole (1972). Dopamine and 
bufutenine were approximately equipotent w ith 5-HT, but 6-HT was 
approximately 100 times less potent than 5-HT. Tryptamine, noradrenaline 
and adrenaline all showed equally low potency with 5-HTP, N-acetyl-5-HT, a- 
Me-dopa and melatonin having no effect at all.
Aim s
The aim of the present study was to attempt to characterize the 5-HT 
receptor mediating relaxation in the PRM of Helix aspersa as one of the 
vertebrate 5-HT receptor types. Using organ bath methodology, the relaxant 
effect mediated by 5-HT in the PRM has been investigated. This was achieved 
by utilising 5-HT's ability to inhibit ACh-induced contraction in the muscle, 
which proved to be dose-dependent and was quantifiable. In an attempt to 
characterize the receptor, specific 5-HT receptor agonists and antagonists have 
been tested on the muscle preparation. Because the evidence relating to 
smooth muscle preparations amongst molluscs has suggested that 5-HT might 
be mediating its relaxant effect through elevated cAMP levels, measurements 
of cAMP concentrations in the muscle, under appropriate conditions, were 
obtained in order to provide further information with which to characterize 
this 5-HT receptor.
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Before the PRM was finally selected, not only for its consistent response 
to 5-HT, but also for the overwhelming evidence that 5-HT was indeed the 
relaxant neurotransmitter in this m uscle, a number of other muscle 
preparations from Helix were investigated with reference to the action of 
5-HT. The search for a suitable preparation as a bioassay included muscles of 
the visceral type, because previous evidence had shown that both molluscan 
rectal and oesophageal preparations could be used in pharmacological assays 
and were responsive to 5-HT. The preparations used from the Helix therefore 
included the rectum and the oesophagus. The same experimental protocol 
was used as that utilized for the PRM and the effects of 5-HT on these muscle 
preparations were monitored. The results both with the rectum and the 
oesophagus are shown and discussed later in further detail.
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METHODS AND MATERIALS
Anim als
Common garden snails. H e l ix  aspersa were obtained from Blades 
Biological. They were maintained in humid tanks enclosed with wire mesh, 
at room temperature and fed at regular intervals. All snails used in this study 
were kept in the active state for at least one week prior to use.
Dissection
The snail shell was cut away carefully with the aid of a pair of sharp 
scissors and removed entirely. The snail was then pinned in a wax-bottomed 
dissecting dish. The body wall was cut dors ally from near the top of the head 
and the genital organs were removed. A diagram of the internal organs is 
given in Fig. 4.1. In the case of the PRM, the position of which is shown in 
Fig. 4.2, the visceral organs were lifted with forceps and cut away from the 
buccal mass. The nerve collar which comprises a pair of cerebral ganglia and 
which cover the oesophagus, was slipped forward over the buccal mass and 
then cut away. This left visible the buccal mass and the PRM attached to its 
ventral surface. The muscle was then ligated at both ends with short pieces of 
silk thread. The ligated preparation with the two small thread loops could 
then be cut away from the rest of the body, at one end close to the buccal mass 
and at the other end close to the columella of the shell. In the case of the 
oesophagus, once the snail was opened the crop was lifted, thus making 
visible the oesophagus. The oesophagus was again ligated with short pieces of 
silk thread which were knotted to form small loops at each end. The 
preparation was then cut away from the rest of the body. The rectum was 
rather difficult to find and required that the snail be completely opened up. 
The easiest way was to trace the gut from the oesophagus through the 
digestive gland past the nephridium and out towards the anus. Once the 
rectum had been identified it, like the other preparations, was ligated also with 
silk thread leaving small thread loops. The rectum was then cut away from 
the rest of the snail body.
Experimental protocol
Once all these preparations had been cut away from the animal they 
were mounted vertically and secured, by means of the small thread loops, in
87
flagellum
anus
rectum
ureter
pulmonary
plexus
nephridium
auricle
ventricle
collar
penis 
dart sac
mucous glandcerebra
parietalvisceral
w
posterior 
esophagus
digestive gland
ocullferous
tentacle
oviduct 
sperm duct 
duct of
copulatory bursa
- stomach
copulatory bursa
gonad
foot
hermaphroditic duct 
albumen gland
FIGURE 4.1
Diagram of the internal organs of the snail. Helix aspersa. This diagram 
shows the intestinal tract with reference to the oesophagus, anterior and 
posterior parts, and the rectum which were tested for their responses to 5-HT 
in this study. This figure was modified from Invertebrate Zoology ed. R.D. 
Barnes, Sanders College (1980).
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FIGURE 4.2
Diagram to show the position of the PRM in H e l ix  aspersa  and its 
innervation. As can be seen from the diagram, the PRM runs from the buccal 
mass to the columella of the shell where it is attached. In this diagram the 
PRM is shown in the elongated form. In a non-active snail inside its shell, the 
m uscle w ould be considerably shortened. The main innervation of the 
muscle comes from connections to the suboeosophageal ganglia. The drawing 
was modified from Leake and Walker (1980).
10ml organ baths containing physiological saline (NaCl 80mM, KCl 5mM, 
C a C l2 7mM, M gCl2 5mM, Hepes 20mM; pH 7.5). Fig. 4.3 shows 
diagrammatically the experimental apparatus. The upper end of the 
preparation was connected via a small hook to a Dynamometer (UFI) 
isometric transducer, which in turn was connected to an 8-channel Lectromed 
recorder. The lower end of the preparation was attached to an L-shaped 
stainless steel wire support which was clamped above the bath. In this way 
any muscle movement could be detected by the transducer. This type of 
transduction measured the shortening of the m uscle/gut preparation. All the 
experiments were undertaken at room temperature (18-20^0 and were gassed 
by a 95% O2, 5% CO2 mixture.
In the case both of the oesophagus and rectum preparations, these were 
used only as trials in an attempt to find a preparation which responded well to 
5-HT. Here 5-HT was added to the bath in appropriate concentrations in a 
Gilson pipette. The drugs were always added to the airstream caused by the 
gassing mixture so that this ensured rapid and even dispersion. The 
sensitivity of the tissue to the 5-HT was then observed on the chart recorder, 
examples of which are shown later. N o other drugs were tested on these two 
preparations.
In the case of the PRM it was found that the effect of 5-HT on the 
muscle was to cause relaxation. This response was adequately observed only if 
the muscle had previously been contracted. ACh was used to contract the 
muscle. Full concentration-effect curves to ACh were obtained because ACh 
caused dose-dependent increases in the size of contraction. These curves were 
obtained both in the presence and absence of eserine (IpM), a naturally 
occurring tertiary amine which acts effectively as an acetylcholinesterase 
inhibitor. Once a full concentration-effect curve for ACh had been established 
a concentration resulting in approximately 50-70% maximum contractile 
response was chosen. This concentration of ACh, usually 3pM, was then used 
to induce contraction in the PRM. The appropriate ACh concentration was 
added to the bath every 20 minutes, the muscle allowed to contract and the 
drug washed out with fresh physiological saline. In this way the muscle gave 
reproducible responses to ACh which were consistent in size and the muscle 
tissue did not appear to exhibit desensitization.
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FIGURE 4.3
Diagram of the experimental apparatus used in the muscle experiments. 
The ligated PRM (A) was suspended in a 10ml jacketed organ bath (B) in 
physiological saline at room temperature. The muscle was held in position 
between a fixed L-shaped steel wire support (D) which was kept rigid in a 
clampstand above the bath, and a wire hook (E) which was attached to a force 
transducer (F). In this way any movement of the muscle could be monitored. 
The physiological saline was gassed with a 95% O2, 5% CO2 mixture (C).
Effects of agonists
For the experimental protocol involving 5-HT and th^ testing of the 
relevant agonists and antagonists, eight muscle preparations were set up in 
individual organ baths. ACh at a concentration of 3jiM was then added to 
each of the eight organ baths once every 20 minutes. This allowed the PRM to 
contract and the ACh to be w ashed out properly before the next 
administration. Of the eight muscle preparations, two would act as control 
with ACh added every 20 minutes for the whole period of the experiment. No 
other drugs were added to the control preparations. This could then be used to 
verify the sensitivity of the PRM to ACh and to demonstrate any deterioration 
of the contractile response to ACh.
Of the remaining preparations, once the ACh contractile responses were 
consistent, a concentration of 5-HT was added to the baths three minutes 
before the next administration of ACh. These drugs were then washed out of 
the bath once a contractile response had been obtained. 5-HT caused an 
inhibition of the ACh-induced contractile response so that this response had 
to return to its original size before the next concentration of 5-HT could be 
added. ACh was repetitively administered every 20 minutes with three 
washes of fresh physiological saline being used to remove the drug from the 
bath. After the contractile response to ACh had returned to its original size, 
the next concentration of 5-HT could be added and the same procedure 
followed.
The results are expressed as a percentage of inhibition of the ACh- 
induced contraction that was measured from the experiments and these 
values were plotted against log of the molarity of the 5-HT concentration to 
give the log concentration-effect curves. The range of concentrations over 
which 5-HT and other test agonists were tested was O.lpM to lOOpM. From the 
concentration-effect curves, the EC50 (molar concentration of each compound 
to produce 50% inhibition) value could be obtained. This was used to provide 
an indication of the potency because the EC50 value for the test agonist was 
divided by that of 5-HT to give the relative potency value (ECr). Where 
quoted, the EC50 value is usually the pECso value (negative logarithm)g of 
the EC50 value). The maximum percentage inhibitions elicited by the agonists 
tested were compared to that obtained with 5-HT. All values shown in the 
results are the arithmetic mean ± s.e. mean from n experiments. The values
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for n are given in the results section. All concentrations stated are the final 
bath concentrations to which the PRM was exposed. The agonists tested were 
5-CT and sumatriptan (both 5-HT) receptor agonists), a-Me-5-HT (a 5 -HT2 
receptor agonist) and 2-Me-5-HT (a 5-HTg receptor agonist). The LSD 
derivative, methysergide and the ergot derivative ergotamine were also tested 
as agonists in this preparation.
Effects of antagonists
For antagonists, their effect was tested by the addition to the bath of the 
antagonist over a period of at least 30 minutes both before, during, and after 
ACh administration, to test if the antagonist affected the contractile response 
to ACh in any way. The same procedure as for the agonist was followed, the 
only difference being the presence of the said antagonist. If antagonist action 
was established, the agonist concentration-ratio could then be calculated for 
each antagonist concentration (Apperley et a l ,  1976). The estimates of 
concentration-ratio could then be used to calculate the PA2 values 
(Arunlakshana and Schild, 1959). The antagonists tested were methiothepin 
(a 5-HT) receptor antagonist), ketanserin (a 5 -HT2 receptor antagonist), 
ondansetron and metoclopramide (both 5-HTg receptor antagonists).
Drugs used
The full list of the drugs used in the experiments and from where they 
were obtained is given: 5-HT creatinine sulphate (Sigma), ACh chloride 
(Sigma), eserine/physostigm ine salicylate (Sigma), ergotamine tartrate 
(Sigma), m ethysergide hydrogen m aleate (Sandoz), m etoclopram ide 
hydrochloride (Sigma), m ethiothepin maleate (Hoffman La Roche) and 
ketanserin (Janssen). 5-CT maleate, a-Me-5-HT hydrochloride, sumatriptan 
and ondansetron were all synthesized by the Chemistry Reseach Department 
at Glaxo. All stock solutions of the drugs were made up fresh on the day of 
use in physiological saline and kept on ice, with the exception of ketanserin 
and ondansetron both of which were first dissolved in O.IM tartaric acid with 
further dilutions in physiological saline. Where appropriate, vehicle controls 
were made to see if the solvent had any effect.
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Measurement of cAMF
The same experimental protocol as in the previous chapter was 
followed for measurement of cAMP. There were, however, two differences in 
the apparatus. The muscle tissue was hom ogenized using a teflon-glass 
motor-driven homogenizer (Jencons Scientific) and the optical density of each 
protein assay sample was determined at 750nm on a Phillips PU8620 UV 
spectrophotometer. The results were expressed as pmoles cAMP.mg"^ tissue 
protein. These values were the arithmetic mean ± s.e. mean of n, n being the 
number of experiments.
91
RESULTS
Results relating to the effect of 5-HT on the oesophagus and rectum of Helix
The degree of torsion within the shell of Helix aspersa resulted in the 
dissection of the rectum being more difficult than that of the oesophagus. A 
simplified version of the internal organs of Helix is shown in Fig. 4.1. As can 
be seen from this figure, when the snail is cut open the intestinal tract from 
the buccal mass to the rectum was easy to identify, once the genital organs had 
been removed, and could be followed throughout the animal. In this way 
small pieces of the oesophagus and the rectum could be ligated and mounted 
in an organ bath.
The spontaneous activity of the freshly isolated oesophagus was highly 
irregular despite frequent washes and periods of approximately 30-45 minutes, 
in order to allow the muscle to settle. Different parts of the oesophagus were 
also used in the various preparations. It was found that the anterior 
oesophagus, the region between the buccal mass and the crop, was the most 
robust preparation, having a high degree of spontaneous activity and giving a 
good response to the application of 5-HT. Examples of the activity of the 
anterior oesophagus, and its response to 5-HT, are shown in Figs. 4.4 and 4.5. 
The less spontaneously active posterior oesophagus, and its different response 
to 5-HT application, is demonstrated in Fig. 4.6. In most preparations 5-HT 
reduced the tone of the oesophagus and decreased the frequency of 
contractions in a dose-dependent manner (Figs. 4.4 and 4.5). However, in a 
small minority of the preparations, those from the posterior region of the 
oesophagus, 5-HT was observed to have a contractile effect and to increase the 
frequency of contractions (Fig. 4.6). The observed spontaneous activity of the 
oesophagus, in particular the anterior region, made quantification of the 
response to 5-HT extremely difficult. Eventually the PRM was used in 
preference to the oesophagus because the relaxant response to 5-HT seen in the 
PRM was easier to quantify and allowed for the testing of specific agonists and 
antagonists. The response to 5-HT in the PRM was also consistent as 
compared to the varying responses seen with different parts of the intestinal 
tract.
The rectum was also used in several preparations. This tissue was 
difficult to dissect from the animal and much more fragile than the
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FIGURE 4.4
Three examples of the response shown by an isolated Helix oesophagus 
to increasing concentrations of 5-HT (A, B and C). The addition of 5-HT is 
indicated by a closed circle. The stated concentration of 5-HT was the final bath 
concentration to which the oesophagus was exposed. Washes with fresh 
physiological saline are indicated by the letter w.
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FIGURE 4.5
Three examples of the response shown by an isolated Helix oesophagus 
to increasing concentrations of 5-HT (A, B and C). The addition of 5-HT is 
indicated by a closed circle. The stated concentration of 5-HT was the final bath 
concentration to which the oesophagus was exposed. Washes with fresh 
physiological saline are indicated by the letter w.
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FIGURE 4.6
Three examples of the response shown by an isolated Helix  oesophagus 
to increasing concentrations of 5-HT (A, B and C). The addition of 5-HT is 
indicated by a closed circle. The stated concentration of 5-HT was the final bath 
concentration to which the oesophagus was exposed. Washes with fresh 
physiological saline are indicated by the letter w.
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oesophagus, and therefore easily damaged. The rectum, once isolated in the 
organ bath, was quiescent and showed little or no response to 5-HT. The 
results are not shown here because only two experiments were undertaken 
before the rectum preparation was discarded in preference for the PRM,
Effect of ACh on the PRM
The PRM was usually quiescent when isolated in the organ bath and 
only infrequently showed spontaneous activity. It was a robust preparation 
and easily dissected from the animal. The position of the PRM in the snail is 
shown in Fig. 4.2. After mounting the PRM in the organ bath with an initial 
tension the PRM relaxed back to its resting state. Once the relaxation was 
complete and the baseline steady, ACh was applied to the organ bath.
The contractile response of the PRM to applications of increasing 
concentrations of ACh was dose-dependent (Fig. 4.7A). The PRM tissue was 
desensitized not only to higher concentrations of ACh (Fig. 4.7B), but also if 
the ACh was incompletely removed from the organ bath leaving enough time 
for complete recovery. The experimental protocol, therefore, demanded that 
the ACh applications be made at 20 minute intervals, with three washes of 
fresh physiological saline between each application. In the presence of eserine 
(l|iM) the PRM became much more sensitive to applications of ACh (Fig. 4.8). 
The PRM also showed more rapid desensitization and this was apparent at 
lower concentrations of ACh in the presence of eserine. In the presence of 
eserine, the PRM required more frequent washes and a longer time interval 
betw een ACh applications in order to avoid desensitization. The 
concentration-effect curve for ACh, in the absence of eserine, had a threshold 
concentration of approximately 50nM reaching a maximum at 50pM. In the 
presence of eserine, the threshold was lowered to lOnM, whereas the 
maximum response was achieved at a lower ACh concentration (Fig. 4,9). 
Eserine was seen also to potentiate the effect of ACh, increasing the maximum 
response seen and shifting the concentration-effect curve to the left.
Due to the problems with desensitization of the ACh responses in the 
PRM in the presence of eserine, and the subsequent longer time course of the 
experiment to avoid this problem, a decision was taken not to use eserine in 
the following experiments. A response of approximately 50-80% of the 
maximum was taken from the concentration-effect curve (Fig. 4.9) and that 
concentration of ACh (3pM) was then used to contract the PRM in the
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FIG URE 4.7
A. The contractile responses of Helix PRM to increasing concentrations 
of ACh are shown in the figure. The additions of ACh to the bath are 
indicated by arrows. The stated concentration was the final bath concentration 
to which the PRM was exposed. Washes with fresh physiological saline are 
indicated by the letter w.
B. The desensitization shown by Helix PRM to higher concentrations of 
ACh. The additions of ACh to the bath are indicated by arrows. The stated 
concentration was the final bath concentration to which the m uscle was 
exposed. The letter w  indicates washes with fresh physiological saline.
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FIG URE 4.8
The contractile responses of Helix PRM to increasing concentrations of 
ACh in the presence of l|iM  eserine are shown in this figure. The ACh was 
added to the bath as indicated by the arrows and the concentration stated was 
the final bath concentration to which the PRM was exposed. The letter w  
indicates washes with fresh physiological saline. Note the desensitization of 
the PRM to ACh concentrations >5|xM in the presence of IpM eserine.
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FIGURE 4.9
log ACh concentration (M)
The concentration-effect curves for ACh-induced contraction in the 
PRM in the absence (closed circles) and the presence (open circles) of IpM  
eserine are shown in this figure. The x axis gives the log of the ACh 
concentration while the y axis gives the percentage maximum contractile 
response. Vertical bars represent the arithmetic mean ± s.e. mean of n=6 .
follow ing experim ents. This value was just above the EC50  value 
(approximately IjiM) that was obtained for the contractile effect of ACh on the 
PRM. The response of the muscle to repetitive additions of ACh was 
consistent and showed less than 5% deterioration over the time course of an 
experiment which could last for anything up to 7 hours. This small 
deterioration in the ACh response is not shown in the results because it did 
not interfere with the results and was, therefore, considered insignificant.
Effect of 5-HT on ACh-induced contraction in the PRM
Because 5-HT was known to have a relaxant effect on the Helix PRM, 
the response to 5-HT could be adequately seen only if the muscle had 
previously been contracted. ACh (3jiM) was used to induce the contraction in 
the PRM. 5-HT relaxed the ACh-induced contraction in the PRM and 
increased the rate of relaxation in a dose-dependent manner (Fig. 4.10). The 
PRM was in the process of relaxing after the contraction due to ACh (3|iM) 
when 5-HT was added and a rapid response was seen. However, this relaxant 
response in the PRM to 5-HT was difficult to quantify because the ACh 
contractions were not w ell maintained and an alternative approach to 
observing the effect of 5-HT was investigated.
Finally it was found that if 5-HT was added to the bath three minutes 
before the addition of ACh, 5-HT caused a subsequent inhibition of the ACh- 
induced contraction and that this was dose-dependent (Fig. 4.11). This 5-HT 
response could easily be quantified as the percentage inhibition of ACh- 
induced contraction in the PRM. When plotted against the log of the 5-HT 
concentration, a typical sigm oid concentration-effect curve for 5-HT was 
obtained (Fig. 4.12). 5-HT had a thresold range of 5-1 OnM, reaching a 
maximum at a concentration of lOOpM. The threshold for inhibition of ACh- 
induced contraction by 5-HT was the same for that seen for the relaxant 
response. An increased rate of relaxation was seen also and was comparable 
once again to that seen with the relaxant response of 5-HT on the PRM. The 
time course of the experiment was limited by the fact that over time the ACh 
contractile responses were themselves very slowly desensitized. Thus 5-HT 
along with the specific 5-HT receptor agonists and antagonists were tested over 
a concentration range of only O.lpM-lOOpM. The EC50  value for 5-HT was 
between 0.3-0.5|iM.
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FIGURE 4.10
The relaxant effect of increasing concentrations of 5-HT (A-C) on Helix  
PRM are show n after the m uscle has been contracted w ith 3|xM ACh. 
Application of ACh is indicated by arrows. The addition of 5-FIT is indicated 
by closed circles. The stated concentration of 5-HT was the final bath 
concentration to which the PRM was exposed.
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FIG URE 4.11
The contractile responses of Helix PRM to a given concentration of ACh 
and inhibition of this ACh-induced contraction of the PRM by 5-HT. Five 
examples (A-E) are given in this figure to illustrate the ability of 5-HT to 
inhibit the ACh-induced contractions in the PRM. Each example shows a 
control response to ACh, a response to ACh in the presence of 5-HT and a 
response to ACh after 5-HT has been thoroughly washed out. ACh (3|iM) was 
applied at the arrows. The concentration of 5-HT was increased from A-E. 
The stated concentration of 5-HT was the final bath concentration to which the 
PRM was exposed. The letter w  indicates washes with fresh physiological 
saline.
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FIGURE 4.12
log 5-HT concentration (M)
The concentration-effect curve for the inhlbiton of ACh-induced  
contraction by 5-HT in the PRM is shown in this figure. The x axis gives log of 
the 5-HT concentration while the y axis gives the percentage inhibition of 
ACh-induced contraction. The ACh concentration used to induce contraction 
in the PRM was 3|iM. Vertical bars represent the arithmetic mean ±  s.e. mean 
of n=6 .
Effects of 5-HT agonists
The 5-HT receptor agonists were tested for their ability to induce 
inhibition of ACh-induced contraction in the PRM. These were 5-CT, 
sumatriptan, a-Me-5-HT and 2-Me-5-HT (Figs. 4.13 and 4.14). Also tested as 
agonists on this system were ergotamine and methysergide. Of the agonists 
tested, 5-CT was the most potent. 5-CT caused a 75% inhibition at a 
concentration of 10|iM (Fig. 4.15). Sumatriptan caused a similar percentage 
inhibition (73%) to 5-CT at lOpM. Ergotamine and methysergide shared 
similar potency, causing a 50-60% inhibition of ACh-induced contraction at 
lOpM (Figs. 4.15 and 4.16 respectively). a-Me-5-HT and 2-Me-5-HT were much 
less effective showing only a 5-10% inhibition of ACh-induced contraction at 
10|xM (Fig. 4.17). From the examples of inhibition caused by these agonists in 
the figures quoted above, log concentration-effect curves could be obtained. 
EC50 values for each agonist could then be obtained and these were used to 
estimate the relative potency values (ECr).
Ergotamine and m ethysergide were potent as agonists on this 
preparation in showing no antagonist effect (Fig. 4.16). Sumatriptan showed 
similar agonist effects to the two latter compounds but was more effective (Fig. 
4.15) whereas 5-CT was clearly the most potent agonist mimicking closely the 
inhibition of ACh-induced contraction effects by 5-HT (Fig. 4.15). Both a-Me- 
5-HT and 2-Me-5-HT showed little agonist effect producing only maximum  
inhibitions of only 27% and 23% respectively (Fig. 4.17). 5-CT was only found 
to be 3 times less potent whereas sumatriptan was 16 times less potent than 
5-HT. Ergotamine and methysergide were approximately similar, being 40-45 
times less potent than 5-HT. No ECr  values for a-Me-5-HT or 2-Me-5-HT 
were obtained because they failed to even elicit a 50% inhibition value. The 
full rank order of potency for inhibition of ACh-induced contraction in the 
PRM was 5-HT > 5-CT > sumatriptan > ergotamine = methysergide » >  a-Me- 
5-HT = 2-Me-5-HT. The agonist results are summarized in Table 4.1 overpage.
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FIG URE 4.13
The contractile responses of Helix  PRM to 3pM ACh and inhibition of 
this ACh-induced contraction by the specific 5-HT receptor agonists tested. An 
example of the ability of the stated agonist to inhibit the ACh-induced  
contraction in the PRM, at a concentration of lOfxM, is shown in this figure. 
The agonists are 5-CT (A), sumatriptan (B) and ergotamine (C). Each example 
shows the control response to ACh, the response to ACh in the presence of 
agonist (lOjiM) and the response to ACh once the agonist had been thoroughly 
washed out. ACh (3)iM) was applied at the arrows. The letter w  indicates 
washes with fresh physiological saline. The stated agonist concentration was 
the final bath concentration to which the PRM was exposed.
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FIG URE 4.14
The contractile responses of Helix  PRM to 3pM ACh and inhibition of 
this ACh-induced contraction by the specific 5-HT receptor agonists tested. An 
example of the ability of the stated agonist to inhibit the ACh-induced  
contraction in the PRM, at a concentration of lOpM, is shown in this figure. 
The agonists are methysergide (A), a-Me-5-HT (B) and 2-Me-5-HT (C). Each 
example shows, the control response to ACh, the response to ACh in the 
presence of agonist (lOjiM) and the response to ACh once the agonist had been 
thoroughly washed out. ACh (3|iM) was applied at the arrows. The letter w  
indicates w ashes w ith fresh physiological saline. The stated agonist 
concentration was the final bath concentration to which the PRM was exposed.
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FIGURE 415
log 5-HT concentration (M)
The concentration-effect curves for inhibition of ACh-induced  
contraction in Helix PRM for 5-HT (closed circles), for 5-CT (open circles) and 
for sumatriptan (squares) are shown in this figure. The x axis gives log of the 
5-HT concentration while the y axis gives percentage inhibition of ACh- 
induced contraction. The ACh concentration used to induce contraction in 
the PRM was 3|iM. Vertical bars represent the arithmetic mean ± s.e. mean of 
n=8 for 5-HT and n -5  for 5-CT and sumatriptan.
100 1
011x iI
'o
gI
80-
60-
40-
20 -
0 I
-6
FIGURE 4.16.
log 5-HT concentration (M)
The concentration-effect curves for inhibition of A Ch-induced  
contraction in Helix PRM for 5-HT (closed circles), for ergotamine (diamonds) 
and for methysergide (open circles) are shown in this figure. The x axis gives 
log of the 5-HT concentration while the y axis gives percentage inhibition of 
ACh induced contraction. The ACh concentration used to induce contraction 
in the PRM was 3pM. Vertical bars represent the arithmetic mean ± s.e. mean 
of n~8  for 5-HT and n=5 for ergotamine and methysergide.
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FIGURE 4.17
log 5-HT concentration (M)
The concentration-effect curves for inhibition of ACh-induced  
contraction in Helix PRM for 5-HT (closed circles), for a-M e-5-HT (open  
circles) and for 2-Me-5-HT (diamonds) are shown in this figure. The x axis 
gives log of the 5-HT concentration w hile the y axis gives percentage 
inhibition of ACh-induced contraction. The concentration of ACh used to 
induce contraction in the PRM was 3|xM. Vertical bars represent the 
arithmetic mean ± s.e. mean of n=8 for 5-HT and n=5 for a-Me-5-HT and 2- 
Me-5-HT.
TABLE 4.1 Summary of the 5-HT agonists tested in Helix  PRM. The ECr and
Agonist n EC50 ECr % inhibition
5-HT 20 6.5 ± 0.6 1 100
5-CT 5 6.0 ± 0.5 3.0 ± 0.4 86 ± 5
Sumatriptan 5 5.3 ± 0.3 16.0 ±4.0 78 ± 6
Ergotamine 5 4.9 ± 0.3 40.0 + 6.0 74 + 4
Methysergide 5 4.8 ± 0.6 44.0 ± 4.0 73 + 5
a-Me-5-HT 27 + 4
2-Me-5-HT 23 + 3
Effects of 5-HT antagonists
The specific antagonists tested against the ability of 5-HT to inhibit ACh- 
induced contraction in the PRM were methiothepin, ketanserin, ondansetron 
and metoclopramide. Methiothepin lacked antagonistic effect on the ability of 
5-HT to inhibit ACh-induced contraction (Fig. 4.18). The 5-HT concentration- 
effect curve in the presence of IpM methiothepin, is superimposed upon the 
5-HT concentration-effect curve in the absence of the antagonist. Ketanserin 
also failed to have antagonist action on the inhibition of ACh-induced 
contraction seen with 5-HT Ondansetron also demonstrated no antagonistic 
properties, as once again, the two 5-HT curves, one in the presence and one in 
the absence of IpM ondansetron showed little difference. The lack of effect of 
both ketanserin and ondansetron have not been shown as figures because both 
antagonists gave similar results to that of methiothepin which has been 
shown as an example. On the other hand metoclopramide would appear to 
have had an effect. The 5-HT concentration-effect curve in the presence of 
IpM metoclopramide was shifted to the right indicating that metoclopramide 
had an antagonist action (Fig. 4.19). Metoclopramide acted as a muscarinic 
antagonist in this preparation. The results are summarized in Table 4.2 
overpage.
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FIGURE 4.18
log 5-HT concentration (M)
The concentration-effect curves for inhibition of A C h-induced  
contraction in Helix  PRM for 5-HT in the absence (closed circles) and in the 
presence (open circles) of IpM methiothepin are shown in this figure. The x 
axis gives log of the 5-HT concentration while the y axis gives percentage 
inhibition of ACh-induced contraction. The ACh concentration used to 
induce contraction in the PRM was 3pM. Vertical bars represent the 
arithmetic mean ± s.e. mean of n=8 .
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FIGURE 4.19
log 5-HT concentration (M)
The concentration-effect curves for inhibition of ACh-induced  
contraction in Helix PRM for 5-HT in the absence (closed circles) and in the 
presence (open circles) of IjiM metoclopramide are shown in this figure. The 
X axis gives log of the 5-HT concentration while the y axis gives percentage 
inhibition of ACh-induced contraction. The ACh concentration used to 
induce contraction in the PRM was 3|iM. Vertical bars represent the 
arithmetic mean ± s.e. mean of n=8 .
TABLE 4,2 Summary of the 5-HT antagonists tested on Helix PRM.
Antagonist Concentration 
tested (|iM)
n Effect
M ethiothepin 1 8 N o effect seen
Ketanserin 1 8 No effect seen
Ondansetron 1 8 No effect seen
Metoclopramide 1 8 Shift of 5-HT curve to 
right and lowering of 
maximum response
Cyclic AMP measurement
5-HT caused a dose-dependent increase in cAMP levels within the 
muscle cells in the PRM (Fig. 4.20). The presence of IBMX (lOOpM), a 
phosphodiesterase inhibitor, had no effect on the cAMP levels and indicated 
that IBMX is a relatively poor inhibitor of Helix  cAMP phosphodiesterase 
enzyme. Forskolin, a potent cAMP activator, (lOpM) increased the cAMP 
levels in the absence of 5-HT to 5 times greater than that obtained in the 
controls.
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FIGURE 4,20
The increase seen in cAMP levels in the PRM tissue with increasing 
concentration of 5-HT are shown in this figure. The bar chart shows two sets 
of results. The first set of results (solid columns) were obtained under normal 
conditions and functioned as controls while the second set of results (dashed 
columns) were obtained in the presence of lOOpM IBMX. The x axis gives log 
of the 5-HT concentration which includes a control, marked by the letter C, 
obtained in the absence of 5-HT and the y axis gives increase in cAMP in 
pm oles.m g-1 protein. Vertical bars represent the arithmetic mean ± s.e. mean 
of n=5
i
TABLE 4.3 Summary of the effects of 5-HT, forskolin and IBMX on cAMP 
levels in Helix PRM tissue.
Treatment n pmoles cAMP.mg"^ 
protein 
normal
pmoles cAMP.mg"! 
protein 
IBMX (lOOpM)
Control 5 11 ± 3 13 + 3
5-HT (lOnM) 5 15 + 3 15 + 2
5-PIT (lOOnM) 5 20 ± 3 18 + 4
5-HT (l|iM) 5 28 ± 4 26 ± 6
5-HT 5 38 ± 5 35 ± 3
5-HT (100|iM) 5 52 ± 4 48 + 3
Forskolin
(lOirM)
5 63 ± 7
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DISCUSSION
Effects of 5-HT on the visceral muscles of Helix
The two visceral preparations from Helix  that were tested for their 
response to 5-HT were the oesophagus and the rectum. The level of 
spontaneous activity, particularly in the oesophagus, made difficult the 
quantification of the response to 5-HT. The two different regions of the 
oesophagus, the anterior and the posterior region, showed different responses 
to 5-HT. The response of the posterior region to 5-HT was excitatory, whereas 
the response of the anterior region to 5-HT was inhibitory. The increase in 
frequency of contractions seen with 5-HT in the posterior region of the 
oesophagus agreed with results presented by Lloyd (1980). These results also 
mirrored those of Craveiro and Mendes (1990). Their results on the effect of 
5-HT on the isolated oesophagus of an amphibious snail, Pomacea lineata,  
were similar in showing an increase in contractile activity. In contrast, the 
inhibitory effects seen here w ith 5-HT on the anterior region of the 
oesophagus were similar to those obtained by Ajimal and Ram (1981), who 
investigated the spontaneous activity and pharmacological sensitivity of 
Aplysia gastrointestinal tract. In their study 5-HT blocked spontaneous 
contractions. This inhibitory effect on spontaneous contractions, seen with 
5-HT, was observed at concentrations as low as 9nM. This is in agreement 
with the present results where the threshold concentration for inhibitory 
effects was found to be approximately lOnM. 5-HT was seen also to inhibit 
ACh-induced responses in the isolated Aplysia oesophagus depending on the 
concentration of 5-HT used.
The rectum of Helix aspersa proved to be a difficult preparation, both to 
dissect without damage, and from which to elicit a response to 5-HT. Of the 
two preparations that were successful, little spontaneous activity was observed 
and the addition to the bath of increasing concentrations of 5-HT were notable 
by the absence of any response in the preparation. This contrasted with results 
observed by Phillis (1966), Greenberg and Jegla (1963) and by Ajimal and Ram 
(1981) on the rectum of Tapes watl ingi,  Mercenaria mercenaria and A p ly s ia  
californica respectively: there 5-HT excited rhythmic contractions and also 
caused an increase in tone.
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Both excitatory and inhibitory effects have been observed previously in 
neuronal and various muscle responses to 5-HT in Helix.  Gerschenfeld and 
Paupardin-Tritsch (1974a) reported that neurones both in Helix  and Aplysia  
could respond to 5-HT in six different ways. In Helix  heart, as seen in the 
preceding chapter, there is good evidence that 5-HT is the excitatory 
transmitter. In addition from the present chapter 5-HT is seen to have aa 
inhibitory or relaxant effect on Helix  PRM. Thus the variety of responses to 
5-HT in different regions of the gastrointestinal tract, in particular the 
oesophagus, conformed with the variety of effects of 5-HT observed elsewhere 
in the CNS and other muscles of Helix.
Lloyd (1980) demonstrated the presence of 5-HT both in the oesophagus 
and the rectum of Helix. His findings were mirrored by Nemcsok et al. (1986) 
who investigated the localization and quanititative distribution of biogenic 
amines in the intestinal tract, not only of the snail, but also the locust and the 
carp. They found 1.14pg 5-HT.g"^wet weight in the intestinal tract of the snail 
which included the oesophagus and rectum. On the basis of their 
morphological and biochemical results, they suggested that the biogenic 
monoamines (such as 5-HT) were involved in the regulation of gut muscle 
functioning both in the form of transmitters as well as neurohormones.
Effects of ACh and 5-HT on Helix PRM
The PRM proved to be a robust preparation in the prolonged assays 
which were designed to attempt the characterization of the 5-HT receptor 
mediating relaxation of the PRM. Potentiation of the ACh contractile 
responses in the PRM in the presence of eserine matched those of Twarog 
(1954) who utilized the result to provide evidence that ACh was the probable 
excitatory transmitter in the ABRM.
The threshold concentration of 5-HT for causing relaxation of ACh- 
induced contractions was found to be lOnM. This is in agreement with the 
investigation by Lehman and Greenberg (1987). 5-HT had a threshold 
concentration for relaxation of the Helix PRM of 10-50nM. The prevention of 
ACh-induced contraction by 5-HT in the PRM of Helix pomatia was noted also 
by Sorokin (1986). Against a background of 5-HT, ACh-induced phasic 
contractions were smaller than those seen in the absence of 5-HT. These 
contractions had a greater rate of relaxation in the presence of 5-HT in
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comparison to those seen in the absence of 5-HT. In the present investigation 
a quantifiable response for the relaxation caused by 5-HT was sought. The 
contraction to ACh was not well maintained, unlike that caused by contractile 
agonists in isolated porcine vena cava which has allowed the relaxant effects 
of 5-HT and its associated agonists to be studied (Sumner et ah, 1989). In this 
way the 5-HT receptor in porcine vena cava had been characterized as a 5-HT%- 
like receptor. That method of characterization could not be used in the 
isolated Helix  PRM. Therefore, the quantifiable response of inhibition of 
ACh-induced contraction in the Helix PRM, mediated by 5-HT was utilised in 
this study.
Effect of the 5-HT agonists on ACh-induced contraction in the PRM
5-HT proved to be the most potent agonist although 5-CT was only 3 
times less potent. Sumatriptan was 16 times less potent than 5-HT whereas 
ergotamine and methysergide (which were found to have agonist activity in 
the PRM) shared the same potency of approximately 40-44 times less than that 
of 5-HT. a-Me-5-HT and 2-Me-5-HT failed to elicit a response to provide an 
EC50 value. Consequently they were considered to be only weak agonists at 
this 5-HT receptor. The full rank order of potency of the agonists was 5-HT > 
5-CT > sumatriptan > ergotamine = methysergide »  a-Me-5-HT = 2-Me-5-HT; 
but this failed to provide an indication of what the 5-HT receptor type might 
be, being unlike any other rank orders of potency which have been elucidated 
for the vertebrate 5-HT receptors.
Effects of 5-HT antagonists on the inhibition of ACh-induced contraction by 
5-HT
Murakami et ah (1986) suggested that the 5-HT receptor of the ABRM 
subserving the relaxant response appeared to be similar to those of the 5-HT% 
type of vertebrate receptors. M ethysergide, cyproheptadine and 5- 
methoxygramine all acted as competitive antagonists of the 5-HT induced 
relaxation of catch contraction. Because both m ethysergide and 
cyproheptadine had been observed to act as antagonists of both 5-HT% and 5- 
HT% receptors in the brain (Leysen et ah, 1981), the antagonistic effects of 
mianserin, the specific 5-HT2 antagonist, were investigated (Murakami et ah, 
1986).
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Mianserin had no significant effect on the 5-HT-induced relaxation of 
catch contraction. In the present study ketanserin, a specific 5-HT2 receptor 
antagonist, had no antagonistic action on the inhibition of ACh-induced 
contractions by 5-HT on the PRM. This result concurs with the above finding 
with mianserin and therefore precludes the 5-HT receptor being of the 5-HT2 
type. Increasing evidence for non-involvement of the 5-HT2 receptor type 
also comes from the lack of agonist action of a-Me-5-HT in inhibiting ACh- 
induced contraction in the PRM.
In contrast to Murakami et al. (1986), methysergide here acted as an 
agonist in the present study and mimicked the effect of 5-HT and its ability to 
elicit inhibition of ACh-induced contraction in the PRM. Methysergide had 
already been noted as a potent antagonist of the relaxation induced by 5-HT in 
ABRM (Northrop, 1964). Of the effects of the ergot alkaloids on the ABRM 
studied by Twarog et al. (1977), most imitated 5-HT and proved to be effective 
as relaxants of catch contraction. This was reflected in the results seen here 
with ergotamine, which mimicked the effects of 5-HT and caused inhibition of 
ACh-induced contraction in the PRM. Both methysergide and ergotamine 
proved to be equipotent on the PRM, being approximately 40-44 times less 
potent than 5-HT.
Twarog et al. (1977) suggested that both methysergide and bromo-LSD 
possessed blocking action against 5-HT in the ABRM, due to the fact that they 
both were unique in that they were substituted at or near the indole nitrogen. 
This substitution presumably decreased the effectiveness with which these 
ergots bound at the indole nitrogen and hindered combination at the relaxing 
site. In this way they were not as effective relaxants as the unsubstituted ergot 
derivatives.
A more recent study by Murakami et al. (1988) attempted to characterize 
the type of 5-HT%-like receptor that they had previously reported in the 
ABRM. The ability of indole and non-indole 5-HT agonists to produce 
relaxation of catch contraction in the ABRM was investigated. Changes in 
cAMP levels in the indole and non-indole agonist-treated ABRM were studied 
also. Spiperone, propranolol and pindolol did not have any effect on the 
5-HT-induced relaxation of catch contraction. They inferred that these 
presumably specific 5HT%^ and 5HT%g antagonists (Pedigo et al., 1981; Hoyer 
et al., 1985) failed to recognise the 5-HT%-like recognition sites in the ABRM.
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5-Me-OT and 5-MeODMT induced dose-dependent relaxation of the catch 
contraction. Because both of these agonists were selective for SHT^a receptors 
(Sills et a l ,  1984), the results suggested the presence of a 5-HT|A"1^^^ receptor 
in the ABRM. 8-OH-DPAT also induced relaxation of catch contraction, 
adding more evidence that the 5-HT%-like receptor was of the 5 -H T |a  type. 
8-OH-DPAT was a selective 5-HT%A receptor agonist(Middlemiss and Fozard, 
1983). The results with the 5-HT non-indole agonist were varied: TFMPP, 
quipazine and mCPP were selective for 5-HT%g whereas PAPP was more 
selective for 5-HT% A subtypes (Sills et a l ,  1984). TFMPP, PAPP and mCPP 
induced dose-dependent relaxation of the catch contraction but quipazine did 
not. This led them to believe that the 5-HT%-like receptor was of the 5HT% A 
subtype, despite some inconclusive evidence with the non-indole agonists. 
This would appear not to be the case in the Helix PRM because methiothepin, 
a non-specific 5-HT%-like receptor antagonist, failed to have an antagonistic 
effect on the inhibition of ACh-induced contraction by 5-HT.
The results seen with metoclopramide were of interest because this 
drug appeared to antagonize the action of 5-HT. However in the present 
study, it is unlikely that metoclopramide was acting as a 5-HT receptor 
antagonist because ondansetron, the more specific 5 -HT3 receptor antagonist, 
failed to have any effect on the inhibition of ACh-induced contraction by 
5-HT. If it had been a 5-HT3 receptor mediating the relaxant response of 5-HT 
in the PRM, both ondansetron and metoclopramide would have behaved as 
antagonists. Since this was not the case metoclopramide must be acting, not as 
a 5 -HT3 antagonist but rather as a muscarinic antagonist. Fosbraey and 
Johnson (1980) found that metoclopramide had selective antagonist properties 
on pre-junctional ACh receptors in the guinea pig illeum. Metoclopramide 
(>20pM) antagonized the post-junctional responses to ACh in a non­
competitive manner. This was consistent with the findings of Bury and 
Mashford (1976) who had suggested that the antagonistic actions of 
metoclopramide might be due to a local anaesthetic action based on the 
structural sim ilarity of m etoclopram ide to the tertiary amine local 
anaesthetics.
Kerkut and Leake (1966) found that the PRM of Helix was stimulated by 
ACh. These ACh-induced contractions were blocked by atropine, nicotine and 
muscarine, which indicated the presence both of nicotinic and muscarinic 
receptors in Helix PRM. It is likely, therefore, that metoclopramide acts on the
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muscarinic receptors in the PRM in a competitive manner. By blocking the 
ACh receptors the contractile response to ACh can be seen to decrease in size 
w ith  corresponding increases in m etoclopram ide concentration. 
Metoclopramide acting as a muscarinic antagonist would be seen to have the 
same effect as if it was acting as a 5-HT receptor antagonist. The most probable 
explanation is that metoclopramide is acting as a muscarinic antagonist.
Possible mediation of the action of 5-HT by cAMP
5-HT elevated cAMP levels significantly in the PRM, as had already 
been demonstrated in other molluscan muscles (Achazi et a l ,  1974; Kohler 
and Lindl, 1980; Ishikawa et a l ,  1981). However, although the 5-HT-induced 
relaxation of catch contraction in the ABRM has been coupled to elevated 
cAMP levels, several experimental results were inconsistent with the 
hypothesis that cAMP was the intracellular mediator for relaxation induced by 
5-HT in the ABRM. 8-bromo-cGMP relaxed catch tension in the ABRM 
without any increase in cAMP levels (Painter, 1982), despite the fact that this 
drug seemed to act on relaxing nerve terminals to increase release of relaxing 
transmitter. W hether cGMP was involved  in relaxation remained 
inconclusive because 5-HT had failed to increase cGMP levels in the ABRM 
(Kohler and Lindl, 1980; Ishikawa et a l ,  1981). Neural stimulation with 
repetitive pulses did not increase cAMP levels, although it produced 
contraction followed by rapid relaxation (Kohler and Lindl 1980). Ishikawa et 
a l  (1981) reported that dopamine could relax catch without any increase in 
cAMP levels. Kohler and Lindl (1980) reported that although lO'^M dopamine 
increased cAMP levels, the increased amount was only 10% of that induced by 
10”^ M 5-HT. Because dopamine was thought to relax catch tension by acting 
on its receptors on the muscle fibre membrane (Twarog et a l ,  1977) this could 
not be explained by the cAMP hypothesis.
However, Kohler and Lindl (1980) have pointed out some discrepancies 
between relaxing events and intracellular levels of cAMP. Catch tension, the 
prolonged contraction exhibited by certain muscles in lamellibranchs, was 
relaxed in the ABRM by 5-HT at concentrations as low  as InM, whereas an 
increase in cAMP could be observed only at a concentration of 0.5jiM or 
higher. When lOpM 5-HT was applied the maximum cAMP concentration 
was reached in 2-3 minutes whereas complete relaxation required only 30-60
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seconds. From these results they postulated that cAMP might not be the 
physiological second messenger for relaxation of catch tension.
In the investigation reported by Murakami et al. (1988) 5-MeOT and 
5-MeODMT significantly reduced cAMP levels at a concentration sufficient to 
relax catch contraction. Of the other agonists tested TFMPP, QUIP and 8-OH- 
DPAT reduced cAMP levels whereas PAPP did not. Murakami et al. (1988) 
concluded from these results that changes in cAMP levels induced by the 5-HT 
agonists were unlikely to be directly coupled to the relaxation induced by 
them.
Such discrepancies are also shown by the results presented here. 5-HT, 
at a concentration of IpM, fully relaxed ACh-induced contraction in the PRM 
in 20-40 seconds whereas increases in cAMP were seen after 2 minutes. The 
levels of cAMP showed only a marked increase at a concentration of O.lpM 
whereas the relaxation is observed between 10-50nM. Further investigation is 
needed to prove whether cAMP is the intracellular second messenger for 
relaxation of ACh-induced contraction in the PRM, and that it is linked to the 
5-HT receptor mediating relaxation in the PRM.
Such discrepanies between the threshold action of 5-HT and the 
associated increases in cAMP levels also have been noted in the Helix  heart 
(see previous chapter). In heart muscle tissue, it is hypothesised that cAMP 
might not be the only intracellular signal through which 5-HT mediates its 
excitatory effects. As with the Helix  heart, the action of 5-HT on molluscan 
muscle is associated also with calcium mobilization (Bloomquist and Curtis, 
1975a,b; Ishii et a l ,  1989). In the M ercenaria  heart, recent findings have 
implicated the possible involvem ent of protein kinase C and inositol 
phospholipids (Deaton and Gray, 1990). Unfortunately phosphatidylinositol 
hydrolysis, which results in calcium mobilization cannot be implicated in the 
action of 5-HT on the PRM; it is muscle contraction that is associated with 
phosphatidylinositol turnover rather than muscle relaxation.
Conclusion
The 5-HT receptor mediating relaxation in Helix PRM could not be 
characterized as any of the already existing 5-HT receptor types present in the 
vertebrates. No specific 5-HT receptor antagonist was found to inhibit the 
action of 5-HT on Helix  PRM. The rank order of potency of the 5-HT receptor
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agonists was unlike any of those that had been elucidated for the different 
5-HT receptor types in vertebrates. Presently it appears, as does Helix  heart 
5-HT receptor, to be unique and quite unlike the 5-HT receptors in vertebrates. 
As in the heart, the lysergic acid derivative methysergide and ergots like 
ergotamine are agonists, but it is not clear whether they act at the same 
receptor as 5-HT because no specific blocker was found. That the receptor 
mediates its effect through cAMP is still unclear. 5-HT does undoubtedly 
cause an increase in cAMP levels within the muscle tissue, but the complete 
pathway requires to be elucidated. Certainly the discrepancies with the cAMP 
levels, as already mentioned seem to question the involvement of cAMP.
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GENERAL DISCUSSION
Involvement with cAMP and possible linkage to a G-protein receptor family
The action of 5-HT has been implicated in the activation of cAMP in 
many invertebrate tissues. In the CNS of Helix and Aplysia  5-HT stimulated 
adenylate cyclase (Drummond et a l ,  1980b) and these workers found a good 
correlation between cyclase activation and 5-HT-sensitive pHJLSD binding. 
From the present, and previous, evidence 5-HT appears to be linked closely to 
adenylyl cyclase and cAMP is implicated in the action of 5-HT both in Helix  
heart and PRM tissue. One could suggest that the 5-HT receptors within Helix 
may be members of the G-protein super family, as has been shown for 5-HT%Q, 
5 -H T2 and 5-HT%A" This receptor family has been characterized by the 
presence of seven transmembrane domains in each receptor and by the ability 
to activate G-protein dependent processes (see Hartig, 1989). The 5-HT2 
receptor shared overall sequence identity of 49% with the 5-HT%(] receptor but 
the amino acid identity within the putative transmembrane domains was 
over 80% (Julius et ah, 1990). Julius et al, concluded that the stringent 
sequence conservation was likely to reflect the fact that those regions of the 
molecule were required for the maintenance of two primary functions shared 
by the 5-H T |c and 5-HT2 receptor—ligand binding and G-protein-mediated 
activation of phospholipase C. The close structural and functional 
relationship between those two 5-HT receptors suggested that they should be 
grouped by nomenclature (Pritchett et al., 1988).
The similarities between the neuronal 5-HT response in Helix  and the 
5-HT response mediated by the 5-HTg receptor in vertebrate tissues and cell 
lines suggested that the Helix  neuronal receptor, under study, may be an ion 
channel; the same as the 5-HTg receptor has been shown to be (Derkach et a l ,  
1989). However it is more probable that the neuronal 5-HT receptor in Helix  
regulates ion channels through a specific G protein. It has been argued that 
specific G proteins, in response to a variety of receptors, can regulate one of 
several different channels and that it may be able to achieve this through 
multiple pathways, which include classical second messangers and potential 
direct interaction with the channel complex (see Sternweis and Pang, 1990). A
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good example providing evidence for this hypothesis has been shown already 
in invertebrates; behavioural sensitization in A p ly s ia .  Klein and Kandel 
(1978) found that 5-HT and cAMP closed single K+ channels in A p ly s ia  
sensory neurones. They identified a 5-HT-sensitive K+ channel which was 
active at the resting potential and was not dependent on the activity of 
intracellular calcium. Application of 5-HT to the cell body, or intracellular 
injection of cAMP, caused prolonged and complete closure of the channel, 
thereby reducing the effective number of active channels in the membrane. 
The depression of outward current, bought about by closure of these channels, 
delayed repolarization of the action potential and extended* the duration of 
calcium influx into the presynaptic terminals, thereby contributing to the 
facilitation of transmitter release that is thought to underly behavioural 
sensitization in Aplysia.
Families of G-protein-coupled receptors have also been identified for 
cholinergic and adrenergic transmitters. The muscarinic acetylcholine 
receptors defined a family of receptors that were highly homologous to one 
another (Bonner et al., 1987). The 5 -H T |a  receptor gene was obtained by 
hybridization to a p2 -adrenoreceptor clone (Fargin et aU, 1988). A strong 
nucleotide sequence homology was found to exist between the two receptors. 
In several amino acid stretches the 5-HT%A more closely resembled the p2" 
adrenoreceptor than it did the other cloned 5-HT receptors. This evidence has 
raised intriguing questions about the functional and evolutionary  
relationships among these different receptors.
In the past there has been a strong tendency to base receptor 
characterization and subsequent classification on the characteristics of the 
binding sites for competitive antagonists, largely because the affinities of such 
antagonists could be determined reliably by the Schild method. Colquhoun et 
al. (1987), in their review of nicotinic ACh receptors, stated that if this had still 
been the case there would have been a major problem in defining nicotinic 
receptors. This was because antagonists which were thought primarily to be 
competitive on some receptors were not competitive on others but exerted 
effects on the ion channels. They concluded that it was not sensible to define 
nicotinic receptors solely in terms of their agonist and antagonist binding sites 
but that they must ultimately be defined, by means of recombinant DNA
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m ethods, in terms of the structure of the entire receptor ion channel 
molecule.
It would be of interest to discover if the molluscan 5-HT receptors 
shared any sequence identity with those of the vertebrate 5-HT receptors 
which already have been cloned, particularly within the transmembrane 
regions where 80% of the amino acid sequence was shared by 5-HT%(] and 
5-HT2 (Julius et ah, 1990). 5-HT has been found in the tissues of coelenterates, 
flatworms and the nervous tissue of annelids (Welsh, 1968): these are some of 
the most primitive of the invertebrate phyla. It would appear, therefore, that 
5-HT and its associated receptors arose at an early stage in the evolution of the 
nervous system of animals.
The application of modern techniques—such as radioligand binding, 
monoclonal antibodies and gene cloning technology—has enabled marked 
advances in the quantity and quality of information concerning receptor 
structure. In a review of the evolution of neurotransmitter receptor systems, 
concerning, in particular the adrenergic and cholinergic systems. Venter et al. 
(1988) proposed that the large family of receptors which mediate their effects 
via the cyclic nucleotide regulated systems (such as adenylate cyclase and 
phosphatidylinositol turnover) will be shown to have structural homology 
and a common ancestry. This proposal was based on the fact that tryptic-digest 
maps both of adrenergic and muscarinic cholinergic receptors, together with 
monoclonal antibody cross reactivity data, had indicated that adrenergic and 
muscarinic cholinergic receptors were structurally hom ologous. The 
subsequent cloning of the genes for the beta adrenergic receptor and the 
muscarinic cholinergic receptors clearly established the presence of major 
sequence and structural hom ology among these receptors. The review  
evidence presented by Venter et al. (1988) also indicated that adrenergic and 
cholinergic receptors were ancient proteins whose existence dated back, at 
least, some 600 million years. Is it possible that the serotonergic system, albeit 
within different species, might show the same degree of homology? Certainly, 
classical muscarinic receptors have been found in Aplysia californica (Murray 
et a l ,  1985). The m uscarinic receptors in this gastropod exhibited  
stereospecificity in the binding of the isomers of quinuclidinyl benzoate. 
Muscarinic agonists (e.g. carbachol) and antagonists (e.g. atropine) were found 
also to have IC50  values (concentration required to inhibit 50% binding)
109
similar to those of mammals. Possibly this also could be the case for the 5-HT 
receptors and their basic structure could have been highly conserved 
throughout evolution: a speculation that it is a member a G-protein super 
family would explain the close links with adenylyl cyclase and cAMP. The 
differential evolution of the fundamental 5-HT receptor within the different 
phyla could possibly have resulted in duplication and mutation, leading to 
changes in amino acid sequences. These changes in the amino acid sequence 
w ould therefore account for the different affinities shown by the 5-HT 
receptors, within the different species, to the different 5-HT receptor agonists 
and antagonists. This hypothesis would explain w hy none of the 5-HT 
receptors within the different tissues in Helix were susceptible to inhibition by 
the specific 5-HT receptor antagonists which have been identified because of 
their inhibitory actions against vertebrate 5-HT receptor types.
Characterization of 5-HT receptors in Helix
The lack of any specific 5-HT receptor antagonists to the 5-HT response 
in the three different tissues of Helix made difficult the characterization of the 
receptors. Criticisms of the use of antagonists to characterize and classify 5-HT 
receptors have, however, been advanced by Leff and Martin (1988). In their 
review they examined whether tryptamine analogues could provide a more 
quantitative, and therefore secure, basis for 5-HT receptor classification. This 
entailed the extensive use both of agonist and antagonist compounds. They 
argued that the complex variety of pharmacological actions of 5-HT 
necessitated reliable receptor classification. However, in bioassays, which are 
essential to classification, many of the conventional 5-HT receptor probes 
demonstrated variable pharmacodynamics and failed to fulfil theoretical 
criteria for valid use. Non-surmountable antagonism and variable affinity in 
different assays were often evident. They suggested that whether such 
phenomena represented 5-HT receptor heterogeneity, or problems, such as 
multiple actions, with the probes were not always clear. Their approach 
showed that the same receptor type occurring in different tissues could be 
defined with quantitative consistency using tryptamines when conventional 
antagonists failed.
From the agonist data presented in this investigation, the three 
preparations showed some differences in the rank order of agonist potencies.
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For the identified neurones in the visceral ganglion, it was difficult to obtain 
an accurate value of agonist potency unless the potency was assumed to be 
relative to the amplitude of the 5-HT-evoked response. Other features of the 
iontophoretic technique also could have affected the 5-HT-evoked response in 
the same way as the potency. The differences observed in agonist potency in 
the three preparations from Helix could possibly be due to the different 
techniques utilised in the investigation. An alternative hypothesis could be 
that the 5-HT receptors within Helix show a similar heterogeneity of receptors 
to that which has been proved to occur in vertebrates.
The previous studies which have been undertaken to attempt to 
characterize the 5-HT receptors in different molluscs have shown varying 
affinities for the 5-HT receptor agonists and antagonists that have been tested. 
This has, in part, been dependent on the species tested and on the 
methodology utilized. In this way no molluscan 5-HT receptor has been truly 
characterized.
Methysergide, an LSD derivative and the other ergot derivatives (such 
as ergotamine) that were tested against the 5-FIT response in the three 
preparations of Helix, had diverse actions. Despite the fact that methysergide 
had been described, in the majority of studies, as a competitive antagonist (for 
example the study by Boyd et al. (1985) on Helix  heart), in the present study 
methysergide behaved as a partial agonist in Helix heart. This result was also 
mirrored by the other ergot derivatives that were tested on the H elix  heart 
although LSD appeared to act purely as an agonist. From the data, however, it 
was difficult to ascertain whether these compounds were acting directly on the 
5-HT receptor under investigation. This was because they demonstrated a 
high degree of agonist activity and their block of the 5-HT response in Helix  
heart proved to be only minimal. The potent agonist activity of LSD has been 
well documented but, more importantly, can this high degree of agonism be 
attributable to activation of a 5-HT receptor? Could LSD and the other ergot 
derivatives possibly be exerting their effects through an "ergot" receptor 
present in Helix  tissue? A specific receptor blocking drug for either the 5-HT 
receptor or the putative ergot receptor will be necessary to test this hypothesis.
I l l
Conclusion
The 5-HT receptors within Helix  cannot be characterized according to 
the classes of 5-HT receptor types which have been described in vertebrates: 
they are unique. The H elix  5-HT receptors show little affinity for any of the 
specific 5-HT receptor antagonists which have been used to characterize, and 
subsequently classify, the vertebrate 5-HT receptors. It has become clear in this 
investigation that to define the 5-HT receptors within Helix, solely in terms of 
their currently available agonist and antagonist binding is not possible. 
Ultimately they must be defined in terms of their established structure, by 
means of gene cloning technology. Only in this w ay will the extent of 
homology of the 5-HT receptors within different species become apparent.
112
REFERENCES
Abbott, B.C. and Lowy, J. (1958a). Contraction in molluscan smooth muscle. J. 
Physiol., 141, 385-397.
Abbott, B.C. and Lowy, J. (1958b). Mechanical properties of Helix and M ytilus  
muscle. J. Physiol., 141, 398-407.
* Achazi, R.K., Dolling, B. and Haakshorst, R. (1974). 5-Ht-induzierte
Erschlaffung und cyclisches AMP bei einen glatten Molluskenmuskel. 
Pfliigers Arch., 349,19-27.
Ajimal, G.S. and Ram, J.L. (1981). Aplysia gastrointestinal tract motility:
Spontaneous activity and pharmacological sensitivity. Comp. Biochem. 
Physiol., 68C, 133-144.
Akagawa, M., Furuawa, Y. and Kobayashi, M. (1988). Dual effects of 5- 
hydroxytryptamine on the heart of a pulmonate, Achatina fulica 
Férussac. Comp. Biochem. Physiol., 89C, 327-331.
Amin, A.H., Crawford, T.B.B. and Gaddum, J.H. (1954). The distribution of 
substance P and 5-hydroxytryptamine in the central nervous system of 
the dog. J. Physiol., 126,596-618.
Apperley, E., Humphrey, P.P.A. and Levy, E.P. (1976). Receptors for 5-HT and 
noradrenaline in rabbit isolated ear artery and aorta. Br. J. Pharmacol., 
58, 215-224.
Arunlakshana, O. and Schild, H.O. (1959). Some quantitative uses of drug 
antagonists. Br. J. Pharmacol., 14, 48-58.
Bennett, J.P. and Snyder, S.H. (1976). Serotonin and lysergic acid diethylamide 
binding in rat brain membranes: Relationship to post synaptic 
serotonin receptors. Mol. Pharmacol., 12, 373-389.
Berridge, M.J. (1972). The mode of action of 5-hydroxytryptamine. J. exp. Biol., 
56,311-321.
Bertaccini, G. and Zamboni, P. (1961). The relative potency of
5-hydroxytryptamine like substances. Archs. Int. Pharmacodyn. Ther., 
133,138-156.
Blaschko, H. and Hope, D.B. (1957). Observation on the distribution of
monoamine oxidase in invertebrates. Arch. Biochem. Biophys., 69, 10- 
15.
Bloomquist, E. and Curtis, B.A. (1972). The action of serotonin and calcium- 
4^Ca efflux from the anterior byssus retractor muscle of M ytilus edulis. 
J. Gen. Physiol, 59, 476-485.
113
Bloomquist, E. and Curtis, B.A . (1975a). 45(2^ efflux from anterior byssus
retractor muscle in phasic and catch contraction. Am. J. Physiol., 229, 
1237-1243.
Bloomquist, E. and Curtis, B.A. (1975b). Net calcium fluxes in anterior byssus 
retractor muscle with phasic and catch contraction. Am. J. Physiol., 229, 
1244-1248.
Bobker, D.H. and Williams, J.T. (1990). Ion conductances affected by 5-HT 
receptor subtypes in mammalian neurons. Trends Neurosci. 13,169- 
173.
Bokisch, A.J., Gardner, C.R. and Walker, R.J. (1983). The actions of three
mammalian serotonin receptor agonists on Helix central neurones. Br. 
J. Pharmacol., 80, 512P.
Bokisch, A.J. and Walker, R.J. (1986). The ionic mechanism associated with 
the action of putative transmitters on identified neurons of the snail. 
Helix aspersa. Comp. Biochem. Physiol., 84C, 231-241.
Bonner, T.I., Buckley, N.J., Young, A.C. and Brann, M.R. (1987). Identification 
of a family of muscarinic acetylcholine receptor genes. Science, 237, 527- 
532.
Boyd, P.J., Gardner, C.R. and Walker, R.J. (1985). Actions of some
5-hydroxytryptamine analogues on the isolated heart of the snail Helix 
aspersa. Comp. Biochem. Physiol., 81C, 233-239.
Bozler, E. (1930). The heat production of smooth muscle. J. Physiol., 69, 442- 
462.
Bradley, P.B. and Candy, J.M. (1970). Iontophoretic release of acetylcholine, 
noradrenaline, 5-hydroxytryptamine and D-lysergic acid diethylamide 
from micropipettes. Br. J. Pharmacol., 40,194-201.
Bradley, P.B., Humphrey, P.P.A. and Williams, R.H. (1985). Tryptamine-
induced vasoconstrictor responses in rat caudal arteries are mediated 
predominantly via 5-hydroxytryptamine receptors. Br. J. Pharmac., 84, 
919-925.
Bradley, P.B., Engel, G., Feniuk, W., Fozard, J.R., Humphrey, P.P.A.,
Middlemiss, D.N., Mylecharane, E.J., Richardson, B.P. and Saxena, P.R. 
(1986). Proposals for the classification of nomenclature of functional 
receptors for 5-hydroxytryptamine. Neuropharmacol., 25, 563-576.
Brittain, R.T. and Collier, H.O.J. (1957). Antagonism of 5-hydroxytryptamine 
by dock leaf extract. J. Physiol., 135,58-59P.
114
Bullard, B. (1967). The nervous control of the anterior byssus retractor muscle 
of M ytilus edulis. Comp. Biochem. Physiol., 23, 749-759.
Burridge, J., Butler, A. and Kilpatrick, G.J. (1989). 5-HTg receptors mediate
depolarisation of the guinea pig isolated nerve. Br. J. Pharmac., 96, 269P.
Burton, R.F. and Mackay, J.M. (1970). The influence of cations on contractions 
in the superfused ventricle of Helix aspersa. Experentia, 26, 151-152.
Bury, R.W. and Mashford, M.L. (1976). The effect of metoclopramide in
modifying the response of isolated guinea pig ileum to various agonists. 
J. Pharmacol. Exp. Ther., 197, 641-646.
Butler, A., Hill, J.M., Ireland, S.J., Jordan, C.C. and Tyers, M.B. (1988).
Pharmacological properties of GR 38032F, a novel antagonist at 5-HT3 
receptors. Br. J. Pharmac., 94, 397-412
Butler, A., Elswood, C.J., Burridge, J., Ireland, S.J., Bunce, K.T., Kilpatrick, G.J. 
and Tyers, M.B. (1990). The pharmacological characterization of 5-HT3 
receptors in three isolated preparations derived from guinea-pig tissues. 
Br. J. Pharmac., 101, 591-598.
Caine, G.D. (1978). A pharmacological investigation of histamine H% and H% 
receptors in the brain of the pulmonate mollusc Helix aspersa. Ph.D. 
Thesis, University of Southampton.
*Cardot, J. (1971). Variations saisonnières de la 5-hydroxytryptamine dans les 
tissues nerveaux et cardiaque chez le Mollusque Helix pomatia. C.R. 
Seances Soc. Biol., 165, 338-341.
Carpenter, D.O., Swann, J.W. and Yarowsky, P.J. (1977). Effect of curare on
responses to different putative neurotransmitters in Aplysia neurons. J. 
Neurobiol., 8, 119-132.
Clarke, D.E., Craig, D.A. and Fozard, J.R. (1989). The 5-HT4  receptor: naughty, 
but nice. Trends Pharmacol. Sci., 10, 385-386.
Cole, R.A. and Twarog, B.M. (1972). Relaxation of catch in a molluscan
smooth muscle - 1. Effects of drugs which act on the adenyl cyclase 
system. Comp. Biochem. Physiol.., 43A, 321-330.
Colquhoun, D., Ogden, D.C. and Mathie, A. (1987). Nicotinic acetylcholine 
receptors of nerve and muscle: functional aspects. Trends 
Pharmacol. Sci., 8, 465-472.
Cossery, J.M., Mienville, J., Sheehy, P.A., Mellow, A.M. and Chuang, D. (1990). 
Characterization of two distinct 5-HT receptors coupled to adenylate
115
cyclase and ion current generation in NCB-20 cells. Neurosci. Letters, 
108,149-154.
Cottrell, G.A. (1970). Direct postsynaptic responses to stimulation of serotonin- 
containing neurones. Nature, 225, 1060-1062.
Cottrell, G.A. (1971). Action of imipramine on a serotonergic synapse. Comp, 
gen. Pharmac., 2, 125-128.
Cottrell, G.A. and Osborne, N.N. (1969). A neurosecretory system terminating 
in the Helix heart. Comp. Biochem. Physiol., 28, 1455-1459.
Cottrell, G.A. and Osborne, N.N. (1969). Localization and mode of action of
cardioexcitatory agents in molluscan hearts. In "Comparative Phsiology 
of the Heart: Current Trends" ed. F.V. McCann Birkhauser Verlag, Basel 
and Stuttgart.
Cottrell, G.A. and Osborne, N.N. (1970). Subcellular localisation of serotonin 
in an identified serotonin-containing neurone. Nature, 225, 470-472.
Cottrell, E.A. and Macon, J.B. (1974). Synaptic-connections of two
symmetrically placed giant serotonin-containing neurones. J. Physiol., 
236,435-464.
Cottrell, G.A., Price, D.A. and Greenberg, M.J, (1981). FMRFamide-like activity 
in the ganglia and in a single identified neurone of Helix aspersa.
Comp. Biochem. Physiol., 70C, 103-107.
Craveiro, J.P.M. and Mendes, E.G. (1990). Pharmacological assays on the
isolated eosophagus of an amphibian snail, Pomacea lineata (Spex 1827) 
(Mollusca, Gastropoda, Prosobranchia). Comp. Biochem. Physiol., 95C, 
91-97.
’^ Dahl, E., Falck, B., Von Mecklenberg, C., Myhrberg, H and Rosengren, E.
(1966). Neuronal localization of dopamine and 5-hydroxytryptamine in 
some mollusca. Z. Zellforsch mikrosk Anat., 71, 489-498.
Dahlstrohm, A. and Fuxe, K. (1964). Evidence for the existence of
monoamine-containing neurones in the central nervous system. I. 
Demonstration of monoamines in cell bodies of brainstem neurones. 
Acta Physiol. Scand., 62 (Supp 1233), 1-55.
Deaton, L.E. and Gray, K.R. (1990). Excitation of the clam heart by phorbal 
esters. Comp, Biochem. Physiol., 95C, 155-157.
Derkach, V., Surprenant, A. and North, R.A. (1989). 5-HTg receptors are 
membrane ion channels. Nature, 339,706-709.
116
Deterre, P., Paupardin-Tritsch, D., Bockaert, J. and Gerschenfeld, H.M. (1982).
cAMP-mediated decrease in K+ conductance evoked by serotonin and {
dopamine in the same neuron: A biochemical and physiological single- |
cell study. Proc. Natl. Acad. Sci. USA, 79, 7934-7938. j
Drummond, A.H., Bucher, F. and Levitan, LB. (1980a). D-[^H] lysergic acid j
diethylamide binding to serotonin receptors in the molluscan nervous |
system. J. Biol. Chem., 225, 6679-6686. |
Drummond, A.H., Bucher, F. and Levitan, LB. (1980b). Distribution of j
serotonin and dopamine in Aplysia tissues: analysis by [^H] LSD j
binding and adenylate cyclase stimulation. Brain Res. 184, 163-177. ^
Drummond, G.I., Wernham, S. and Lukowiak, K. (1985). Stimulation of |
adenylate cyclase in the heart of Aplysia californica by biogenic amines. |
Comp. Biochem. Physiol., 80C, 129-133.
Dumuis, A., Bouhelal, R., Sebben, M., Cary, R. and Bockaert, J. (1988). A 
nonclassical 5-hydroxytryptamine receptor positively coupled with 
adenylate cyclase in the central nervous system. Mol. Pharmacol., 34,
880-887.
Dumuis, A. ,Sebben, M., Monferini, E., Nicola, M., Turconi, M., Ladinsky, H. 
and Bockaert, J. (1991). Azabicycloalkyl benzimidazolone derivatives as 
a novel class of potent agonists at the 5-HT4 receptor positively coupled 
to adenylate cyclase in brain. Naunyn-Schmiedeberg's Arch 
Pharmacol., 343, 245-251.
Eisenstadt, M., Goldman, J.E., Kandel, E.R., Koike, H., Koester, J. and Schwartz,
J.H. (1973). Intrasomatic injection of radioactive precursors for studying 
transmitter synthesis in identified neurons of Aplysia californica. Proc.
Nat. Acad. Sci. USA., 70,3371-3375.
*Erspamer, V. (1940). Pharmakologische Studien fiber Enteramine. I. Uber die 
Wirkung von Acetonextrakten der Kaninchenmagenschleimhaut auf 
den Blutdruck und auf isolierte überlebende Organe. Arch. F. exper.
Path, u PharmakoL, 196, 343-365.
Erspamer, V. (1954). Pharmacology of indolealkylamines. Pharmacol. Rev., 6, 
425-487.
Erspamer, V. and Ghiretti, F. (1951). The action of enteramine on the heart of 
molluscs. J. Physiol., 115, 470-481.
117
Erspamer, V. and Asero, B. (1952). Identification of enteramine, the specific 
hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. 
Nature, 169, 800-801.
Fain, J.N. and Berridge, M.J. (1979). Relationship between hormonal
activation of phosphatidylinositol hydrolysis, fluid secretion and 
calcium flux in the blowfly salivary gland. Biochem. J., 178, 45-58.
Falck, B., Hillarp, N-A., Thieme, G. and Torp, A. (1962). Fluorescence of
catecholamines and related compounds condensed with formaldehyde. 
J. Histochem. Cytochem., 10, 348-354.
Fargin, A., Raymond, J.R., Lohse, M.J.., Kobilka, B.K., Caron, M.G. and
Lefkowitz, R.J. (1988). The genomic clone G-21 which resembles a p- 
adrenergic receptor sequence encodes the 5-HT%A receptor. Nature, 335, 
358-360.
Feniuk, W. (1984). An analysis of 5-hydroxytryptamine receptors mediating 
contraction of isolated smooth muscle. Neuropharmac., 23, 1467-1472.
Filippov, A.K., Porotikov, V.I., Novoselova, V.D., Bessonov, B.I. and Butsuk, 
S.V. (1988). Action potentials and ionic currents of myocardial fibres in 
the mollusc Spisula sachalinensis. Comp. Biochem. Physiol., 89A, 1-5.
Fosbraey, P. and Johnson, E.S. (1980). Modulatory action on the twitch
response of the guinea pig ileum of endogenous substances released by 
high frequency electrical stimulation. Eur. J. Pharmac., 67, 393-402.
Fozard, J.R. (1984c). MDL 72222: a potent and highly selective antagonist at 
neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg’s 
Arch. Pharmacol., 326, 36-44.
Fozard, J.R. and Mwaluko, G.M.P. (1976). Mechanism of the indirect
sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of 
the rabbit. Br. J. Pharmac., 57, 115-125.
Fozard, J.R. and Mobarok Ali, A.T.M. (1978). Dual mechanism of the
stimulant action of N , N-dimethyl-5-hydroxytryptamine (bufotenin) on 
cardiac sympathetic nerves. Eur. J. Pharmac., 49, 25-30.
Frontali, N., Williams, L. and Welsh, J.H. (1967). Heart excitatory and
inhibitory substances in molluscan ganglia. Comp. Biochem. Physiol., 
22, 833-841.
Gaddum, J.H. (1953). Antagonism between lysergic acid diethylamide and 
5-hydroxytryptamine. J. Physiol, 121 ,15P.
118
Gaddum, J.H. and Paasonen, M.K. (1955). The use of some molluscan hearts 
for the estimation of 5-hydroxytryptamine. Br. J. Pharmac., 10, 474-483.
Gaddum, J.H. and Picarelli, Z.P. (1957). Two kinds of tryptamine receptor. Br. 
J. Pharmac., 12, 323-328.
Gerschenfeld, H.M. (1971). Serotonin: Two inhibitory actions on snail 
neurones. Science, 171, 1252-1254.
Gerschenfeld, H.M. and Stefani, E. (1966). An electrophysiological study of 
5-hydroxytryptamine receptors of neurones in molluscan nervous 
system. J. Physiol., 195,684-700.
Gerschenfeld, H.M. and Stefani, E. (1968). Evidence for an excitatory
transmitter role in molluscan central synapses. Advances Pharmacol., 
6A, 369-392.
Gerschenfeld, H.M. and Paupardin-Tritsch, D. (1974a). Ionic mechanisms and 
receptor properties underlying the responses of molluscan neurones to 
5-hydroxytrytamine. J. Physiol., 243, 427-456.
Gerschenfeld, H.M. and Paupardin-Tritsch (1974b). On the transmitter 
function of 5-hydroxytryptamine at excitatory and inhibitory 
monosynaptic junctions. J. Physiol., 243, 457-481.
Gerschenfeld, H.M., Hamon, M. and Paupardin-Tritsch, D. (1978). Release of 
endogenous serotonin from two identified serotonin-containing 
neurones and the physiological role of serotonin re-uptake. J. Physiol., 
274, 265-278.
Gerschenfeld, H.M., Paupardin-Tritsch, D. and Deterre, P. (1981). Neuronal 
responses to serotonin. In "A second view in Serotonin, 
Neurotransmission and Behaviour " eds. B.L. Jacobs and A. Gelperin. 
MIT Press, Cambridge, MA.
Greenberg, M.J. (1960a). The responses of the Venus heart to catecholamines 
and high concentrations of 5-hydroxytryptamine. Br. J. Pharmac., 15, 
365-374.
Greenberg, M.J. (1960b). Structure-activity relationship of tryptamine
analogues on the heart of Venus mercenaria. Br. J. Pharmac., 15, 375- 
388.
Greenberg, M.J. and Jegla, T.C. (1963). The action of 5-hydroxytryptamine and 
acetylcholine on the rectum of the venus clam, Mercenaria mercenaria. 
Comp. Biochem. Physiol., 9, 275-290.
119
Greenberg, M.J., Agarwal, R.A., Wilkens, L.A. and Ligon, P.J.B. (1973).
Chemical regulation of rhythmical activity in molluscan muscle. In. 
Neurobiology of Invertebrates ed. J. Salanki Akademici Kiado Budapest, 
123-142.
Greenberg, M.J. and Price, D.A. (1980). Cardioregulatory peptides in molluscs. 
In "Peptides: Integrators of cell and tissue function" ed. F.E. Bloom. 
Rowen Press, N ew  York.
Guthrie, P.B., Neuhoff, V. and Osborne, N.N. (1975), Monoamine oxidase 
activity in Helix pomatia. Experentia, 31, 775-776.
Hales, T.J., Lambert, J.J. and Peters, J.A. (1988). 5-HT-induced currents in NCB- 
20 neuroblastoma hybrid cells and their blockade by a 5-HTg antagonist. 
Br. J. Pharmac., 94, 393P.
Hartig, P. (1989). Molecular biology of 5-HT receptors. Trends Pharmacol. Sci., 
10,64-69.
Hess, S.D., Reiss, P.D. and Higgins, W.J. (1981). The effects of theophylline and 
3-isobutyl-1 -methyIxanthine on the contractility, cyclic AMP content 
and phosphodiesterase activity of the M. mercenaria ventricle. Comp. 
Biochem. Physiol., 69C, 13-18.
Hidaka, T., Osa, T. and Twarog, B.M. (1967). The action of 5-
hydroxytryptamine on Mytilus smooth muscle. J. Physiol, 192, 869-877. 
Higgins, W.J. (1974). Intracellular actions of 5-hydroxytryptamine on the
bivalve myocardium. I. Adenylate and guanylate cyclases. J. Exp. Zool., 
190,99-110.
Higgins, W.J. (1977). 5-hydroxytryptamine-induced tachyphylaxis of the
molluscan heart and concomitant densitization of adenylate cyclase. J. 
Cyclic Nucleotide Rev., 3, 293-302.
Higgins, W.J. and Greenberg, M.J. (1974). Intracellular actions of
5-hydroxytryptamine on the bivalve myocardium. II. Cyclic nucleotide- 
dependent protein kinases and microsomal calcium uptake. J. Exp. 
Zool., 190, 305-316.
Higgins, W.J., Price, D.A. and Greenberg, M.J. (1978). FMRFamide increases 
the adenylate cyclase activity and cyclic AMP level of molluscan heart. 
Eur. J. Pharmacol., 48, 425-430.
Hill, R.B. (1974). Effects of 5-hydroxytryptamine on action potentials and on 
contractile force in the ventricle of Dolabella auricularia. J. Exp. Biol.,
61,529-539.
120
Hill, R.B. and Yantorno, R.E. (1979). Inotropism and contracture in aplysiid 
ventricles as related to the action of neurohumours on the resting and 
action potential of molluscan hearts. Am, Zool., 19, 145-162.
Hiripi, L. and Salânki, J. (1973). Seasonal and activity-dependent changes of 
the serotonin level in the C.N.S. and heart of the snail {Helix pomatia 
L.). Comp. gen. Pharmac., 4, 285-292.
Hoyer, D., Engel, G. and Kalkman, H O . (1985b). Molecular pharmacology of 
5-HT% and 5-HT2 recognition sites in rat and pig brain membrane. 
Radioligand binding studies with pH] 5-HT, [3h] 80H+DPAT, (-)[125i] 
iodocyanopindolol, pH ] mesulergine and [^H] ketanserin. Eur. J. 
Pharmac., 118,13-23.
Hoyer, D. and Middlemiss, D.N. (1989). Species difference in the
pharmacology of terminal 5-HT autoreceptors in mammalian brain. 
Trends. Pharmacol. Sci., 10, 130-132.
Huddart, H. (1986). Influence of glutamate, dopamine and
5-hydroxytryptamine on calcium efflux from locust foregut and hindgut 
visceral muscle. Dependence upon extracellular calcium and calcium 
channel activity. Comp. Biochem. Physiol., 84C, 401-408.
Humphrey, P.P.A. and Feniuk, W. (1987), Pharmacological characterization of 
functional neuronal receptors for 5-hydroxytryptamine. In "Neuronal 
messengers in vascular function." eds. A. Nobin, C. Owman and B. 
Arnekbo-Nobin, Elsevier.
Humphrey, P.P.A., Feniuk, W., Perren, M.J., Connor, H., Oxford, A.W., Coates, 
I.H. and Butina, D. (1988). GR43175, a selective agonist, for the 5-HT%- 
like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94,1123- 
1132.
Irisawa, H., Shigato, N. and Otani, M. (1967). Effect of Na+ and Ca^+ on the 
excitation of the M ytilus  (bivalve) heart muscle. Comp. Biochem. 
Physiol., 23,199-212.
Ishii, N., Simpson, A.W.M. and Ashley, C.C. (1989). Effects of 5-hydroxy­
tryptamine (serotonin) and forskolin on intracellular free calcium in 
isolated and fura-2 loaded smooth-muscle cells from the anterior 
byssusus retractor (catch) muscle of M ytilus edulis. Pfliigers Arch., 414, 
162-170.
Ishikawa, T., Murakami, H. and Iwayama, Y. (1981). Changes in cAMP and
GMP levels induced by relaxing drugs in acetylcholine- and potassium-
121
treated molluscan smooth muscle. Comp. Biochem. Physiol., 70C, 171- 
176.
Jacques, R. and Schacter, M. (1954). The presence of histamine,
5-hydroxytryptamine and a potent slow contracting substance in wasp 
venom. Br. J. Pharmac., 9, 53-58.
Jaeger, C.P. (1963). Physiology of Mollusca - IV. Action of serotonin on the 
penis retractor muscle of Strophocheilos oblongus. Comp. Biochem. 
Physiol., 8,131-136.
Jones, H.D. (1983). The circulatory system of gastropods and bivalves. In'The 
Mollusca" Vol. 5 Physiology, Part 2. eds. K.M. Wilbur and ASM 
Saleuddin. Academic Press, N ew  York, 189-238.
Jones, R.S.G. (1982). A comparison of the responses of cortical neurones to 
iontophoretically applied tryptamine and 5-hydroxytryptamine in the 
rat. Neuropharmac., 21, 209-
Julius, D., Huang, K.N., Livelli, T.J., Axel, R. and Jessell, T.M. (1990). The
5-HT2 receptor defines a family of structurally distinct but functionally 
conserved serotonin receptors. Proc. Natl. Acad. Sci. USA. 87, 928-932.
Kandel, E.R., and Tauc, L. (1966a). Input organization of two symmetrical 
gaint cells in the snail brain. J. Physiol., 183, 269-286.
Kandel, E.R. and Tauc, L. (1966b). Anomalous rectification in the metacerebral 
gaint cells and its consequences for synaptic transmission. J. Physiol., 
183, 287-304.
Kaumann, A.J., Murray, K.J., Brown, A.M., Sanders, L. and Brown, M.J. (1989). 
A receptor for 5-HT in human atrium. Br. J. Pharmac., 98, 664P.
Kehoe, J. (1972a). Ionic mechanisms of a two component cholinergic 
inhibition in Aplysia neurones. J. Physiol., 225, 85-114.
Kelly, J.S. (1975). Microiontophoretic application of drugs onto single
neurones. In "Handbook of Psychopharmacology" Vol. 2: Principles of 
receptor research eds. L.L. Iversen, S.D. Iversen and S.H. Snyder.
Plenum Press, N ew  York.
Kerkut, G.A. and Laverack, M.S. (1960). A cardio-accelerator present in the 
tissue extracts of the snail Helix aspersia. Comp. Biochem. Physiol., 1, 
62-71.
Kerkut, G.A. and Cottrell, G.A. (1962). Neuropharmacology of the pharyngeal 
retractor muscle of the snail Helix aspersa. Life Sci., 6, 229-231.
122
Kerkut, G.A. and Cottrell, G.A. (1963). Acetylcholine and 5-hydroxy-
tryptanrdne in the snail brain. Comp. Biochem. Physiol., 8, 53-63.
Kerkut, G.A., Walker, R.B. and Woodruff, G.N. (1968). The effect of histamine 
and other naturally occurring imidazoles on neurones of Helix aspersa. 
Br. J. Pharmac., 32, 241-252.
Kerkut, G.A. and Leake, L.D. (1966). The effect of drugs on the snail
pharyngeal retractor muscle. Comp. Biochem, Physiol., 17, 623-633.
Kerkut, G.A., Lambert, J.D.C., Gay ton, R.J., Loker, J.E. and Walker, R.J. (1975). 
Mapping of nerve cells in the suboesophageal ganglion of Helix aspersa. 
Comp. Biochem. Physiol, 50A, 1-25.
Kilpatrick, G.J., Jones, B.J. and Tyers, M.B, (1987). Identification and
distribution of 5-HT3 receptors in rat brain using radiobiological 
binding. Nature, 330, 746-748.
Kiss, T. and S-Rozsa, K. (1973). The role of mono and divalent cations in the 
spike generation of myocardial cells in the snail. Helix pomatia L.
Comp. Biochem. Physiol, 44A, 173-178.
Kiss, T. and S-R6zsa, K. (1978). Pharmacological properties of 5-HT receptors of 
Helix pomatia L. (Gastropoda) heart muscle cells. Comp. Biochem. 
Physiol, 61C, 41-46.
Klein, M. and Kandel, E.R. (1978). Presynaptic modulation of voltage-
dependent Ca^ *^  current: Mechanism for behavioural sensitization in 
Aplysia californica. Proc. Natl. Acad. Sci. USA., 75, 3512-3516.
Kohler, G. and Lindl, T. (1980). Effects of 5-hydroxytryptamine, dopamine and 
acetylcholine an accumulation of cyclic AMP and cyclic GMP in the 
anterior byssus retractor muscle of M ytilus edulis L. (Mollusca).
Pfliigers Arch., 383, 257-262.
*Kunze, H. (1921). Zur Topographie und Histologie des Central
Nervensystems von Helix pomatia L. Z. wiss. Z ool, 68 , 539-566.
Kuo, J.F. and Greengard, P. (1969). Cyclic nucleotide-dependent protein 
kinases. IV. Widespread occurrence of adenosine 3',5’- 
monophosphate-dependent protein kinase in various tissues and phyla 
in the animal kingdom. Proc. Natl. Acad. Sci., 64, 1349-1355.
Lambert, J.J., Peters, J.A., Hales, T.G. and Dempster, J. (1989). The properties of 
5-HT3 receptors in clonal cell lines studied by patch-clamp techniques. 
Br. J. Pharmac., 97, 27-40.
123
Lattimer, N., Rhodes, K.R and Saville, V.L. (1989). Possible differences in
S-HTg-like receptors in the rat and the guinea pig. Br. J. Pharmac., 96, 
270P.
Leake, L.D., Evans, T.G. and Walker, R.J. (1971). The role of catecholamines 
and 5-hydroxytryptamine on the heart of Patella vulgata. Comp. Gen. 
Pharmacol., 2,151-158.
Leake, L.D. and Walker, R.J. (1980). Invertebrate Neuropharmacology. Blackie 
London and Glasgow.
Leff, P. and Martin, G.R. (1988). The classification of 5-hydroxytryptamine 
receptors. Medicinal Res. Rev., 8,187-202.
Lehman, H.K. and Greenberg, M.J. (1987). The actions of FMRFamide-like 
peptides on visceral and somatic muscles of the snail Helix aspersa. J. 
exp. Biol., 131, 55-68.
Leonhardt, S., Herrick-Davis, K. and Titeler, M. (1989). Detection of a novel 
serotonin receptor subtype 5-HT%g in human brain: interaction with a 
GTP binding protein. J. Neurochem., 53, 465-471.
Lesser, W. (1990). Actions and distributions of cardioactive peptides in two 
molluscs. PhD thesis. University of St. Andrews.
Leysen, J.G., Awouters, P., Kennis, P.M., L., Laduron, P.M., Vanderberk, J. and 
Janssen, P.A.G. (1981). Receptor binding profile of R41 468 on novel 
antagonist 5-HT2 receptors. Life Sci., 88, 1015-1022.
Liebeswar, G., Goldman, J.G., Koester, J. and Mayeri, E. (1975). Neural control 
of circulation in Aplysia. III. Neurotransmitters. J. Neurophysiol., 38, 
767-779.
Lloyd, P.E. (1978). Distribution and molecular characteristics of cardioactive 
peptides in the snail Helix aspersa. J. Comp. Physiol., 128, 269-276.
Lloyd, P.E. (1980a). Modulation of neuromuscular activity by 5-hydroxy­
tryptamine and endogenous peptides in the snail. Helix aspersa. J. 
Comp. Physiol., 139, 333-339.
Lloyd, P.E. (1980b). Mechanism of action of 5-hydroxytryptamine and 
endogenous peptides on a neuromuscular preparation. J. Comp. 
Physiol., 139, 341-347.
Loker, J.E., Kerkut, G.A. and Walker, R.J. (1975). An electrophysiological,
pharmacological and fluorescent study of twelve identified neurones 
from the brain of Helix aspersa. Comp. Biochem. Physiol., 50A, 443-452.
124
Loveland, R.E. (1963). 5-hydroxytryptamine, the probable mediator of
excitation in the heart of Mercenaria (Venus) mercenaria. Comp. 
Biochem. Physiol., 9, 95-106.
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein
measurement with the folin phenol reagent. J. Biol. Chem, 193, 265-275.
Mandelbaum, D.E., Koester, J., Schonberg, M. and Weiss, K.R. (1979). Cyclic 
AMP mediation of the excitatory effect of serotonin in the heart of 
Aplysia. Brain Res., 177, 388-394.
Mansour, T.E., Sutherland, E.W., Rail, T.W. and Bueding, E. (1960). The effect 
of serotonin (5-hydroxytryptamine) on the formation of adenosine 3', 
5'-phosphate by tissue particles from the liver fluke. J. Biol. Chem,, 235, 
466-470.
Marchand-Dumont, G. and Baguet, F. (1975). The control mechanism of
relaxation in molluscan catch-muscle (ABRM). Pfliigers Arch., 354, 87- 
100.
McKenna, D.J. and Peroutka, S.J. (1989). Differentiation of 5-hydroxy­
tryptamine receptors subtypes using 125i-R-(_)2, 5-dimethoxy-4-iodo- 
phenylisopropylamine and ketanserin. J. Neurosci., 9, 3482-3490.
Meech, R.W. and Thomas, R.C. (1977). The effect of calcium injection on the 
intracellular sodium and pH of snail neurones. J. Physiol., 265, 867-879.
Middlemiss, D.N. and Fozard, J.R. (1983). 8-hydroxy-2-(di-n-propylamine)
tetraline discriminates between subtypes of the 5-HT% recognition site. 
Eur. J. Pharmac,, 90, 151-153.
Murakami, H., Toshinari, I. and Sano, M. (1986). Pharmacological properties 
of the serotonin receptor in the smooth muscle of M ytilus.  Comp. 
Biochem. Physiol., 84C, 225-230.
Murakami, H., Sano, M., Tsukimura, T. and Yamazaki, A. (1988). The 
relaxation induced by indole and non-indole 5-HT agonists in the 
molluscan smooth muscle. Comp. Biochem. Physiol., 90C, 249-255.
Murray, T.F., Mpitsos, G.J., Sienbenaller, J.F. and Barker, D.L. (1985).
Stereoselective L-[^H]quinuclidinyl benzilate-binding sites in nervous 
tissue of Aplysia californica: Evidence for muscarinic receptors. J. 
Neurosci., 5, 3184-3188.
Nejit, H.C., Te Duits, I.J. and Vijverberg, H.P.M. (1988). Pharmacological 
characterization of serotonin 5-HTg receptor-mediated electrical
125
responses in cultured mouse neuroblastoma cells. Neuropharm., 27, 
301-307.
Nejit, H.C., Plomp, J.J. and Vijverberg, H.P.M. (1989). Kinetics of the
membrane current mediated by serotonin 5-HTg receptors in cultured 
mouse neuroblastoma cells. J. Physiol., 411, 257-269.
Nemcsok, J., Vig, E., Halasy, K., Fekete, E. and Benedeczky, I. (1986)
Localisation and quantitative distribution of biogenic monoamines in 
the intestinal tract of locust, snail and carp. Neurochem. Int., 9, 505-510.
Nishizuka, Y. (1984). The role of protein kinase C in cell surface signal 
transduction and tumour promotion. Nature, 308, 693-697.
Northrop, R.B. (1964). Pharmacological responses of the anterior byssus
retractor muscle of M ytilus  to dopamine, serotonin and methysergide. 
Am. Zool., 4, 423.
Osborne, N.N. and Cottrell, G.A. (1970). Occurrence of noradrenaline and
metabolites of primary catecholamines in the brain and heart of Helix. 
Comp. Gen. Pharmac., 1,1-10.
Osborne, N.N., Hiripi, L. and Neuhoff, V. (1975). The in vitro uptake of 
biogenic amines by snail (Helix pomatia) nervous tissue. Biochem. 
Pharmacol, 24, 2141-2148.
Paciotti, G.F. and Higgins, W.J. (1985). Potentiation of the 5-
hydroxytryptamine-induced increases in myocardial contractility in 
Mercenaria mercenaria ventricle by forskolin. Comp. Biochem.
Physiol, 80C, 325-329.
Painter, S.D. (1982). FMRFamide catch contractures of a molluscan smooth 
muscle: Pharmacology, ionic dependence and cyclic nucleotides. J. 
Comp. Physiol, 148, 491-501.
Payza, K. (1987). FMRFamide receptors in Helix aspersa. Peptides, 8, 1065-1074.
Pedigo, N.W., Yamamura, H.J. and Nelson, D.L. (1981). Discrimination of 
multiple [^H]-5-hydroxytryptamine binding sites by neuroleptic 
spiperane in rat brain. J. Neurochem., 36, 220-226.
Pellmar, T.C. (1981). Does cyclic 3', 5'-adenosine monophosphate act as a 
second messenger in a voltage-dependent response to 
5-hydroxytryptamine in Aplysia. Br. J. Pharmac. 74, 747-756.
Pellmar, J.C. and Wilson, W.A. (1977). Unconventional serotonergic 
excitation in Aplysia. Nature, 269, 76-78.
126
Pellmar, J.C. and Carpenter, D.O. (1979). Voltage-dependent calcium current 
induced by serotonin. Nature, 277, 483-484.
Pellmar, J.C. and Carpenter, D.O. (1980). Serotonin induces a voltage-sensitive 
calcium current in neurons of Aplysia californica. J. Neurophysiol., 44, 
423-429.
Peroutka, S.J. (1988). 5-hydroxytryptamine receptor subtypes: molecular,
biochemical and physiological characterization. Trends Neurosci., 11, 
496-500.
Peroutka, S.J. and Snyder, S.H. (1979). Multiple serotonin receptors: 
differential binding of [^H] lysergic acid diethylamide and [^H] 
spiperidol. Mol. Pharmacol., 16, 687-699.
Peters, J.A. and Usherwood, P.N.R. (1983). 5-hydroxytryptamine responses of 
neuroblastoma cells: ions and putative antagonists. Br. J. Pharmacol., 
80,523P.
Peters, J.A., Hales, T.G. and Lambert, J.J. (1988). Divalent cation modulate
5-HT3 receptor-induced currents in NIE-115 neuroblastoma cells. Eur. J. 
Pharmac., 151i491-495.
Phillis, J.W. (1966). Regulation of rectal movements in Tapes watlingi. Comp. 
Biochem. Physiol., 17, 909-928.
Pierce, P.A. and Peroutka, S.J. (1989). The 5-hydroxytryptamine receptor 
families. The Neurosciences, 1, 145-153.
Price, D.A. and Greenberg, M.J. (1977). Structure of a molluscan 
cardioexcitatory neuropeptide. Science, 197, 670-671.
Price, D.A., Cottrell, G.A., Doble, K.E., Greenberg, M.J., Jovenby, W., Lehman, 
H.K. and Riehm, J.P. (1985). A novel FMRFamide-related peptide in 
Helix: pQDPFLRFamide. Biol. Bull., 169, 256-266.
Pritchett, D.B., Bach, A.W.J., Wozny, M., Taleb, O., Dal Tosa, R., Shih, J.C. and 
Seeburg, P.H. (1988). Structure and functional expression of cloned rat 
serotonin 5-HT2 receptor. EMBO, 7, 4135-4140.
Prosser, C.L. (1940). Acetycholine and nervous inhibition in the heart of
Venus mercenaria. Biol. Bull. Mar. biol. Lab., Woods Hole, 78, 92-102.
Ramsay, J.A. (1940). A nerve-muscle preparation from the snail. J. exp. Biol, 
17,96-115.
Rapport, M.M. (1949). Serum vasoconstrictor (serotonin). V. The presence of 
creatinine in the complex. A proposed structure of the vasoconstrictor 
principle. J. Biol. Chem., 180, 961-969.
127
Rapport, M.M., Green, A.A. and Page, I.H. (1948). Serum vasoconstrictor
(serotonin). VI. isolation and characterization. J. Biol. Chem., 176, 1243- 
1251
Richardson, B.P., Engel, G., Donatsch, P. and Stadler, P.A. (1985). Identification 
of serotonin M-receptor subtypes and their specific blockade by a new  
class of drugs. Nature, 316,126-131.
Richardson, B.P. and Engel, G. (1986). The pharmacology and function of 
5-HTg receptors. Trends Neurosci., 9, 424-428.
*Ripplinger, J. (1957). Contribution à l'étude de la physiologie du coeur et son 
inervation extrinsique chez l'escargot {Helix pomatia). Ann. Sci. univ., 
Besançon. Zool. et Physiol., 8, 3-179.
"^Ripplinger, J. and Ripplinger, T. (1975). L'electrogramme ventriculaire de 
l’escargot (Helix pomatia) au cours d'inhibition vagale. C.R. Hebd. 
Seances. Acad. Sci. Ser., D 281, 283-286.
Roberts, M.H.T. and Straughan, D.W. (1967). Excitation and depression of 
cortical neurones by 5-hydroxytryptamine. J. Physiol., 193, 269-294.
S-Rôzsa, K. and Perényi, L. (1966). Chemical identification of the excitatory
substance released in Helix heart during stimulation of the extracardial 
nerve. Comp. Biochem. Physiol., 19, 105-113.
Sanger, J.W. (1979). Cardiac fine structure in selected arthropods and molluscs. 
Am. Zool., 19, 9-27.
Satchell, D.G. and Twarog, B.M. (1978). Identification of 5-hydroxytryptamine 
(serotonin) released from the anterior byssus retractor muscle of 
M ytilu s  californianus in response to nerve stimulation. Comp. 
Biochem. Physiol., 59C, 81-85.
Sato, M., Tanasige, M. and Ozeki, M. (1960). Electrical activity of the retractor 
pharynx muscle of the snail. Jap. J. Physiol., 10, 85-98.
Sawada, M., Ichinose, M., Ito, I., Maeno, T. and McAdoo, D.J. (1984). Effects of 
5-hydroxytryptamine on membrane potential, contractility, 
accumulation of cyclic AMP, and Ca^+ movements in anterior aorta 
and ventricle of Aplysia. J. Neurophys., 51, 361-374.
Seamon, K.B. and Daly, J.W. (1982). Forskolin a unique diterpene activator of 
cyclic AMP-generating systems. J. cycl. Nucl., Res., 7, 201-224.
Sedden, C.B., Walker, R.J. and Kerkut, G.A. (1968). The localization of
dopamine and 5-hydroxytryptamine in neurones of Helix aspersa.
Symp. Zool. Soc. (Lond), 22,19-23.
128
Sills, M.A., Wolfe, B.B. and Frazer, A. (1984). Determination of selective and 
non-selective compounds for the 5-HT%^ and 5-HT%g receptor subtypes 
in rat frontal cortex. J. Pharmac. exp. Ther., 231, 480-487.
Smith, P.A. and Walker, R.J. (1974). The action of 5-hydroxytryptamine and 
related compounds on the activity of Retzius cells of the leech, Hirudo 
medicinalis. Br. J. Pharmac., 51, 21-27.
Sorokin, L.V. (1986). Influence of serotonin on acetylcholine-induced
contractions of smooth muscle of the pharyngeal retractor of the snail. 
Helix pomatia. J. Evol. Biochem. Physiol., 21, 160-163.
Sperelakis, N. (1984). Hormonal and neurotransmitter regulation of Ca^+ 
influx through voltage-dependent slow channels in cardiac muscle 
membrane. Membrane Biochem., 5, 131-166.
Stahl, W.L., Neuhoff, V. and Osborne, N.N. (1977). Role of sodium in uptake 
of 5-hydroxytryptamine in Helix ganglia. Comp. Biochem. Physiol., 56C, 
13-18.
Stefani, E. and Gerschenfeld, H.M. (1969). Comparative study of acetylcholine 
and 5-hydroxytryptamine receptors on single snail neurones. J. 
Neurophysiology, 32, 64-74.
Sternweis, P.C. and Pang, L.H. (1990). The G protein-channel connection. 
Trends Neurosci., 13, 122-126.
Sumner, M.J., Feniuk, W. and Humphrey, P.P.A. (1989). Further
characterization of the 5-HT receptor mediating vascular relaxation and 
elevation of cyclic AMP in porcine isolated vena cava. Br. J. Pharmac., 
97,292-300.
Sutherland, E.W. and Robison, G.A. (1966). Metabolic effects of
catecholamines. A. The role of cyclic- 3', 5-AMP in response to 
catecholamines and other hormones. Pharmac Rev., 18, 145-161.
Tada, M. and Kirchberger, M.A. (1975). Regulation of calcium transport by 
cyclic AMP. A possible mechanism for the beta-adrenergic control of 
myocardial contractility. Acta Cardiol., 30, 231-237.
Trevethick, M.A., Feniuk, W. and Humphrey, P.P.A. (1986). 5-carbox-
amidotryptamine: a potent agonist mediating relaxation and elevation 
of cyclic AMP in the isolated neonatal porcine vena cava. Life Sci., 38, 
1521-1528.
129
Twarog, B.M. and Page, I.H. (1953). Serotonin content of some mammalian
tissues and urine and a method for its determination. Amer. J. Physiol., 
175,157-161.
Twarog, B.M. (1954). Responses of a molluscan smooth muscle to
acetylcholine and 5-hydroxytryptamine. J. Cell Comp. Physiol., 46,439- 
476.
Twarog, B.M. (1959). The pharmacology of a molluscan smooth muscle. Br. J. 
Pharmacol,, 14, 404-407.
Twarog, B.M. (1960a). Innervation and activity of a molluscan smooth 
muscle. J. Physiol., 152, 250-235.
Twarog, B.M. and Cole, R.A. (1972). Relaxation of catch in a molluscan 
smooth muscle - II. Effects of serotonin, dopamine and related 
compounds. Comp. Biochem. Physiol., 43A, 331-335.
Twarog, B.M., Muneoka, Y. and Ledgere, M. (1977). Serotonin and dopamine 
as neurotransmitters in M ytilus: Block of serotonin receptors by an 
organic mercurial. J. Pharmac. Exp. Ther., 201, 350-356.
Udenfriend, S., Lovenberg, W. and Sjoerdsman, A. (1959). Physiologically 
active amines in common fruits and vegetables. Arch. Biochem. and 
Biophys., 85, 487-490.
Van Neuten, J.M., Schuurkes, J.A.J., De Ridder, W.J.E., Kuyps, J.J.M.D. and
Janssen, W.J. (1986). Comparative pharmacological profile of ritanserin 
and ketanserin. Drug Development Res., 8, 187-195.
Vandermaelen, C.P. (1985). Serotonin. In "Neurotransmitter actions in the 
vertebrate nervous system" eds. M.A. Rogawski and J.L. Barker.
Plenum Press, N ew  York.
Vane, J.R. (1959). The relative activities of some tryptamine analogues on the 
isolated rat stomach strip preparation. Br. J. Pharmac., 14, 87-98.
Venter, J.C., Porzio, U.D., Robinson, D.A., Shreeve, S.M., Lai, J., Kerlavage, 
A.R., Fracek, S.P., Lentes, K-U. and Fraser, C.M. (1988). Evolution of 
neurotransmitter receptor systems. Prog. Neurobiol., 30, 105-169.
Von Wachtendonk, D. and Kappler, M. (1977). Amino acids and biogenic 
amines in smooth muscles and hemolymphs of different molluscs. 
Comp. Biochem. Physiol., 56C, 19-24.
Wabnitz, R.W. and Von Wachtendonk, D. (1976). Evidence for serotonin (5- 
hydroxytryptamine) as transmitter in the penis retractor muscle of Helix 
pomatia L. Experentia, 32, 707-709.
130
Walker, R.J. (1985). The pharmacology of serotonin receptors in invertebrates. 
In "Neuropharmacology of Serotonin" ed A.R. Green. Oxford 
University Press.
Walker, R.J. and Woodruff, G.N. (1972). The effect of bufotenin, metatonin 
psilocybin and related compounds on the 5-hydroxytryptamine 
excitatory receptors of Helix aspersa neurones. Comp. gen. Pharmac., 3, 
27-40.
Weinreich, D., McCaman, M.W., McCaman, R.E., and Vaughn, J.E. (1973). 
Chemical, enzymatic and ultrastructural characterization of 
5-hydroxytryptamine-containing neurons from the ganglia of Aplysia  
californica and Tritonia diomedia. J. Neurochem., 20, 969-976.
Welsh, J.H. (1943). Acetylcholine level of rat cerebral cortex under conditions 
of anoxia and hypoglycoma. J. Neurophysiol., 6, 326-336.
Welsh, J.H. (1953). Excitation of the heart of Venus mercenaria. Archs. exp. 
Path. Pharmak., 219, 23-29.
Welsh, J.H. (1954). Hydroxytryptamine: a neurohormone in the invertebrates. 
Fedn. Proc. Am. Soc. exp. Biol., 13,162-163.
Welsh, J.H. (1968). Distribution of serotonin in the nervous system of various 
animal species. Adv. Pharmacol. 6A, 171-188.
Welsh, J.H. and Moorhead, M. (1960). The quantitative distribution of
5-hydroxytryptamine in the invertebrates especially in their nervous 
systems. J. Neurochem., 6, 146-169.
Werman, R. (1966). A review and criteria for identification of a central 
nervous system transmitter. Comp. Biochem. Physiol., 18, 745-766.
Wilkens, L.A. and Greenberg, M.J. (1973). Effects of acetylcholine and
5-hydroxytryptamine and their ionic mechanisms of action on the 
electrical and mechanical activity of molluscan heart smooth muscle. 
Comp. Biochem. Physiol., 45A, 637-651.
Wilson, W.A. and Goldner, M.M. (1975). Voltage clamping with a single 
microelectrode. J. Neurobiol., 6, 411-422.
Wollemann, M. and S-R6zsa, K. (1975). Effects of serotonin and
catecholamines on the adenylate cyclase of molluscan heart. Comp. 
Biochem. Physiol., 51C, 63-66.
Yavari, P., Walker, R.J. and Kerkut, G.A. (1979). The effect of d-tubocurarine 
on the responses of snail neurons to ACh, 5-HT, glutamate and
131
dopamine - receptors or ionophores? Comp. Biochem. Physiol., 64C, 
101-114.
York, B. and Twarog, B.M. (1973). Evidence for the release of serotonin by
relaxing nerves in molluscan muscle. Comp. Biochem. Physiol., 44A, 
423-430.
’*■ References not seen in original form.
132
